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ABSTRACT 
Nuclear pre-mRNA splicing in eukaryotes involves the removal of the intervening 
sequences (introns) from pre-messenger RNA by a two-step trans-esterification 
mechanism. This process occurs on a large ribonucleoprotein particle called the 
spliceosome, which consists of five small nuclear RNAs (snRNAs) and a number of 
protein factors. The spliceosome is a highly dynamic machine and over fifty known 
protein factors mediate its assembly and function. 
One of these protein factors in the yeast Saccharomyces cerevisiae is Prp45p (the 
name derived from its involvement in pre-mRNA processing). The 42kDa Prp45p is 
essential for pre-mRNA splicing. It was previously shown that Prp45p is associated 
with an Ntc-protein complex and directly interacts in vivo with the splicing factor 
Prp46p, another member of this protein complex. Apart from this, in recent years, 
extensive research was done for the homologues of Prp45p in human and Drosophila 
melanogaster regarding the role of these proteins as regulators of transcription in 
different pathways. 
In this study we aimed to understand the role Prp45p executes within the 
spliceosome and the splicing mechanism. Part of this work was a detailed 
investigation into the relationships between the structure and the function of this 
protein by employing a screen for temperature-sensitive mutants. 
Prp45p is known to associate with the spliceosome throughout the splicing reactions 
but at what stage the protein is involved in spliceosome assembly i.e. pre-
spliceosome, inactive or active spliceosome remained to be determined. Using a 
PRP45 conditionally regulated strain it was found, upon depletion of Prp45p from 
yeast cells and analysis of the in vitro splicing systems by native gel fractionation, 
that the formation of the active spliceosome does not take place. This behaviour is 
compatible with Prp45p being a component of the Ntc-protein complex, which is 
known to be involved in this step of spliceosome assembly. Moreover, co- 
immunoprecipitation experiments with a tagged allele of the splicing factor Prp46p, 
confirmed the interaction between these two proteins suggested by two-hybrid 
screens. 
Using random PCR mutagenesis there were identified two mutants with growth 
defects at 37C. The mutants, named prp45-57 and prp45-113, contained mutations 
in two regions, designated A and B and located respectively upstream and, 
downstream of the absolutely conserved SNWKN motif. To understand which of the 
mutations were responsible for the temperature-sensitive phenotype, the substitutions 
in region A and/or region B were recreated by site-directed mutagenesis. It was 
proved that the phenotype requires mutations in both segments, which strongly 
suggests that regions A and B together play roles in protein function, perhaps through 
intra- or inter-protein interactions. However, co-immunoprecipitation experiments 
revealed that these substitutions in Prp45p do not alter the interaction with Prp46p in 
vitro. In order to investigate the role of these mutations within the cell, two strains 
were created that carry these mutations in a c-Myc tagged PRP45 ORF. When 
growing these strains at non-permissive temperature and employing a 0-
galactosidase assay, it was found that they had a mild effect on pre-mRNA splicing 
and do not affect the transcription/translation of the reporter genes. These results 
were confirmed by microarray analysis and by Northern blotting showing that introns 
are not accumulating but the intron-encoded snoRNA species do. This indicates that 
Prp45p could be involved in other metabolic processes like pre-mRNA turnover. 
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Chapter 1: Introduction 
1.1 Pre-mRNA splicing 
In 1977 it was discovered that most of the nuclear protein-coding genes are 
discontinuous, being interrupted by non-coding intervening sequences known as 
introns (Berget et al, 1977; Chow et a!, 1977; Abelson, 1979). All the information 
within the genes, including introns, is transcribed into pre-mRNA. Then, the introns 
are excised within the nucleus and the coding sequences or exons are joined to form 
the mature mRNA that is subsequently exported to the cytoplasm. This process is 
called pre-mRNA splicing and since then intensive research has been performed to 
understand its molecular mechanism. 
The use of either nuclear extract of HeLa cells or whole extract of yeast cells 
has facilitated the understanding of the catalytic mechanism of splicing and the 
biochemistry of the cellular components of this process. However, although the 
basics are the same, there are a lot of differences among eukaryotes from the number 
and size of introns and exons to the function and organisation of the splicing 
machinery. For instance, in higher eukaryotes, a gene can contain more than 50 
introns and the introns can have up to 200,000 nucleotides in length. In contrast, in 
the unicellular eukaryote Saccharomyces cerevisiae (referred to here as a yeast) only 
4% of the 6000 genes have introns (most of them having only one) with an average 
size of 600 nucleotides. 
There are some important traits of splicing conserved among yeast and higher 
eukaryotes (Ruby et al., 1991). Firstly, the molecular organisation of the introns. 
These are: three short conserved sequences required for splicing: the 5'splice site 
(5'SS), the 3'splice site (3SS) and the so-called branchpoint sequence (BP) (Figure 
1.1). In yeast these sequences are strongly conserved while in mammalian cells they 
are less conserved. The also contain a pyrimidine-rich region (PY)n  upstream of 
3'splice site. 
2 
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Saccharomyces cerewsiae 
5 Splice 	 3 Splice 
Site 	 Branchpolnt 	Site 
I 	 I 	 I____ 
EXON GUAUGU _UACUAAC_(Y) -YAGI 	EXON 
Mammals 
5 Splice 	Brancripoint 	3 Splice 
Site 	 Site 
I II____ 
EXON GURAGU—YNYRY— (Y)—YAG 	EXON 
Figure 1.1 Schematic representation of the conserved sequences within the 
introns in S. cerevisiae and mammals. 
The three sequence elements : the 5' splice site, the branchpoint and the 3' splice site 
are indicated. (Y) 1 represents the polypyrimidine tract, Y-pyrimidine. R-purine, N-
any base. 
A second common feature between all eukaryotes is the chemistry of the 
splicing reaction: an ATP-dependent process consisting in two successive trans-
esterification reactions (Figure 1.2). In the first step the 2'OH group of a specific 
adenosine, the branchpoint nucleotide, attacks the phosphate at the 5'splice site. In 
the second step the 3'OH group of the S'exon attacks the phosphate at the 3' splice 
site resulting in the ligation of the two exons. The intron is liberated and degraded. 
3 
5 1 SS 	 BP 	3'SS 
pre-mRNA EXON t_FGU 	2A—AG"{ EXON2 	kH 




Intermediates r EXON 1 -0+'-.. A' G' 	EXON 2 	-OH 
lariat 
Iu 
CAO Products - 
4, Second trans-esterification (Step 2) 




Figure 1.2 Catalytic steps of nuclear pre-mRNA splicing. 
Exons are shown as boxes and the intron as a line. The dashed arrows symbolise the 
nucleophylic attack of the hydroxyl groups at the splice site. 
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1.2 The spliceosome 
1.2.1 Spliceosome Components 
Nuclear pre-mRNA splicing requires the formation of a large, dynamic 
ribonucleoprotein complex, the spliceosome. This is composed of small nuclear 
ribonucleoprotein (snRNP) particles and non-snRNP protein factors. Five small 
nuclear RNA molecules (UI, U2, U4, U5 and U6 snRNA) associate with numerous 
proteins to form spliceosomal snRNPs. Regarding these snRNA-associated proteins, 
they can be classified into two groups. One consists of core or Sin proteins (B. D 1 , 
D2, D3, E, F and G as they were originally named in metazoa) shared by UI, U2, U4 
and U5 snRNPs but not by the U6 snRNP; b) proteins specific for a certain snRNP 
(Will et al., 1997). 
The pathways by which snRNPs are formed are evolutionarily highly 
conserved in eukaryotes although there are differences between U6 snRNP 
biogenesis and the other four snRNPs (for review, Will and Luhrmann, 2001). First 
of all, Ui, U2, U4, and US snRNAs are transcribed by RNA polymerase II and are 
5'end capped (7-methyl guanosine cap structure) and then exported to the cytoplasm 
where they associate with the core proteins. The Sm/core proteins form a ring-like 
structure that binds through a specific amino acid motif (Sm motif) to the conserved 
Sm-site present in all these snRNAs (Lazar et al., 1982). This association promotes 
hypermethylation of the snRNA cap structure and 3'end processing. In addition to 
this, the U snRNAs are internally modified before their association with proteins. 
These chemical modifications consist of 2'-O-methylation of ribose moieties and 
pseudouridylation (Yu et al., 1998) and, at least for US snRNA, they are generated 
by small nucleolar RNP (snoRNPs) particles (Jady and Kiss, 2001). SnoRNPs are 
nucleolar particles composed of snoRNAs and associated proteins and some are 
known to be needed for processing of ribosomal RNA, like cleavage, 2'-0-
methylation and pseudouridylation. After the addition of the snRNP-specific proteins 
the newly assembled snRNP is imported into the nucleus where it contributes to the 
5 
Chapter 1: Introduction 
spliceosome assembly and/or splicing reaction. 
As for U6 snRNP, its snRNA is transcribed by RNA polymerase III, acquires a 
different 5' cap (y - monomethyl cap structure) and does not present the Sm-binding 
site. As a consequence, U6 snRNA undergoes processing pathways different from 
the other spliceosomal snRNA, i.e. it is not exported into the cytosol and 
hypermethylated I associated with Sm proteins. However, sequence similarities and 
biochemical analyses (Fromont-Racine et al., 1997) led to identification of nine 
proteins that contain the Sm motif. Therefore they were called Sm-like proteins or 
Lsm proteins. Seven of these assemble ring like-structures (Achsel et al., 2001) that 
perform different functions within the cell (Mayes et al., 1999). Thus, Lsm2-8p is 
involved in pre-mRNA splicing, U6 accumulation, U6 snRNP biogenesis, and in 
processing and stability of stable RNAs, including rRNA (Mayes et al., 1999; 
Salgado-Garrido ci al., 1999; Kufel et al., 2003) while Lsml-7p complex functions 
in cytoplasmic mRNA degradation promoted by mRNA decapping (Boeck et al., 
1998; Tharun et al., 2000). U6 snRNA is also pseudouridylated and 2'-O-methylated, 
processes catalysed by snoRNPs (Ganot ci al., 1999). 
1.2.2 Spliceosome Assembly 
Spliceosome assembly is an ordered, dynamic process, which involves multiple 
RNA-RNA, RNA-protein and protein-protein interactions. The earliest step in 
spliceosome assembly is the binding of Ui snRNP to the 5'splice site of the pre-
mRNA in an ATP-independent manner (Figure 1.3). The complex formed - 
commitment complex (CC) or early complex (E) - is very stable due to the base-
pairing interactions between complementary sequences of Ul snRNA and the 
conserved 5' splice site. This commitment complex triggers the addition of U2 
snRNP and its binding via Watson-Crick base pairing with the branchpoint sequence. 
The new complex is called pre-spliceosome/complex A/complex III. The 
branchpoint adenosine (UACUAC) is excluded from this base-pairing and thus it is 
activated for the specific attack of the 5'splice site. 
n. 
Ui 









111~ PI . 
	

























Figure 1.3 Schematic spliceosome assembly pathway. 
U 1 snRNP binds to the 5' splice site (5' SS) to form the commitment complex (CC). 
U2 snRNP binds to the branchpoint (BP) to form the pre-spliceosome. Pre-formed 
U4/U6.U5 tri-snRNP associates to form the inactive splicing complex. This loses the 
U I and U4 snRNPs and turned into an active spliceosome able to perform the two 
steps of splicing. The trans-esterification reactions finished, mature mRNA is 
released and spliceosome components are dissembled and then recycled. The intron 
lariat product is linearized by debranching enzyme and degraded. 
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Subsequently, the pre-formed U4/U6.U5 tri-snRNP and other non-snRNP 
factors are incorporated to create a complex that is unable to support splicing and 
thus denominated inactive spliceosome/complex B/complex II. The spliceosome now 
undergoes a conformational rearrangement which involves the formation of new 
and/or rearrangement of existing protein-RNA and RNA-RNA interactions. For 
instance, U41U6 and Ui snRNA-S'splice site basepairing are destabilised and RNA-
RNA interactions between U2 snRNA and U6 snRNA promote the formation of the 
catalytic centre of splicing (Madhani and Guthrie. 1992; Field and Friesen. 1996). 
This step of the cycle produces the active spliceosome (or complex C/Il), which 
performs the two trans-esterifi cation reactions. The US snRNA also plays a role in 
both steps of splicing reaction. The highly conserved loop in the US snRNA 
molecule interacts with exon sequence at the 5' and the 3' splice sites. In this way the 
U5 loop probably aided by U5 snRNP proteins such as Prp8p can anchor and tether 
the 5'exon splicing intermediate produced by the first transesterification, and then 
assist the alignment of the 5' and the 3' exons for the second catalytic step (Newman 
and Norman. 1992; Sontheimer and Steitz, 1993; Newman, 1997; Dix et al., 1998). 
The two reactions completed, the spliced rnRNA is released, the spliceosome 
disassembles and the snRNPs and non-snRNP proteins can reassemble onto other 
pre-rnRNA molecules. 
However, recent studies promote another theory, namely the existence of a 45S 
penta-snRNP complex comprising all five snRNAs and the associated proteins, 
which binds the pre-rnRNA substrate as a whole rather than discrete particles as 
previously described (Stevens and Abelson, 2002). This complex was purified from 
yeast extract at low salt concentration (50 mM) compatible with the in vitro splicing 
conditions in contrast with the previous studies in which snRNP particles have been 
analysed under higher salt concentrations (150 - 250 mM) that could destabilise the 
complex. This model suggests that pre-mRNA interacts with the pre-formed pentra-
snRNP, the subsequent steps being the traditional ones: the 5' splice site base pairing 
to the Ui snRNA and the branchpoint binds to the U2 snRNA, followed by the 
displacement of Ui snRNA by 5' splice-site - U6 snRNA interaction. Alternatively, 
a discrete U I snRNP initially interacts with pre-mRNA substrate and the preformed 
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tetra-snRNP complex is recruited and the assembly and subsequent splicing reactions 
proceed as usual. 
Concurrent with spliceosome assembly, activation, chemical modification of the pre-
mRNA substrate, then mRNA release, there are important alterations in the 
constituents and conformation of the spliceosome. It is believed that ATP hydrolysis 
drives these rearrangements of RNA-RNA and RNA-protein interactions (for review. 
see Staley and Guthrie, 1998; Schwer, 2001). Some proteins required for pre-rnRNA 
splicing possess a set of sequence motifs conserved among ATPases. The proteins 
proposed to play such a role in splicing belong to so-called the DEAD/H-box protein 
family. This family of proteins is defined by the presence of eight conserved 
domains, one of which is the DEAD/H motif responsible for ATPase function while 
another, the SAT domain, plays a role in RNA unwinding. This is the reason why 
these proteins are thought to be RNA-dependent ATPases and ATP-dependent RNA 
helicases, although the latter role has been experimentally proved only for some 
members of the family. Each of these factors is involved in a different stage of the 
splicing cycle (Lin el al., 1987; Burgess et al., 1990; Chen and Lin, 1990; Company 
ci al., 1991; Schwer and Guthrie. 1991; Arenas and Abelson, 1997). 
Thus Prp28p is involved in unwinding the Ul-5'splice site sequence (Chen ci 
al.. 2001) while Brr2p is believed to unwind the U4/U6 duplex (Raghunathan et al., 
1998), both events are leading towards the activation of the spliceosorne. 
ATP hydrolysis by Prp2p is required for activation of the spliceosome prior to 
the step I trans-esterification (Kim et al., 1996). This hydrolysis is followed by a 
change in the pre-mRNA structure promoting the first splicing reaction. The 
specificity of its action might be controlled by Spp2p which can act as a mediator 
between Prp2p and the spliceosome (Roy et al., 1995). 
The 121 kDa Prpl6p is essential for step 2 (Schwer and Guthrie. 1991). 
Importantly, purified Prpl6p has been shown to exhibit ATP-dependent RNA 
helicase activity in vitro (Wang ci al., 1998). ATP hydrolysis by Prpl6p elicits a 
conformational change in the spliceosome that results in protection of the 3'splice 
site from RNase H prior to the second transesterification reaction (Schwer and 
Guthrie, 1992). To induce the conformational changes, Prpl6p needs the recruitment 
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of splicing factors Slu7p, Prpl 8p and Ssfl to the spliceosome (Ansari and Schwer, 
1995; Brys and Schwer, 1996). Slu7p and Prpl 8p are required in 3' splice site 
selection especially when the distance between the branchpoint and the 3'splice site 
is longer than 12 nucleotides (Brys and Schwer. 1996; Zhang and Schwer, 1997). 
Prp43p was originally discovered as a DEAH-box protein sharing sequence 
homology with the Prp2p, Prpl6p and Prp22p. It was shown that Prp43p is involved 
in disassembly of the spliceosome after the release of mature mRNA (Arenas and 
Abelson, 1997; Company el al., 1991). 
Prp22p (130 kDa) was first isolated in a screen for temperature-sensitive 
mutants in pre-mRNA splicing (Vijayraghavan et al., 1989). Two different roles 
have been proposed for the functions of Prp22 protein. Firstly. Prp22p is required for 
the release of mRNA from the spliceosome after the second step of splicing. 
Experiments using nuclear extracts from a prp22-1 temperature-sensitive strain 
showed the retention of the niRNA and intron-lariat products of splicing within the 
spliceosome parallel with the accumulation of unspliced pre-mRNA (Schwer and 
Gross, 1998; Company et al., 1991). It is thought that ATP hydrolysis by Prp22p 
determines rearrangements within the spliceosome and drives the release of mRNA 
from the complex by disrupting RNA-RNA interactions (Schwer and Gross, 1998). 
Secondly, Prp22p is required during the second step of splicing in an ATP-
independent manner. The involvement of the protein is necessary only when the 
distance between the branchpoint and the 3' splice site is longer than 21 nucleotides 
(Schwer and Gross. 1998). It has been suggested that Prp22p acts in concert with 
SIu7p and Prpl8p to protect the 3' splice site from the activity of RNase H and 
further to position for catalysis the 3' splice site PyAG and the 3'OH terminus of the 
S'exon (Schwer and Gross, 1998). Using crosslinking analysis it was determined that 
Prp22p transiently contacted the 3' splice site between the first and the second step of 
splicing and this association is dependent on Prpl6p (McPheeters et al., 2000). 
Following the discovery of the splicing process, many experimental lines were 
followed to identify the components of spliceosomal machinery and their functions. 
In yeast the use of genetic analyses like random screens for temperature/cold-
sensitive mutants, two-hybrid screens, suppressor screens or synthetic lethal screens 
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led to identification of many splicing factors (for review, see Beggs, 1995 and 
references therein). Sophisticated proteomic analyses of yeast and mammalian cell 
extracts have been developed in recent years. They involve affinity purification of 
protein/ spliceosome/snRNP complexes using well-characterized and tagged splicing 
factors or pre-mRNA substrates, followed by mass spectrometry to identify the 
protein components (Ohi et al.. 2002; Jurica et al., 2002: Makarov et al.. 2002: 
Stevens and Abelson, 2002). 
One of the splicing factors identified by two-hybrid screens and then by biochemical 
analyses is Prp45p and this is the subject of the present work. 
1.3 Prp45 Protein 
1.3.1 Prp45p Structure 
The PRP45 gene was first identified in a screen for essential genes on chromosome I 
in S. cerevisiae and named Fun20 (Fun = functionunknown) (Diehl and Pringle. 
1991). PRP45 is essential for cell viability, as shown by Diehl and Pringle, 1991 and 
confirmed by Albers et cii.. 2003. 
The 379 amino acid Prp45p has a molecular weight of 42.4 kDa and a 
hydrophilic character. Due to its amino acid sequence within the N-terminal/central 
region, Prp45p was assigned to be a member of the SNW protein family found in 
many eukaryotes from the simple parasite Encephalitozoon cuniculi to human. The 
name of this family derived from a sequence, SNWKN, which is highly conserved 
among the members with the exception of E. cuniculii in which the asparagine 
residue (N) substituted with methionine (M) (Figure 1.4). The conserved nature of 
this motif does not confer specific function to the protein, at least in yeast, as 
Martinkova c/ al. (2002) showed that the substitution of the SNW residues 
(17OSNWI72) with triple alanine was compatible with cell viability. 
iiJ 
P. falciparum 1 ----MTDFLRNIPKPKKKAYDDEN 	- ELHDFKESNNSIKKKEEIKKXNQCYEILK 
P.yoelii 1 ---- MTEFLRNI.KKKXTYD ----------- IDENEVSPKQINTKDETKK--QCYQLK 
A. thaliana 1 ----- MKSLNDAKSTTTTYYD ---- HSNDAWFKNRVTESETVKSSSIKFKVvPArLN 
H.vulgare 1 ------------------------------------------------------------ 
D.melanogaster 1 ----- MS:SSLLPTPTNAIWRED ---- ERR --- LVARGAPKIGALVSAK--IAAPPYGQ 
A. garnbiae 1 ----- MSISTVIPAPSNPVDRDD ---- ERK --- MKT --- PSNGALVSAK--VAAPPYGQ 
H.sapiens 1 ----- MALTSFLiATQLSQDQLE ---- AEE --- KARSQRSRQTSLVSSR--REPpPGY 
M.musculus 1 -----HkLTSFLPAFTQLSQDQLE ---- AEE --- RARSQRSLQTSLVSSR--REPPPYGY 
S.japonicuxn 1 ------------------------------------------------------------ 
C. elegaris 1 --- MSRDILPAVADEAASQ ---- IRDPWFGGRDNEPSAALVS ---- KEpPPYCK 
N. crassa 1 MASIAAG:SQALPKKYSGEYEES ---- KSQQRGPRIVGAGQIDETQVVLRRTGPPPYGN 
S.pombe 1 MALLSEELSSILNIDFDDEEEDY ---- VERETS ------- HADERQIGVKFHIPP-GQ 
D.discoideuni 1 ---- MTSSSLKKNVYSNEEEDPLFQPKPKPQQQKQQQQQQQELNDKPKKVJ T:GN 
S.cerevisiae 1 ------ MFSNRLPPK -------------------------------------------- 
E.cunicuii 1 ------------------------------------------------------------ 
P.falciparuxn 50 PRHLRITCNEDFQGGGAYPEIH1iN..1?NNIGLKSDNiNN --------------- IVLKYI 
P.yoelii 44 QYLRISCNSDFQDGGAYPEIHINi?NNr;LNGKKNN --------------- IVFKYI 
A. thaliana 52 -QGLRPKNPEDFGDGGAFPEIHLPçYPLL14:;K1KsN PG-------------AKTLPVTV 
H.vulgare 1 -------------------------------------LG-------------SKILALTV 
D.melanogaster 47 iKDWVPHTDADFGDGGAFPEIHVA2VPLGL1;APGNVGKK ------------- SDALAVRL 
A. gambiae 44 KGWI PRTDADFGDGGAFPEIHVA;PLGM:;APGNASKK-------------SNALAVQL 
H.sapiens 47 PKGWIPRLLEDFGDGGAFPEIHVAQ'fpLDNpJ(---I(M ------------- SNAAIQV 
M.musculus 47 RKGWIPRLLEDFGDGGAFPEIHVAQYPLDMJRK---:XN ------------- SNALAIQV 
S.japonicum 1 ----------------------------- IEE --- FNV ------------- SNAEVMKT 
C. elegans 50 iTSFRPRGPEDFGDGGAFPEIHVAQFPLGL;LGDMRGKP ------------- ENTLALQY 
N.crassa 57 FQGWRPRAPEDFGDGGAFPEIPVAp--WKDASN:S --------------- NALVVQV 
S. pombe 49 FKGwFPSSPEDFGDGGAFPEIHVA:pLDMRKRSAySA ------------- GNTLALQV 
D.discoideum 57 PKGYLPKNIEDFGDGGAFPEIHIVPr D" RKGKST - SSNSNTSNMNGGGTTTSIVPVSV 
S.cerevisiae 11 --------------------------------------------------------HSQG 
E.cuniculi 1 ------------------------------------------------------------ 
P. falciparum 95 ENNif XYDNLIN.QIHIYNNEIDKIEPNERINKLRKKKILSDTKDREKYNEPTYKPNN 
P .yoeiii 89 :1 ENNNK'DNLINESVHIYNNNIDMIETNESIKKLRKKKILsQAEDRE:KyNDAIyKpsE 
A. thai iana 99 --AQ NVFDA IV} NENSRKIV 	QHK II KFLKNEG-DLGTVDEE:ELQKEIQTAE 
H. vuigare 11 AH :5 AFLAV\JK. 	ENAKKIV:. KHST IVPKIATAD-----SEAVEDEEYEKLVEETTE 
D.meianogaster 94 LJDKKVKYDATAF HGKDKIV: SISQLLPAEVLAED-ADELQRPDEE ---- TVMTTF 
A. gambiae 91 DQTLKVXYDAIA. HSKDKIV 	NINQLLPAEVLAED-SEELQNPDQE ---- TIN:I: 
H. sapiens 91 DSE'KIK?DAIAF. QSKDKVI1KYTL:VPKEVMNAD-DPDLQRPDEE ---- AIKI 
N. musculus 91 DPE(KIKYDAIAF- 	QSKDKVI 	KYT:VPKEVMNAD-DPDLQRpDEE ---- AIKi I 
S. japonicum 16 FKDRIRYDELV HSKDRII: :KFSi. LTKPID-DD-DPEFSKP5QE--TIEFTTE 
C. elegans 97 GTDCKLQHE 	A I HVKDKVV-KLNDNK-AKTWNED-DDDIQKPDDD ---- A\TIDATE 
N.crassa 100 GEKDTAA 	HSSDRVIHASFK I IPLRQRAEAGDLDLSRPSKE----E\TEATAE 
S.pombe 96 TSSA:IDNA1A HEHGELVQASFR: :IPLRARLGVGEISLEKPSDE----QKQEVAN 
D.discoideum 117 DSTGRVKHEAILGEKG5 ---- LH::QYKi IPKQHTEHE --- LQRPDDD ---- ELQETLD 
S.cerevisiae 15 RVSTALSSDRVEPAILTDQIAKNVKLDLFIPKRQSNFE--L5vpLpTKA ---- EIQECrA 
E.cunicuii 1 ------------------------------------------------------------ 
continued... 
Figure 1.4 The alignment of S. cerevisiae NH 2-terminal/central domain with the putative 
members of SNW family. 
The sequences were identified using NCBI BLAST and then aligned using Clustal W (1.82). The 
identities and similarities are emphasized using BOXSHADE 3.21. The conserved amino-acids are 
in hold and colored in red; the semi-conserved ones are in blue. The conserved SNWKN is 
highlighted in black. 
The blue bars above the alignment delineate the regions A and A where specific amino acids residues 
(highlighted) are mutagenized in this work (Chapter 4). 
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P.falciparuin 155 DEENEiIENTKRNIENILNEi-LNKSNIVNKKEEiE YRYIPQNKL NNLEE-. 	RiKG 
P.yoelii 149 KEEMEIIENTKKNIENIINEKINKNSINNKKEDKIYRYIPQNKL NNLEE-RIIKV\TEKS 
A.thaliana 158 ETKA.IEYI.NVRLSAQESNIARQS-GDSQKKP;..SSAF KE-PYIRMVENP 
H.vulgare 66 RVAALQIWRLSAQEKNVPT}iD-SESKFKii(PSccSAAF KE-PJIRS1SENA 
D.melanogaster 149 ETRLALEKLTNQKITSALPVHAQKA-GPAQPYTPSQQGDTF KQRVIR1VEA 
A. gambiae 146 NTRALELTNQE IVS.M:'VRAAEKQ-APAQ 	*YTPSQçGDAF AKQ- RIIR1.WEA. 
H.sapiens 146 KTRWLEKs:sQEVAA-NivRAADKL-APAQ:EYTPsQQGVAF KQ-PVIRMEN. 
M.musculus 146 KQ-RV1FJEN. 
S.japoriicum 70 KTRR 7  ESLEM7JAAAPVRRAEKT-NPAEiEYTPSQQGAAF:: KQ-RLVF:EN 
C.elegaris 151 KTRMALE}I NSEVASALPVRHADKL-APAQ: 	YTPSQQNGAAG:--QQ-RIIFJ: EE. 
N.crassa 156 RKNALAALSGAVASQKPKNININTKREPTFVRYTPSAc-MGDKKQD-RIMKr ER. 
S .pombe 152 K 	LALQKILSKQIAQSQKSAWQQRDDPV:: ?YTPSNç-MGQALSKQ--RIIKrF  TAE 
D.discoideum 165 RTKNkLEKIVNGFIKSSKSTNYVEVEKKSAT. 7 KTPENçLGSNGSLNSKIVPJFDVA 
S.cerevisiae 69 R:KSYIQRLNAELANS ---------- NNRASSEvrETHQAPA:LLLNNSHHIE\rSK; 
E.cuniculi 1 --------------------------- 
A 
P.falciparum 214 T 	L, -- ,V--S 	i'H-K L NIKN 	DY ILF 	-T 	LNKE END if 
P.yoelii 208 TZLDV--S 	EN-K L NIKN. PNYDILR-TEELTKEEEKEQL 
A. thaliana 216 VDPLDP--Di rKH-KRV 	ASG.EPPVPBSP-Pr-PVTVKDçQD.T}::  
H.vulgare 124 SDPLDP- -'EH-KRV 	ASGDDFVPVMBSP-PRPVTVKDçQD :y:  
D. melanogaster 207 LDPHEP--PYFBINKDI 	GPPSPPAPVLHSP-SRK\rVKETKE.. _ 
A. gambiae 204 VDPMEP--PRRINKT 	GPPSPPAPLHSP_TRKVTVF!1:KEKV:  
H.sapiens 204 KDPMEP--PR 	 PEAT:NSP-SRKMTVKEQE;}. ei 
M.musculus 204 KDPMEP--PRKIN 	APEDiADIEEEP-SR(NTVKEQQE0JK:. 
S. japonicuni 128 KDPMEP--P 	KINQ IPPELEP; LNNEP-ARKVTVKEQQDWK2  
C.elegans 207 KDPMEP--D EINQ  	PEDADTEiEP-PRKMTAKDQNDQ 
N. crassa 214 RDPMEP--PKFEH-K I 	GPPTPPPI-J0DSP-PRKLTAEDCEAWR 7 . 
S.pombe 209 QDPMEP--PJEFRH-K V 	GPPSPPPPVLHSP-PRYVSAQEQD:Q 
D.discoideum 225 QDPLEP--PFYFTFT 	EHG-3PPAPVMHSP-TiDL 	QDEQD T  
S.cerevisiae 119 MILL RFVGKKAR EVAPTENDEV\TLDMDGSNDRGEADPNE  
E.cuniculi 30 P 	LRI --- TYYRGA QE KEAAVDK ------- SHKAFGSKTKI LEA 
B 
P.falciparum 270 N 	IQ[ENKK:NN VA 	N- 	HLD YL V-EL. - 	;EIQINSVMKQKKLH EE 
P. yoelii 264 NIALEKRIQSIJYKKDNNDEiNEK_FA4SEYYVAEKKAREEIKN- NNIIKQKXLI1Ei EQ 
A. thaliana 272 TIP1.DKRLAADGE,L.DLQINDN_. 1 LSEAYVAEQKAREASM;SKVQKEMVMLDLER 
H.vulgare 180 T1PLDKRLAGFL-EQINDN- 	LE AYVAEQkAREArQMPSKVQRELMLKEKER 
D . melanogaster 264 TI PLDKRLAADGRGLQQAHINEK- MAE4YIADRKAP.EA EARSQLEKKLAQKEKEK 
A. gambiae 261 TIPLDKRLAADGRGLQQIH1NEK- 	KAE4YIADRKAREA EA.- ------ AAGKEIGP 
H. sapiens 261 TIPLDKRLAADGRGLQTHINEN- LAEAZYIADRKAREAEMFAQVERKNAQKEIK-- 
M . xnusculus 261 TIPLDKRLAADGRGLçTHINEN-  FALLAEAYIADRKAREA EMEAQVERKMAQKEKEK 
S. japonicum 185 TIPLDKRVAADGRGLQTAHINEN--LA- .LLYTADRXAREAAK---------------- 
C. elegans 264 TVGLDKRLAADGRGLQQTHIIJI-N- 	LAD .XWIADRXAREEXETFQLERRVAQNXFSE 
N. crassa 270 TVPLDKRLAADGRGLQDVQI NDK- 	QF 	LFMADRHAREEYRQ-AMNQQRLAEKEKAQ 
S.pombe 265 TIPLDKRLkADGRGLNDE'EINDG- F L.TVEPQAPEERYFAIMRQKNAEKEKQE 
D.discoideum 281 AISIDKRLvSNGLc2L1;EINDK- 	ITT, LI ESNAF.E SAIAELERKLAQLEKER 
S.cerevisiae 179 rVALERRVG-KALDNENNTINDG-FM LS 	LEN 	KKAPQEIRSKNELKPLANEQEMLA 
E . cuniculi 80 IVSLEAPIAHDRFKTIHPEINIRSFEELKSSLDS EHLYFQDNRKAGIKEEKMGGIKGLG 
Figure 1.4 (continued) 
The gene names and accession numbers are: P. falciparuin - Plasmodium frilciparu,n (GI:38445299): P. voelii 
- Plasmodiumvoelii (gi:23479956): A. ihaliana - Arahidopsis thaliana (GI:3540201 ): H. s'ulgare - Hordeum 
vulgare (GI:27948454): D. inelanogaster - Drosophila ineiwiogaster (BX42): A. gwnbiae - Anopheles 
ganbiae (gi:3 1209709): H. sapiens - Homo sapiens (SKIP): M. ,nusculu.s - Mus inusculus (RI KEN): S. 
.japoniculn - Schistosonia japonicuni (gi:2984 1015): C. elegans - C'aenorabditis elegans (Q22836): N. crassa 
- Neurospora crassa (GI:1 1595618): S. pombe - Schizosaccham#nvcespombe (GI:4678690): D. discoideun, - 
Dicrvosteliu,n discoideun, (SN\VA): S. ceret'isiae - Sacchareinvces cere'isiae (Prp45p): E. cuniculi - 
Encephalitozoon cuniculi (gi: 191 72986). 
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Baudino et al. (1998) defined three important domains in human homologue of 
Prp45p, NcoA-62/SKIP, that are fairly conserved (Figure 1.5). These regions are: a) 
the SNW domain that in yeast Prp45p is located between amino acid residues 120 
and 230; b) a proline-rich domain upstream of SNWKN motif that is shared by all 
organisms except S. cerevisiae. It is considered that this sequence constitutes a 
potential binding site for SH3 domains (src homology domain 3) (for review, 
Zarrinpar et al., 2003) and this facilitates interactions with other proteins: c) the C-
terminal region of SNW proteins contains an a-helix and three n-strands that 
resemble the consensus sequence of SH2 domains (src homology domain 2) (Figure 
1.5). SH2 domains are mainly found in tyrosine kinases involved in signal 
transduction cascades and they recognise the phosphotyrosines on the surface of 
proteins. In yeast Prp45p the SH2 domain is poorly conserved and rather degenerated 
and the whole C-terminal region was shown to be dispensable for cell survival 
(Martinkova et al., 2002). Yeast Prp45p also lacks two C-terminally located highly 
charged regions common for its homologues (Figure 1.5) that seem to play crucial 
roles within transactivation processes, aspects discussed in the following sections. 
So far, two different experimental lines performed on Prp45p have shown the 
importance N-terminal half of the protein. Firstly, complementation assays with 
truncated versions of the yeast Prp45p identified the minimum domain necessary for 
cell viability within the N-terminal 190 amino acid residues (Martinkova et al.. 
2002). Secondly, two-hybrid screen analyses mapped the Prp45p minimum region of 
interaction with Prp46p between amino acids 54 and 204 (Albers et al., 2003). An 
alignment of the N-/central region of the SNW proteins is depicted in Figure 1.4. 
The N-terminal region of Prp45p is shorter and less conserved than its 
orthologs that contain conserved stretches of amino acids involved in specific 
functions and interactions (Figure 1.5). 
SNW domain 	
n-strands I 	 I 	




H. sapiens 	 I 11111 I tillic 
Proline-rich  
domaIn 
S. cerevisiae jI 	•1lIIIIII[I 
D.melanogaster NI III •riiuiuiuu 	1 111i' 
elegans 	NJ 	IIII I 	i•• u1 1111uui• 
422836 
A. thaflana 	NJ 	1III •riunui 	in 
S. pombe 	NJ 	Iin 	uiiiiiiii Ic 
discoideurn NI 	 III I•iiiniui1 	11111C 
SNWA 
•I 	I•iuouuuu. 
Figure 1.5 Schematic diagram of the proposed homology among SNW family 
members. 
The proteins are represented as bars. The coloured and dashed boxes indicate the 
common regions. Gene names and accession numbers are indicated on left. I and II 
are the highly charged sequences. B, C and D denominate the three 13-strands. 
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Thus N-terminal domains of S. pombe Snwl (1-180) and D. discoideum SnwA (1-
192) were found to interact with members of cyclophilin family Cyp2 and CypE, 
respectively (Skruzny et al.. 2001). Cyclophilins are enzymes with peptidyl—prolyl 
cis-trans isomerase activity (PPIase) that facilitate conformational modifications of 
their substrates in many cellular processes like transcription, cell cycle and splicing 
(for review, see Hunter, 1998 Teigelkamp etal., 1998). Although these domains of 
Snwl and SnwA contain around 8 well-conserved prolyl-peptide bonds (Figure 1 .4), 
subsequent analyses showed that they are not substrates of the interacting 
cyclophilins. 
1.3.2 Prp45p Functions 
1.3.2.1 Role in Splicing 
Prp45p was identified as a main interactor in a two-hybrid screen with Prp22p as a 
bait (Albers et al., 2003). Considering this two-hybrid association with a splicing 
factor, it was reasonable to investigate the role in splicing of the newly identified 
protein. Indeed yeast cells depleted of Prp45p accumulate pre-mRNA, indicating a 
splicing defect in vivo. In vitro splicing assays with Prp45p-depleted splicing extract 
and radiolabelled substrate showed that the formation of splicing intermediates and 
products did not take place, indicating an in vitro splicing defect. Moreover the 
defect was partially circumvented by the addition of the recombinant Prp45p 
(M.Albers, PhD Thesis). 
Co-immunoprecipitation of in vitro assembled splicing reaction with protein A-
tagged Prp45p (protA:Prp45p) aimed to determine at which specific step Prp45p 
associates (Albers et al.. 2003). The results showed that Prp45p becomes associated 
with the spliceosome prior to the first trans-esterification step and remains associated 
throughout the splicing process till the end of the second step when it remains 
associated with the excised lariat intron. 
Under non-splicing conditions Prp45p associates with U2, U5 and U6 snRNAs 
but not with Ui and U4 snRNA, suggesting that the protein is binding to the 
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spliceosorne after the U I snRNP and U4 snRNP have dissociated and before the 
active spliceosome performs the first trans-esteri fi cation reaction (Albers et al., 
2003). 
As for the Prp45p homologue in human, SKIP, although there have been reports of 
its association with the spliceosome, a direct role in pre-mRNA splicing has not been 
shown till recently. Thus, in 1998 Neubauer et al. purified assembled spliceosomes 
by gel filtration and affinity chromatography, followed by two-dimensional gel 
electrophoresis to separate the components and mass spectrometry to identify them; 
there were identified 3 spots corresponding to SKIP. Makarov et al. (2003) using 
anti-SKIP antibodies precipitated spliceosome complexes and, similarly to Prp45p. 
determined the association of SKIP with U2, U5 and U6 snRNAs and not with U  
and U4 snRNAs. The same study showed that anti-SKIP immunoaffinity-purified 
both activated spliceosorne and the post-splicing 35S snRNP. Thus as for Prp45p. 
SKIP associates with the spliceosome before the first step and dissociates following 
the second step together with the spliced intron. Finally. Jurica et al. (2002) affinity-
purified the C complex containing splicing intermediates, followed by tandem mass 
spectrometry to identify the protein components. The results confirmed the presence 
of SKIP within the spliceosome during splicing reactions the same as for yeast 
Prp45p. 
Relative recently a study by Zhang et cii. (2003) provided functional evidence 
that SKIP is needed for in vivo splicing of a specific pre-mRNA (of a VDR-activated 
gene). A dominant negative version of SKIP (a truncated form containing amino acid 
residues 87-342), transfected in COS-7 cells caused the accumulation of unspliced 
transcripts, indicating an in vivo splicing defect. 
Biochemical purification of interchromatin granule clusters (IGC) from liver 
nuclei followed by mass spectrometry showed that SKIP co-localizes with other 
splicing factors like U2AF35 . U2AF65 (Mintz et al., 1999). IGCs are known to be the 
"headquarters" of pre-mRNA splicing factors. This result is confirmed by the 
interaction between S. pombe homologue, spSNW1 and spU2AF 23 which is the small 
subunit of the polypyrimidine-tract binding protein spU2AF. Moreover, two-hybrid 
assays showed that spU2AF 23 interacts with SNWI homologues in Drosophila 
13 
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(Bx42), D. discoideum (SnwA) and S. cerevisiae (Prp45p). The interaction with 
Prp45p is very interesting knowing that S. cerevisiae lacks the SR proteins, including 
U2AF. 
A Prp45p two-hybrid screen led to the identification of a novel splicing factor, 
Prp46p, and revealed a physical interaction between Prp45p and two other splicing 
factors, Syfip and Syf3p (Albers ci al., 2003). Prp46p was used as bait in a two-
hybrid screen and out of all positive clones, Prp45p was statistically the most 
significant, followed by Syt3p. 
The 451 amino acid protein Prp46p was shown to be an essential gene for cell 
viability (Albers et al., 2003). The Prp46p depleted cells displayed a recognisable 
splicing defect, the accumulation of unspliced precursor, indicating that Prp46p is 
also required for pre-mRNA splicing in vivo (Albers et al., 2003). Prp46p contains a 
cluster of seven highly conserved WD repeats (repeating units of tryptophan. W, and 
aspartatic acid, D) located in the central/C-terminal part. As for its function, it was 
suggested that the WD-repeat propeller structures create a stable platform that can 
reversibly form complexes with several proteins. Two-hybrid assays mapped the 
minimum regions of interactions within the amino acid sequence of the two proteins. 
Thus, Prp45p, through a portion of the conserved SNW domain (between amino 
acids 54 and 204) interacts with region 127 - 432 of Prp46p which contains all the 
seven WD repeats. 
PRLGI, the human putative homologue of Prp46p and member of the WD 
family has been shown to be involved in pre-mRNA splicing (Ajuh et al.. 2001). It 
co-precipitates the spliceosorne from HeLa nuclear extracts (Neubauer ci al.. 1998). 
An interesting feature was shown for another member of the WD family in S. ponibe, 
Prp5p, considered to be the homologue of Prp46p. It was determined that a 
temperature-sensitive prp5-I mutation not only causes a pre-mRNA splicing defect 
at the restrictive temperature (Potashkin et al., 1998) but also arrests the cell cycle in 
G2/M phase. 
The other significant interactor either with Prp45p or with Prp46p is the 
splicing factor Syf3p/Clflp. It is required for both catalytic steps of splicing but the 
exact timing the Syf3p association with spliceosome is still unclear. Some lines of 
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evidence support the idea that Syf3p is recruited before the formation of complex B. 
at the time U4/U6.U5 tri-snRNP enters the spliceosome (Chung et al., 1999). Other 
studies showed that this protein is required for the formation of the active 
spliceosome. after Ui and U4 snRNA exit (Russell et al., 2000). Syf3p contains 15 
tetratricopeptide repeats (TPRs) that serve as a platform for the recruitment of 
splicing factors. 
To date good evidence has been provided to support the presence of Prp45p of 
S. pombe Snwl or of human SKIP in a multi-protein complex as well as Prp46p and 
Syf3p. The yeast Ceflp-associated "Cwc" complex contains U2. U5 and U6 snRNAs 
and more than 20 associated proteins (Ohl et al., 2002). At least eight of them were 
found associated with the yeast Prpl9p in an snRNA-free complex. This protein 
complex was denominated Prp 19-associated or Ntc-complex (Nineteen complex) and 
is believed to associate with the spliceosome simultaneously or immediately after the 
dissociation of U4 (Chen et al., 2002). The composition of the yeast Cwc-complex is 
very conserved to the S. pombe Cwf-complex (Ohi ci al., 2002) and to the human 
35S U5 snRNP described above (Makarov ci al.. 2002). It is suggested that these 
complexes are recruited to the spliceosorne prior to the first catalytic step of splicing, 
remain bound through the process and after the second step when they leave with the 
excised lariat intron. 
Another study performed by Stevens ci al. (2002), isolated under mild 
purification conditions a large penta-snRNPs complex that is able to support pre-
mRNA splicing and contains all five snRNAs and associated proteins. Mass 
spectrometry analysis identified Prp45p, Prp46p, Syf3p as proteins of the yeast 
penta-snRNPs complex. 
1.3.2.2 Role in Transcription 
In recent years, many data reported the involvement of the human homologue of 
Prp45p, NCoA-62/SKIP, in regulation of transcription of different genes. The recent 
finding of SKIP as a splicing factor argues that this protein and/or its homologues 
could add an extra link between transcription and splicing. 
In 1998 Baudino et al., identified and characterized in mammalian cells a 
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Vitamin D Receptor, (VDR)-interacting protein, named NCoA-62 which is the 
homologue of Prp45p. Based on the fact that the interaction of NCoA-62 with VDR 
augments vitamin D, retinoic acid, estrogen and glucocorticoid—activated 
transcription, it was considered that NCoA-62 has a nuclear receptor coactivator role 
within mammalian cells. Other independent studies, a two-hybrid screen isolated 
NCoA-62 as an interactor with the , ,-Ski oncoprotein (known to induce both 
transformation and muscle differentiation depending on the growth conditions) 
therefore NCoA-62 was renamed Ski-interacting protein or SKIP (Dahl etal.. 1998). 
Further analyses showed that NCoA-62/SKIP forms a multiprotein complex 
with VDR-RXR (retinoid X receptor) heterodimer and with SRCs (steroid receptor 
coactivator) that determine Vitamin D-activated transcription (Zhang ci al.. 2001). 
Throughout these interactions, NCoA-62/SKIP contacts the proteins through two 
different domains located in the highly charged C-terminal domain. 
Other studies revealed that SKIP augments Transforming Growth Factor-13 
(TGF-3)-dependent transcription through its interaction with Smad proteins (Leong 
et al., 2001). TGF-3s are multifunctional cell-cell signalling proteins that mediate 
different pathways in growth and development through the activation of Smad 
proteins and thus trigger the transcription of target genes. 
SKIP also interacts with the transcription factor CBF1 that specifically binds to 
the DNA and represses transcription by tethering a co-repressor complex: Historic 
Deacetylase Corepressor complex or HDAC. HDAC represses transcription through 
histone deacetylation, a process that leads to chromatin condensation and 
inaccessibility of promoter regions to transcriptional factors / RNA Polymerase. 
SKIP is believed to be a component of this HDAC complex (Zhou c/ al., 2000a and 
b). 
All the data presented above outline dual action of SKIP on transcription, 
either stimulatory or inhibitory. Regarding the involvement of other SNW proteins in 
transcription, Dahl ci al., (1998) showed that the Drosophila melanogasrer 
homologue of SKIP. Bx42, was found associated with chromatin in transcriptionally 
active puffs of salivary glands. Also Bx42 appears to have a role in transcription 




1.4 This Thesis 
The objective of this thesis is to analyse in more detail the function of Prp45p within 
the splicing machinery in S. cerevisiae. To accomplish this, random mutagenesis has 
been used to render amino acid modifications which might cause a temperature-
sensitive phenotype. In order to identify the mutations responsible for the 
temperature-sensitive phenotype, site-directed mutagenesis has been used to recreate 
the mutations in the wild-type gene. 
From these analyses it appears that mutations within two conserved regions of 
Prp45p, denominated A and B, disrupted the protein function at elevated 
temperatures and determined a mild splicing defect at the second step of splicing. 
In addition, the in vivo interaction between Prp45p and Prp46p identified in 
two-hybrid screens has been confirmed in vitro by co-immunoprecipitation 
experiments. Electrophoresis of splicing complexes on native gels has provided 
evidence that Prp45p is required for the formation of the active spliceosome. 
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2.1 Materials 
2.1.1 General Reagents 
Chemicals were purchased from the following sources, except where stated 
otherwise: Fischer, National Diagnostics, Sigma. 
Restriction enzymes, polymerases and other enzymes used in this work were 
purchased from the following sources except where stated otherwise: Boheringer 
Mannheim, New England Biolabs., Promega, Qiagen. 
Deoxyribonucleotides and ribonucleotides were obtained from Boheringer 
Radiochemicals were from Amersham. 
Reagents for all growth media were purchased from: Beta Lab, Difco 
Laboratories, Oxoid and Sigma. 
All antibiotics used in this work were from Duchefa. 
2.1.2 Sterilisation 
Solution and media were typically sterilised by autoclaving for 15 mins. at 120 and 
15 lb/inch 2 . Alternatively, solutions were sterilised by filtration. Small volumes were 
filtered through acrodisc syringe filters (0.20 pm and 0.45 m, Sartorius AG). Large 
volumes of solutions were filtered through 250 ml and 500 ml filter units (0.2 p.m 
and 0.45 p.m. Nalgene). Glassware such as corex tubes and glass pipettes were dry 
sterilised by baking in an oven at 250°C for 16 hrs. 
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2.1.3 Bacterial and Yeast Growth Media 
All growth media were stored at room temperature after autoclaving. For solid 
media, 2% (w/v) agar was added prior to autoclaving. 
Table 2.1 Bacterial Media 
Medium Components 
1% (w/v) Bacto-tryptone 
Luria-Broth (LB) 0.5% (w/v) Bacto-yeast extract 
0.5% (wlv) NaCl 
pH adjusted to 7.2 with 5 M NaOH 
Table 2.2 Yeast Media 
Medium Components 
YPDA 1% (wlv) Bacto- yeast extract 
2% (w/v) Bacto-peptone 
2% (w/v) Glucose 
0.004% (w/v) Adenine sulphate 
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YMM 0.67% (w/v) Yeast Nitrogen base w/o , amino acids 
2% (w/v) Glucose 
(supplemented with nutrients as required) 
YMM drop-out 0.67% (w/v) Yeast Nitrogen base w/o amino acids 
2% (wlv) Glucose 
0.2% (w/v) Specific drop-out powder 
p1-I adjusted with I pellet of NaOH per 500m1 
YMGRSsup 0.67% (w/v) Yeast Nitrogen base w/o amino acids 
2% (w/v) Galactose 
2% (w/v) Raffinose 
2% (wlv) Sucrose 
0.2% (w/v) Complete drop-out powder 
pH adjusted with I pellet of NaOH per 500m1 
YMGRS drop-out 0.67% (wlv) Yeast Nitrogen base w/o amino acids 
2% (wlv) Galactose 
2% (w/v) Raffinose 
2% (w/v) Sucrose 
0.2% (w/v) Specific drop-out powder 
pH adjusted with I pellet of NaOH per 500m1 
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2.1.4 Nutrients and suplements (Drop-out mix) 
Complete drop-out powder was prepared by mixing 2g of each of the following 
nutrients: adenine, alanine, arginine asparagine, aspartic acid, cysteine, glutamic 
acid, glutamine, glycine, histidine, isoleucine, lysine, methionine, phenylalanine, 
proline, serine, threonine, tyrosine, tryptophan, uracil, valine, and 4g of leucine. 
For a specific drop-out powder, the relevant nutrient(s) were omitted. 
The drop-out powder was ground to ensure complete mixing. It was added to 
the media prior to autoclaving. 
2.1.5 Antibiotics 
Antibiotics were added to liquid media immediately prior to use. For solid media, 
antibiotics were added after autoclaving. All antibiotic stock solutions were stored at 
—20°C. 
Table 2.3 Antibiotics 
Final 
Stock solution 
Antibiotic Abbreviation Solvent concentration 
(mg/ml) 
(J.Lg/ml) 
Ampicillin Amp Water! 100 100 
Ethanol 
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2.1.6 Commonly Used Buffers 
Table 2.4 Commonly used buffers 
Buffer Components 
I M MOPS (3-(N-morpholino) propane sulfonic acid 
lMTris 
20X MOPS 
69.3 mM SDS 
20.5 mM EDTA 
1 M MES (2-(N-morpholino) ethane sulfonic acid 
I MTris 
20X MES 69.3 mM SDS 
20.5 mM EDTA 
137 	m NaCL 
2.7 mM KC1 
lOX PBS 10.1 mMNa2PO4 
1.76 mM KH2PO4 
pH adjusted to 7.2 
2 M Tris 
50X TAE 0.05 MEDTA 
5.7% (v/v) Acetic acid 
890 mM Tris 
lox TBE 890 mM Boric acid 
20 mM EDTA 
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0.5 M Tris-HC1. p1-I 7.5 
1OXTBS-T 1.5MNaCI 
I% (v/v) Tween-20 
100 mM Tris-HC1, pH 7.5 
IOxTE 10mMEDTA 
3.6MNaC1 
0.2 M NaH2PO4 
20X SSPE 
0.02 M EDTA 
pH adjusted to 7.4 with NaOH 
3MNaC1 
20X SSC 
0.3M Sodium citrate 
2.1.7 Escherichia coil Strains 
Strains of bacteria used in this study are listed in Table 2.5. Escherichia coil strain 
TOP 10 was routinely used for plasmid cloning and propagation steps. 
Table 2.5 Escherichia co/i strains 
Strain Genotype Source 
TOPIO F7mcrA A(mrr-hsdRMS-mcrBC) Grant et al., 1990 
80lacThM15 AlacX74 deoR recAl 
araD 139 A(ara-leu)7697 galU galK rpsL 
(Strr) endA 1 nupG 
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2.1.8 Saccharomyces cerevisiae Strains 
Table 2.6 Saccharornyces cerevisiae strains 
Strain Genotype Source 
BMA38a MATa, 	his3A200, 	leu2-3,1 12, 	ura3-1, M. Albers, 
trplM, ade2-1, can l-100 This lab. 
BMA64n MATE, 	his3-1 1,15, 	leu2-3,1 12, 	ura3-1, M. Albers, 
trplAl, ade2-1 This lab. 
YMA45/2 MATa, 	his3200, 	leu2-3,1 12, 	ura3-1, M. Albers, 
trp IA!, ade2-1, HIS3P gaiiProtA:PRP45 This lab. 
YMM45 MATa, 	his3A200, 	leu2-3,1 12, 	ura3-1, This thesis 
trplAl, 	ade2-1, 	canl-100, 	PRP45- 
13Myc:TRP1 
YMM45-57 MATa, 	his3A200, 	leu2-3,1 12, 	ura3-1, This thesis 
trplAl, 	ade2-1, 	canl-100, 	prp45-57- 
13Myc:TRP1 
YMM45-1 13 MATa, 	his3A200, 	leu2-3,1 12, 	ura3-1, This thesis 
trplAl, 	ade2-1, 	canl-100, 	prp45-113- 
1 3Myc:TRPI 
YMAI5I12 MATc, 	his3-11,15, 	ieu2-3,112, 	ura3-1, M. Albers, 
trplAl, ade2-1, TRPI-Pmeu-HA2:PRP46 This lab. 
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2.1.9 Oligonucleotides 
Oligonucleotides used in this study were purchased from Bioline Ltd. (London), 
Genosys Biotechnology Ltd. (Cambridge) or MWG-Biotech AG. 
Table 2.7 Oligonucleotides 
Name Sequence(5'-3') Description (template) 
PS&5-45M GGACTAGTATCCGCCAATACC PRP45 	promoter 	and 
TGCTFCGGCA PRP45 cloning, for. 
PNC3-45M GGCATGCCATGGATTTGGTTG PRP45 promoter cloning, 
AGGTTGCTGATACG rev. 
TNC5-45M GCATGCCATGGGCCCAGGATG PRP45 terminator cloning, 
AGCACTAGGAAAAC for. 
TP3-45M AAAACTGCAGTCCATAAAGTC PRP45 terminator cloning, 
GATACTCCAAGAG rev. 
TXI-1O-45M GGCATGCTCGAGTCCATAAAG PRP45 	terminator 	and 
TCGATACTCCAAG PRP45 cloning, rev. 
PRP45-F- GAAAGAAGTTCAAATTATGGG PRP45 promoter for. 
PROMOTER GTTA 
PRP45-R- AATACAACTCAAGCACAAGA PRP45 terminator, rev. 
TERMIN ATGCT 
PRP45-Fl GAACAACAGCCACCATATTGA PRP45, for. 
GGT 
PRP45-F2 TTGAAAGAATTGAGCCAACGA PRP45, for. 
GCCA 
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F-57-201 AGCTCTTGACGACGAAAATAA prp45-201 	construction 
for. 
R-57-201 TTATTTTCGTCGTCAAGAGC prp45-201 	construction 
rev. 
F-57 CGTTGGGAAGGAGGCGAGAA prp45-57A 	construction 
AGGTTGAAGCACCCACA for. 
R-57 TGTGGGTGCTTCAACCTTTCTC prp45-57A 	construction 
GCCTCCTTCCCAACG rev. 
F-57-B CTCCGAAGCGTCAGAAGACGC prp45-57B 	construction 
TGACAAGAA for. 
R-57-B TTCTTGTCAGCGTCTTCTGACG prp45-57B 	construction 
CTTCGGAG rev. 
57B-New-F GCTCTCCGAAGCGTCAGAAAJ\. prp45-5 7B 	construction 
CGCTGAC for 
57B-New-R GTCAGCGTTTTCTGACGCTTC prp45-5 7B 	construction 
GGAGAGC rev. 
F-i 13 CGTTGGGAAGGAGGCGAGAG prp45-113A 	construction 
AGGTTGTAGCA for. 
R-1 13 TGCTACAACCTCTCTCCGCCTC prp45-113A 	construction 
CTTCCCAACG rev. 
F-I 13-B GTTTATGAAGCCCTCCGAAGC prp45-113B 	construction 
GTTA for. 
R-i 13-B TAACGCTTCGGAGGGCTTCAT prp45-113B 	construction 
AAAC rev. 
F-i 13-C AGTGGCCAGACCAAAAGAGC prp45-113C 	construction 
TGG for. 
R-1 13-C CCAGCTCTTTTGGTCTGGCCA prp45-113C 	construction 
C rev. 
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PRP45-FO GAATACATATCTAATACTATT PRP45-Myc cloning 
C 
TNT-PRP45-46- GGCACTGAATTCTAATACGAC Used to amplify PRP45 
F TCACTATAGGGAGCCACCATG regions R2, R4 and R46. 
TCGGTTCCTTTGCCAACGAA The PCR products were 
used in TNT reactions and 
then in Co-IP to check the 
interaction 	with 	Prp46p, 
for. 
TNT-PRP45-46- GGCACTGTCGACCTACTCTTG Used to amplify PRP45 
R TCTTGCCTTCTTG regions RI and R46. The 
PCR products were used in 
TNT reactions and then in 
Co-IP 	to 	check 	the 
interaction 	with 	Prp46p, 
rev. 
TNT-PRP45-22- GGCACTGAATTCTAATACGAC Used to amplify PRP45 
New-F TCACTATAGGGAGCCACCATG region 	R5. 	The 	PCR 
ATCAGGTCCAAAATGGAATTG product was used in TNT 
reactions and then in Co- 
IP to check the interaction 
with Prp46p, for. 
TNT-PRP45-22- GGCACTGTCGACCTACTGCAG Used 	to 	amplify 	the 
R ATCCGGTTGTTCTGA PRP45 	region 	R2. 	The 
PCR product was used in 
TNT reactions and then in 
Co-IP 	to 	check 	the 
interaction 	with 	Prp46p, 
rev. 
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PRP45TNT-5' GGATCCTAATACGACTCACTA Used to amplify PRP45 
TAGGGAGCCACCATGTTTAGT wild-type and region RI. 
AACAGACTACCACCTC The PCR products were 
used in TNT reactions and 
then in Co-IP to check the 
interaction 	with 	Prp46p. 
for. 
PRP45TNT-3' AGTGCTCATCCTGGGCCTAGG Used to amplify PRP45 
CGCC wild-type and regions R4 
and R5. The PCR products 
were 	used 	in 	TNT 
reactions and then in Co- 
IP to check the interaction 
with Prp46p, rev. 
SDM45-Nco-F GATAACTATGGCGCCATGGCC Used to 	insert 	an NcoI 
CAGGATGAGC restriction site in PRP45 
STOP codon (TAG), for. 
SDM45-Nco-R GCTCATCCTGGGCCATGGCGC Used to 	insert 	an NcoI 
CATAGTTATC restriction site in PRP45 
STOP codon (TAG), rev. 
c-Myc-TRP-Nco- GCATGTCCATGGGCCGGATCC c-Myc-TRPJ 	cassette 
F CCGGGTTAATTAA cloning for. 
c-Myc-TRP-Nco- GCTCATCCTGGGCCATGGCGC c-Myc-TRPJ 	cassette 
R CATAGTTATC cloning rev. 
13-Myc-R GCTCCGGATCAAGATTGTACA c-Myc-TRP1 	cassette 
G cloning rev. 
PRP45-522-F GGTTGGTACAAGAAGCCGGCT PRP45 cloning for. 
G 
PRP45+525R CAGAGAGCATCGCCTGCGGA PRP45 cloning rev. 
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400 TCUGGTCTACCGACGATAGA Actinl-exon2 probe 
TGGGAAGACAGCA 
418 ATTCCAAAGAAGCACCACCAC PGKJ probe 
C 
423 GGAGTTGTGACCGATGAAGTC YMR116C—exon2 probe 
AGCTTCAATTTGGAATTGG 
424 GACCCAACCGTTGTGACCTTC YMR1I6C'—exonl probe 
C 
214 CAGAGATCTTGGTGATAAT U24 probe 
484 GCAACCATTTCTTCCAAATTG EFBJ-exon2 probe 
GTTTCATCATCCCATGG 
EFBI-exonl AATGTATGACTTGTCAGCCAA EFBJ-exonl probe 
AGAAGCGTTTAATTG 
205 GTCAGATACTGTGATAGTC U18 probe 
255 GAGAGGTTACCTATTATTACC snR38 probe 
CATTCAGACAGGGATAACTG 
483 CCACCGACCAAGTTGTTGGAC TEF4 - exon2 probe 
ATGAAAGTCAAGGTAAG 
2.1.10 	 Plasmids 
Table 2.8 Plasmids 
Plasmid Description Reference 
pRS3I4 Yeast-E.coli shuttle vector: Multiple cloning site, 
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Table 2.8 Plasmids 
Plasmid Description Reference 
pGBT9 GAL4 DNA binding domain fusion shuttle and Clontech 
expression vector: 	Multiple cloning site, AmpR,  Laboratories, 
colEl 	ori, 	PADHI, 	Ga14 	DNA-binding 	domain Inc. 
sequence, 	ADHJ 	transcriptional 	terminator, 	2t, 
TRPJ. 
pBTMI 16 LexA DNA-binding domain fussion expression S.Fields, 
vector: Multiple cloning site, 	AmpR,  colEl 	ori, S.U.N.Y., 
PADHI, 	LexA 	sequence, 	ADHJ 	transcriptional Stony Brook 
terminator, 2.i, TRP] 
p283 Modified pGEM1. Contains ACT] coding sequence O'Keefe et aL, 
under regulation of the T7 promotor 1996 
pFA6a- pFA based E. coil cloning vector carrying a protein- Longtine ci al., 
13Myc- tagging module consisting of 13Myc epitope, the S. 1998 
TRP I cerevisiae ADHJ terminator and the S. cerevisiae 
TRPJ marker. 
Table 2.9 Modified Plasmids 
Plasmid Description Reference 
pRS-PT Modified pRS3I4: Two 500 bp fragments 
This work 
representing 	promoter 	and 	terminator 
regions of PRP45 ORF were PCR-amplified 
from 	yeast 	genomic 	DNA 	using 
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oligonucleotide primers pairs PS&5-45M / 
PNC3-45M and TNC5-45M I TP3-45M, 
respectively. The two PCR products were 
gel-purified, cut with SpeI and NcoI 
(promoter region) and with NcoI and PstI 
(terminator region) and then ligated into 
SpeI, PstI restricted pRS413. 
pRS-45 Modified 	pRS314: 	The 	PRP45 	coding This work 
sequence together with its promoter and 
terminator 	regions 	were 	PCR-amplified 
from yeast genomic DNA using primers 
PS&5-45M and TXHO-45M. The PCR 
product was gel-purified, cut with SpeI and 
XhoI (restriction sites incorporated into PCR 
primers) and cloned into the Spel and AlioI 
sites ofpRS3l4. 
pRS-45N Modified pRS-45: The STOP codon of This work 
PRP45 coding region TAG was site-directed 
mutagenesed 	into 	ATG 	using 	primers 
SDM45-Nco-F and SDM45-Nco-R. Thus 
the terminal sequence of the gene CCTAGG 
became 	CCATGG; 	this 	is 	an 	NcoI 
restriction site. 
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pMM45 Modified 	pRS-45N: 	The 	13Myc-TRP] This work 
cassette of pFA6a-13Myc-TRP1 vector was 
PCR-amplified using primers c-Myc-TRP- 
Nco-F and c-Myc-TRP-Nco-R. The PCR 
product was gel purified, cut with NcoI 
(restriction 	site 	incorporated 	into 	PCR 
primers) and ligated into the NcoI restriction 
site 	of pRS-45N 	plasmid. 	Frame 	and 
integrity of the cloned PCR product was 
checked by sequencing. 
p57A Modified pRS-45: PRP45 coding sequence This work 
was site-directed mutagenized in positions 
388 (A to G) and 444 (T to A) using the 
primers F-57 and R-57. 
p57B Modified pRS-45: PRP45 coding sequence This work 
was site-directed mutagenized in positions 
623 (T to C) and 628 (A to G) using the 
primers F-57-B and R-57-13. 
p57AB Modified p57A: PRP45 coding sequence in This work 
p57A vector was site-directed mutagenized 
in position 623 (T to C) using primers 5713- 
New-F and 5713-New-R. 
p57-201 Modified pRS-45: PRP45 coding sequence This work 
was site-directed mutagenized in position 
574 (A to G). 
p1 13A Modified pRS-45: PRP45 coding sequence This work 
was site-directed mutagenized in positions 
388 (A to G) and 397 (A to G) using the 
primers F- 113 and R-1 13. 
p1 13B Modified pRS-45: PRP45 coding sequence This work 
was site-directed mutagenized in position 
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611 (T to C) using the primers F-113-B and 
R-1 13-B. 
p1 I3AB Modified p1 13A: PRP45 coding sequence in This work 
p 1  13A vector was site-directed mutagenized 
in position 611 (T to C) using primers F- 
113-B and R-113-B. 
p1 13C Modified pRS-45: PRP45 coding sequence This work 
was site-directed mutagenized in position 
818 (T to C) using the primers F-1 13-C and 
R-113-C. 
pMM57 Modified p57AB: A 2300 bp fragment This work 
containing c-terminus of PRP45 ORF, the 
I 3Myc-TRPJ cassette and 500 bp PRP45 
terminator was isolated from pMM45 via 
SfoJ, XhoI restriction. The fragment was 
ligated into SfoI, XhoI digested p57AB. The 
identity of the cloned fragment was verified 
by sequencing. 
pMM1 13 Modified p1 13AB: A 2300 bp fragment This work 
containing c-terminus of PRP45 ORF, the 
13Myc-TRPJ cassette and 500 bp PRP45 
terminator was isolated from pMM45 via 
SfoI, XhoI restriction. The fragment was 
ligated into SfoJ, XhoI digested p1I3AB. 
The 	cloned 	fragment 	was 	checked 	by 
sequencing. 
pMA45 Modified 	pBTM1 16: 	PRP45 	coding M. Albers, 
sequence was fused to LexA DNA-binding This lab. 
domain. PRP45 ORF was cloned into the 
EcoRI and Sail sites ofpBTMl 16. 
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pGBT9/SKIP Modified 	pGBT9: 	The 	SKIP 	coding Mike 	Hayman, 
sequence was fused to the GAL4 DNA- S.U.N.Y., 
binding domain sequence in the multiple Stony Brook 
cloning site of pGBT9. 
pGBT9/SKIP Modified pGBD9: The sequence encoding J. Figueroa, 
(1-200) amino acids 1-200 of SKIP was fused to the S.U.N.Y., 
GAL4-DNA binding domain sequence in Stony Brook 
the multiple cloning site of pGBT9. 
pGBT9/SKIP Modified pGBD9: The sequence encoding J. Figueroa, 
(1-300) amino acids 1-300 of SKIP was fused to the S.U.N.Y., 
GAL4-DNA binding domain sequence in Stony Brook 
the multiple cloning site of pGBT9. 
pGBT9/SKIP Modified pGBD9: The sequence encoding J. Figueroa, 
(201-537) amino acids 201-537 of SKIP was fused to S.U.N.Y., 
the GAL4-DNA binding domain sequence Stony Brook 
in the multiple cloning site of pGBT9. 
pGBT9/SKIP Modified pGBD9: The sequence encoding J. Figueroa, 
(334-537) amino acids 331-537 of SKIP was fused to S.U.N.Y., 
the GAL4-DNA binding domain sequence Stony Brook 
in the multiple cloning site of pGBT9. 
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2.1.11 	 Antisera 
The antisera used in this study are listed in Table 2.10. 
Table 2.10 Antisera 
Antibody Description Source 
Anti-HA Mouse monoclonal antibody (clone 12CA5) Boehringer 
raised against the influenza hemagglutinin Mannheim 
protein. 
1: 1,000 dilution for Western blotting. 
4 p.1 for immunoprecipitation. 
Anti-c-Myc Mouse monoclonal antibody raised against SantaCruz 
(sc-40) the human c-Myc COOH terminus. Biotechnology 
1:1,000 for Western blotting. 
Anti-c-Myc Rabbit polyclonal antibody raised against SantaCruz 
(sc-789) the human c-Myc COOH terminus. Biotechnology 
1:1,1000 for Western blotting. 
Anti-Mouse Sheep Anti-mouse IgG covalently linked to Amersham 
IgG-HRP horseradish peroxidase. 
1:1,000 dilution for Western blotting. 
Anti-Rabbit Donkey Anti-rabbit IgG covalently linked to Amersham 
IgG-HRP horseradish peroxidase. 
1:1,000 dilution for Western blotting. 
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2.2 Microbiological Methods 
2.2.1 Growth of Bacteria 
E. coli strains were grown in LB medium at 37°C. To maintain selection for a 
plasmid, transformed bacteria were grown in medium containing the appropriate 
antibiotic (Ampicillin in this work) (see Table 2.3). 
2.2.2 Growth of Yeast 
Yeast strains were routinely grown at 30°C (or at 23°C for temperature-sensitive 
strains) in YPDA or YMGRSsup (Table 2.2). To maintain selection for plasmid 
DNA or to select transformants for integration of a reporter gene into the genome, 
cells were grown in YMM or YMGRS with appropriate dropout powder added to the 
medium (YMM -x or YMGRS —X; Table 2.2). 
2.2.3 Preservation of Bacterial Strains 
E. coli strains were stored for up to two weeks at 4°C. To preserve strains 
indefinitely, bacteria were grown in appropriate medium to stationary phase. One 
millilitre of culture was mixed with an equal volume of sterile 30% (w/v) glycerol, so 
that the final concentration is 15% (wlv) glycerol. This was subsequently snap-frozen 
on dry ice and stored at -70°C. 
2.2.4 Preservation of Yeast 
S. cerevisiae strains were stored for up to two months on solid medium at 4°C. To 
preserve strains indefinitely, yeast cells were grown in appropriate medium to mid- 
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logarithmic phase. One millilitre of culture was mixed with an equal volume of 
sterile 30% (w/v) glycerol, so that the final concentration is 15% (w/v) glycerol. This 
was subsequently snap-frozen on dry ice and stored at -70°C. 
2.2.5 Transformation of E. co/i 
2.2.5.1 Preparation of Electro-competent Cells 
TOP1O E. coil cells were taken from -70°C stock and grown overnight at 37°C on 
solid LB medium (Table 2.1). A single colony was inoculated in 10 ml of LB liquid 
medium and incubated overnight at 37°C. An aliquot of this culture was used to 
inoculate 500 ml of LB liquid medium to an optical density at 600 nm (0D 600) of 0.1 
units. The culture was grown at 37°C until the 0D 600 was 0.5-0.7. The cells were 
placed on ice for 10 minutes. From this stage, all the manipulations were done on ice 
using pre-chilled solutions and containers. Cells were sedimented for 20 minutes at 
4,200 rpm (2°C, Beckman JLA 10.500 rotor), then they were washed once 500 ml 
and once in 250 ml of sterile, distilled water. The cells were then washed in 10 ml of 
10% (v/v) glycerol and sedimented as before. Finally, cells were resuspended in I ml 
of 10% (v/v) glycerol and aliquoted to 40p.I on ice. The competent cells were snap 
frozen on dry ice and stored at -70°C indefinitely. 
2.2.5.2 Transformation of Electro-competent Cells 
Electro-competent TOP 10 E. coli cells were thawed on ice and mixed with 100 ng of 
transforming DNA. Cells were transferred to a pre-chilled electroporation cuvette 
(0.2 cm electrode gap; Equibio) on ice. Residual ice and water from the surface of 
the cuvette was wiped off with a tissue paper. To remove the trapped air between the 
electrodes and to ensure the cells are at the bottom, the electrocuvette was taped few 
times onto the bench. Electroporation was performed using a Biorad Gene Pulser II 
at 200 ohms resistance, 25 .tF capacity and 2.5 KY voltage. Immediately upon 
electroporation, 1 ml of LB (Table 2.1) was added and the cells transferred to a 
sterile Eppendorf tube. The transformed cells were allowed to recover for 1 hour, at 
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37°C, on a rotating wheel. The cells were plated on solid LB medium supplemented 
with the appropriate antibiotic to ensure the maintenance of the transformed plasmid. 
The plates were incubated overnight at 37C. 
2.2.6 Transformation of Yeast 
A single colony of yeast strain to be transformed was grown overnight into 10 ml of 
appropriate liquid medium (Table 2.2) at 30°C. The cells were then diluted into 50 
ml of fresh medium to an 0D600 of 0.1 and this was further incubated till the 0D 600 
reached 0.5 - 0.7. The cells were sedimented at 3,500 rpm (MSE Mistral 1000 
centrifuge) for 5 minutes, washed once in 50 ml of sterile, distilled water and 
harvested as above. The cell pellet was resuspended in 25 ml of sterile LiT solution 
supplemented with 0.25 ml of 1M DTT and incubated for 40 minutes at room 
temperature with gentle shaking. Following this incubation, the cells were 
sedimented by centrifugation as before, and resuspended in 0.75 ml LiT / 7.5 jil 1 M 
DTT. One hundred microlitres of cell suspension was then added to a mixture of: 50 
p.1 LiT, 1-10 p.1 of transforming DNA (0.1-2 p.g/.il) and 50 p.g of single stranded 
salmon sperm carrier DNA (incubated at 100°C for 10 minutes prior to use). The 
samples were incubated at room temperature for 10 minutes. Three hundred 
microlitres of freshly prepared PEG solution was added and the incubation continued 
for another 10 minutes. Subsequently, 50 p.1 of DMSO was added and the cells were 
heat-shocked by transferring the tubes into a water bath at 42°C for 15 minutes. Then 
the cells were sedimented for 1 minute at 4, 000 rpm, the supernatant removed and 
the pellet resuspended in 1 ml of appropriate media. The transformed cells were 
allowed to recover for 1 hour, at 30°C, on a rotating wheel. The cells were harvested 
by centrifugation (4,000 rpm, 60 seconds) and then resuspended in 400 p.1 of sterile, 
distilled water. Finally, 100 p.1 aliquots were spread onto the appropriate selective 
solid media (Table 2.2). The plates were incubated at 30°C (23°C for temperature-
sensitive mutants) for 3-4 days. 
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• LiT: 10 mM Iris-Cl (pH 7.5), 100 mM Lithium acetate 
• PEG: 100% (wlv) PEG4000, 10 mM Tris-Ci (pH 7.5), 100 mM Lithium acetate 
2.2.7 Transformation and Genomic Integration of Temperature-
sensitive Alleles 
A linear DNA fragment containing the temperature-sensitive allele and a cassette 
containing TRPJ gene as a marker and a sequence encoding for 13 Myc epitope was 
generated by PCR. The PCR was performed using plasmid DNA as a template. The 
final PCR product has at least 200 bp of sequence identical to the region immediately 
upstream and downstream of the ORF to be replaced. The PCR product was gel-
purified from the template plasmid DNA and approximately 4jg were transformed 
into haploid yeast cells of strain BMA38a (Table 2.6). Following the 42°C heat-
shock step, the transformed cells were incubated for 3 hours at 23°C on rotating 
wheel. The cells were spread onto medium lacking tryptophan (-Trp) to select for 
TRPJ marker and the plates incubated for up to 4 days at 23°C. Colonies growing on 
these plates were streaked onto fresh solid medium and the integration was 
investigated using PCR, Western blotting and sequencing. 
2.2.8 Growth Curves 
Growth curve analysis was performed on yeast cells that were temperature-sensitive. 
Cells were grown in liquid media to mid-logarithmic phase under permissive 
conditions (23°C). Then aliquots of culture were used to inoculate pre-warmed 
medium to an 0D 600 of 0.05 - 0.1. Cultures were then incubated at the appropriate 
temperature with the growth rate monitored by measuring the 0D 600 at regular 
intervals, typically every hour. In order to keep all 0D6 00 readings below 0.7 and thus 
maintain the cells in logarithmic growth, the cultures were diluted with pre-warmed 
growth medium. 
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2.2.9 -GaIacosidase Assay 
This protocol is modified after the one described by Legrain and Rosbash, 1989. 
The yeast strains of interest were transformed with the reporter plasmids (containing 
URA3 marker) and the transformants plated on medium lacking uracil (-Ura). Five 
milliliters of GGL-U media were inoculated with a single colony and grown at 23°C. 
When the 0D 600 reached 0.5, 2% (v/v) of galactose was added and the cultures 
grown for 2 hours at non-permissive temperature (37C). Then, aliquots of 1 ml were 
removed, the cells were spun for 3 minutes at 14,000 rpm and resuspended in 0.5 ml 
of Buffer Z (supplemented with 0.36% (vlv) of -mercaptoethanol). Two hundred 
microliters of ether was added and the cells were vortexed for 20 seconds. The 
lysates were spun for 1 minute at room temperature to separate the phases and the 
ether let to evaporate. The -galactosidase reaction was started by adding 100 i.l of 
o-nitrophenyl-3-D-galactopyranoside (ONPG, 4 mg/ml in Buffer Z) and incubated at 
30°C. When a pale yellow colour developed, the reactions were stopped with 250 p.1 
of IM Na2CO3 . The reactions were centrifuged for 5 minutes at 14,000 rpm and the 
optical densities were read at 420 nm. The -galactosidase activity was expressed in 
units according to the formula: 
3-galactosidase activity (units) = 1000 * 0D420 / (0D600 * Vol * Time) 
where: 	"0D420" is the absorbance read from the sample at 420 nm; 
"0D600" is the turbidity of cells read 2 hours after galactose induction; 
"Vol" is the volume of culture used for the assay (i.e. I ml); 
"Time" is the time of reaction in minutes. 
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GGL-U media: 0.067% (wlv) Yeast Nitrogen Base w/o amino acids 
2% (w/v) glycerol 
2% (wlv) lactate, pH 5.7 
0.05% (w/v) glucose 
0.2% (w/v) Ura drop-out powder (section 2.1.4) 
pH adjusted with 1 pellet of NaOH per 500 ml 
Buffer Z: 	100 mM Na2HPO4 , pH 7.5 
10 m KCI 
1 MM  MgSO4 
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2.3 Nucleic Acids Methods 
2.3.1 General Methods 
2.3.1.1 Extraction with phenol :chloroform :isoamyl alcohol 
To purify the nucleic acid solution from proteins an equal volume of 
phenol: chloroform:isoamylalcohol (P/C/1) (25:24:1) was added, vortexed for 10 
seconds and centrifugated at 14,000 rpm for 5 minutes. The upper (aqueous) phase, 
containg the nucleic acids was carefully removed into a fresh Eppendorf tube. 
2.3.1.2 Precipitation of nucleic acids 
Nucleic acids were precipitated from aqueous solution by mixing with 1/10 volume 
of 3 M NaOAc (p1-1 5.2) and 3 volumes of ice-cold ethanol (abs.) and freezing at - 
70°C for at least 1 hour. Nucleic acids were pelleted by centrifugation at 14,000 rpm 
for 20 minutes at 4°C and then washed with ice-cold 70% ethanol and spin as before. 
The supernatant was removed and the pellet dried under vacuum, resuspended in the 
appropriate volume of distilled sterile water and, where applicable, the nucleic acid 
concentration was determined. 
2.3.1.3 Spectrophotometric Quantification of Nucleic Acids 
The concentration of DNA or RNA was determined by measuring the absorption of 
diluted solutions (usually 1:1000) at a wavelength of 260 nm using the Cecil CE 
2040 spectrophotometer. The measurements were done in quartz cuvette. For double 
stranded DNA an 0D 260 value of 1.0 represents a DNA concentration of 50 j.tg/ml. 
For single-stranded RNA an 0D260 of 1.0 represents RNA concentration of 
approximately 40 .ig/ml. The calculations were performed using the online 
DNA/RNA calculator at: 
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http://www.geocities.comlCapecanaveral/Lab/9965/calculator-dnaconc.html. 	To 
determine if the nucleic acid solution was protein free, the absorption at wavelengths 
of 260 nni and 280 nm were measured. Pure preparation of DNA / RNA solution 
should give an 0D2 60:013280 ratio value between 1.8 and 2.0. 
2.3.2 DNA Methods 
2.3.2.1 Small Scale Preparation of Plasmid DNA from by Spin Column 
Plasmid DNA from E. coli was prepared using the QlAprep kit (Quiagen) following 
the manufacturer's instructions. DNA was extracted from 3 ml of E. coli cell culture 
grown to stationary phase, eluted with 50 .tl of distilled water and stored at -20°C. 
2.3.2.2 Plasmid Rescue from Yeast Cells 
A single yeast colony containing a plasmid was collected with a toothpick and 
resuspended in an Eppendorf tube with 200 .ti of lysis buffer. Two hundred 
microlitres of glass beads (150-212 tm in diameter; Biospec Products Inc.) and 200 
p.1 of phenol: chloroform: isoamyl alcohol (25:24:1) were added and the tube vortexed 
for 5 minutes and then subjected to centrifugation (14,000 rpm, 5 minutes). The 
upper phase was removed and mixed with 1/2 volume of 7.5M ammonium acetate 
(N1-I4oAc) and 4 volumes of ice-cold ethanol (abs.) and placed on dry-ice for 20 
minutes. The DNA was pelleted by centrifi.igation at 14,000 rpm for 10 minutes at 
4°C then washed with 70% (v/v) ethanol and vacuum dried. The pellet was 
resuspended in 10 p.1 of sterile distilled water. Subsequently, 1.5 p.1 was transformed 
in electro-competent E. coil cells and the transformants plated onto the appropriate 
media (section 2.2.5). A single E. coil colony was collected and plasmid DNA was 
extracted (section 2.3.2.1). 
44 
Chapter 2: Materials and Methods 
Lysis buffer: 	2% (v/v) Triton X-100 
1% (w/v) SDS 
100 mMNaC1 
10 mM Tris-HC1, pH 8.0 
1 mM EDTA 
2.3.2.3 Preparation of Yeast Genomic DNA 
Yeast genomic DNA was prepared using the method of Hoffman and Winston, 1987. 
Ten mililiters of the appropriate selective medium were inoculated with a single 
yeast colony and grown overnight at the appropriate temperature in a shaking 
incubator. The cells were harvested by centrifugation at 3,500 rpm for 5 minutes 
(MSE Mistral 1000 centrifuge) and then washed in 10 ml of sterile, distilled water. 
The cells were resuspended in 1 ml of sterile, water and transferred to an Eppendorf 
tube, pelleted at 14,000 rpm for 10 seconds. Two hundred microlitres of lysis buffer 
(section 2.3.2.2), 200 .x1 of glass beads (150-212 p.m) and 200 ptl of phenol: 
chloroform: isoam yl alcohol (25:24:1) were added and the mixture vortexed for 4 
minutes. Two hundred microlitres of sterile, distilled water was added, the tube 
vortexed for 10 seconds and then centrifuged (14,000 rpm, 5 mm, RT). The upper, 
DNA containing phase was removed and transferred into a fresh Eppendorf tube. 
Then the DNA was precipitated (see section 2.3.1.2), the pellet vacuum dried and 
resuspended in 100 tl of distilled water. Typically, a yield of 0.2 j.tg4tl was obtained. 
2.3.2.4 Restriction Digestion of DNA 
Restriction endonuclease digestion of DNA was typically performed in volumes of 
20-50 p1. These volumes contain the required quantity of DNA (usually 2-5 p.g) and 
the appropriate restriction buffer (as supplied by the manufacturer) at IX 
concentration. The restriction enzyme (typically 2-5 units) was added the last to the 
reaction taking care to keep the restriction enzyme volume below 10% of the total 
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volume. The restriction digest was incubated at the temperature recommended by the 
supplier for a period of 2-10 hours. For the double digest reaction, both enzymes 
were added concurrently providing that both would retain full activity in a suitable 
buffer. The products of the digestion were analysed by agarose gel electrophoresis 
(see section 2.3.2.8) and isolated from the gel and purified (as described in section 
2.3.2. 10). 
2.3.2.5 Removal of 5' Phosphates from DNA 
Plasmid DNA digested with restriction endonucleases (section 2.3.2.4) was 
incubated with 5 units of Calf Intestinal Alkaline Phosphatase (CIP) (for 20 p1 
reaction) for 30 minutes at 37'C. In this way the terminal phosphate groups were 
removed and therefore the recircularisation of the vector DNA in any subsequent 
ligation reactions (see section 2.3.2.11). 
2.3.2.6 Amplification of DNA using the Polymerase Chain Reaction 
Specific regions of DNA were amplified using the polymerase chain reaction (PCR). 
A PCR reaction mix was set-up in a 0.5 ml Eppendorf tube as follows: 
lox Polymerase Buffer 	 1X 
Template DNA 	 10-500 ng of yeast genomic DNA or 
10-30 ng of plasmid DNA 
Oligonucleotid primer 1 
Oligonucleotid primer 2 
dNTPs (CIATP, dCTP, dGTP, dTTP) 
MgC12 
DNA polymerase a 
Sterile distilled water 
0.5 iM 
0.5 j.tM 
200 p.M each 
1.5-6mM 
1.25 units per 50 p.1 
up to 50 p.1 
PCR reactions were carried in a PTC-1 00 Hot Lid reactor (MJ Research) 
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programmed depending on the length of the desired product and the annealing 
temperature of oligonucleotide primers used. 
A typical program contained the following steps: 
Step I - Denaturation: 94°C 3 minutes 
Step 2 - Denaturation: 94°C 1 minute 
Step 3 - Annealing: Td  0C ) 1 minute 
Step 4— Extension: 72°C 1 minute' 
30 cycles of Step 2— Step 4 
Step 5 - Final extension 72°C 3 minute 
'for most applications, Taq DNA polymerase was used. When an accurate 
amplification of the DNA was needed (i.e. cloning of PCR products for gene 
expression), Pfu polymerase was used. 
bTdoc is the annealing temperature calculated for oligonucleotides up to 20 
bases long with the formula: 
Td°C = {4(G+C) +2(A+T)} -4 
'One minute extension time per every kb of the length of the desired product. 
2.3.2.7 PCR from Yeast Colonies 
One large yeast colony was picked with a sterile toothpick and resuspended in 10 t1 
of freshly prepared 0.02 M NaOH. The cell suspension was briefly vortexed and 
boiled for 5 minutes and immediately put on ice until needed. Two microliters of cell 
suspension were added to a 30 t1 PCR reaction assembled on ice. The PCR 
conditions are as above, except that the thermocycler was pre-heated to 94°C before 
the program took place. 
47 
Chapter 2: Materials and Methods 
2.3.2.8 Agarose Gel Electrophoresis 
Agarose gel electrophoresis of DNA fragments produced by restriction endonuclease 
digest (section 2.3.2.4) or generated by PCR (section 2.3.2.6) was typically 
performed in 0.8-1% (w/v) agarose gels. Gels were prepared by melting the 
appropriate amount of agarose in lx TAE buffer (Table 2.4) and adding ethidium 
bromide to a final concentration of 0.1 tgIml. DNA samples to be analysed were 
mixed with 1X Agarose gel loading buffer and loaded directly onto the gel.. The gel 
was placed in IX TAE buffer and run at a constant voltage of I 50-200V. To estimate 
the size of DNA fragments, 1 Kb Plus DNA Ladder (Gibco BRL) was also loaded on 
the gel. The DNA could be visualised on a UV transilluminator. 
lox Agarose gel loading buffer: 	0.25% (w/v) Bromphenol blue 
30% (v/v) Glycerol 
2.3.2.9 Purification of PCR Products 
If the PCR performance generated a single product (as seen on agarose gel), this was 
purified from oligonucleotide primers, unincorporated nucleotides, polymerises and 
salts using the QlAquick PCR purification kit (Quiagen) according to manufacturer's 
instructions. The DNA was eluted in 30 tl of elution buffer (also supplied in a kit) 
and stored at -20°C. 
2.3.2.10 Purification of DNA from Agarose Gels 
As an alternative to the previous protocol, the DNA fragments produced by PCR or 
by restriction endonuclease digestion were purified after separation on an agarose 
gel. Using a clean razor blade, the band of interest was excised from the gel and 
further purified using the QlAquick gel extraction kit (Qiagen), following the 
manufacturer's guidelines. DNA was typically eluted in 30 tl of elution buffer 
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(supplied with the kit) and stored at -20°C. 
2.3.2.11 Ligation of DNA Molecules 
Ligations were typically performed in a total volume of 15 p.1, containing 20-30 ng of 
vector DNA, approximately 8 times this amount of insert DNA, 1X ligation buffer. 
1 mM ATP and 2 units of Fast-Link DNA ligase (Epicentre Technologies). The 
reactions were incubated at room temperature overnight and stopped by heat-
inactivation of the enzyme for 15 minutes at 70°C. The reaction mix was ethanol 
precipitated, the pellet washed (section 2.3.1.2) and resuspended in 1.3 p.1 of sterile, 
distilled water. The whole amount was used to transform 40 p.1 of E.coli competent 
cells (section 2.2.5). 
2.3.2.12 Mutagenic PCR of PRP45 gene using skewed nucleotide concentrations 
This protocol is modified after Leung el al., 1989. 
In order to randomly mutagenized PRP45 gene, the same protocol for PCR 
amplification of plasmid DNA was used except that the concentration of one 
deoxynucleotide (dATP) was lower. 
The mutagenic PCR reaction was set up as follows: 
lox Taq DNA Polyrnerase buffer IX 
Plasmid DNA (pRS-45) 15 ng 
DMSO 10%(vlv) 
MgC12 6 mM 
Direct primer (PS&5-45M) 0.5 p.M 
Reverse primer (TXHO-45M) 0.5 p.M 
dGTP, dCTP, dTTP 1 mm 
dATP 200 p.M 
sterile, distilled water up to 50 p.1 
Taq DNA polymerase 5U 
49 
Chapter 2: Materials and Methods 
The PCR product was gel-purified (section 2.3.2.10), resuspended in 30 .tl of 
sterile water and then quantified by running 10% of the total volume on agarose gel. 
Five hundred nanograms of the purified PCR product were used for transformation. 
2.3.2.13 Site-directed mutagenesis 
Two methods of side-directed mutagenesis have been used in this thesis: 1) site 
directed mutagenesis by overlap extension and 2) site-directed mutagenesis by whole 
plasmid synthesis. Both protocols allow PCR (section 2.3.2.6) to be used for 
introducing site-directed mutations into PRP45. The PCR was carried out on 
miniprep plasmid DNA as a template (section 2.3.2) and using mutagenic primers 
containing desired mutations. 
2.3.2.13.1 Site-directed mutagenesis by overlap extension 
This protocol is adapted after the one described by Ho et al., 1989. Two separate 
PCRs were performed on the template wild-type PRP45 gene to give products T2 
and T3 (Figure 2.1). The primers used P1 and P2 (for T2) and P3 and P4 (for T3) are 
designed as follows: 
- P2 and P3 overlap and contain the desired mutations in the middle with 10-15 bases 
of correct sequence on either side; 
- P1 (PS&5-45M or S) and P4 (TXHO-45M or X) have added restriction sites at 
5'ends SpeI and )UwI, respectively, so that the final product, TI can be ligated into 
the original vector that contained the wild-type gene (pRS-45). 
The PCRs were carried out as described in section 2.3.2.6 with the following 
specifications: 
- the amount of primers, template and dNTPs was 2.5X higher than for the normal 
PCR; 
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ZspellXhol digestion 
Ligation 
Figure 2.1 Site-directed mutagenesis of PRP45 by overlap extension. 
Templates T2 and T3 were run on agarose gel to check their sizes and gel-
purified (section 2.3.2.10). The final product Ti containing prp45 allele was made by 
hybridizing the overlapping strands from the two fragments (around 50 ng each) and 
extending this overlap using a normal PCR protocol and the primers P1 and P4. 
Finally, TI was gel-purified, digested with the restriction enzymes SpeI and XhoI and 
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ligated into the original plasmid (section 2.3.2.11). 
2.3.2.13.2 Site-directed mutagenesis by whole plasmid synthesis 
This method is adapted after the one described by Weiner et al. (1994). The DNA 
template (pRS-45 plasmid) was denatured before being subjected to PCR. Ten 
micrograms of plasmid miniprep was treated with 10 jtl of Denaturing solution in a 
total volume of 50 il and incubated for 15 minutes at 37°C. The DNA was 
precipitated according to the protocol described in section 2.3.1.2 and resuspended in 
20 pJ of sterile water. Two microliters of denatured pRS-45 were used for the PCR 
reaction in a final volume of 50 pl. The oligonucleotide primers (0.5 tM), each 
complementary to opposite strand of the vector and containing the desired 
mutation(s), are extended during temperature cycling by Pfu DNA polymerase. 
The PCR profile used is the following: 
Step 1 - Denaturation: 
Step 2— Denaturation: 
Step 3 - Annealing: 
Step 4— Extension: 
18 cycles of Step 2 - Step 4 









2 minutes / k1 
10 minute 
Incorporation of the oligonucleotide primers generates a mutated plasmid 
containing staggered nicks (Figure 2.2). The PCR product was checked on agarose 
gel. 
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Mutations containing primers 
Denature DNA template 








--- 	Nick repair 
0 
Figure 2.2 Site-directed mutagenesis by whole plasmid synthesis. 
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Then 20U of DpnI was added directly to the PCR reaction and the digestion 
was incubated for 2 hours at 37°C. DpnI restriction enzyme digests the non-mutated 
parental DNA template and selects for the synthesized DNA containing mutations. 
Since DNA isolated from most K coil strains is dam methylated, it is susceptible to 
DpnI digestion, which is specific for methylated and hemimethylated DNA. The 
nicked vector DNA incorporating the desired mutations is then transformed into TOP 
10 E. coii strain. After transformation, the E. coil cells repair the nicks in the mutated 
plasmid. 
Denaturing solution: 	I M NaOH 
1mM EDTA, pH 8.0 
2.3.2.14 End-labelling of Oligonucleotides 
For Northern blot analysis oligonucleotides were labelled in a 20 .tl reaction using 
T4 polynucleotide kinase (PNK. New England Biolabs). The reaction mix was 
prepared as follows: 
Oligonucleotide (1 Opmol/pi) 1.0 	tl 
lOX PNK buffer 2.0 .fl 
[y-32P]ATP (--5000 Ci! mmol) 2.0 	.tl 
T4 PNK (10 units/tl) 0.5 	tl 
Sterile, distilled water 14.5 p1 
The labelling reaction was incubated at 37°C for 30 minutes. Prior to blotting, 
the radiolabelled oligonucicotidc reaction was purified by passing through a 2 tm 
filter. 
54 
Chapter 2: Materials and Methods 
2.3.2.15 DNA Sequencing 
Plasmid DNA to be sequenced was prepared using the QlAprep spin columns 
(section 2.3.2.9) and quantified by visualisation on an agarose gel (section 2.3.2.8). 
For genomic DNA, the segment to be sequenced was first amplified by PCR (section 
2.3.2.6), purified using QlAquick PCR purification kit and 10% of the eluted product 
was quantified by visualisation on agarose gel. Sequencing reactions were performed 
with the BigDye Terminator Cycle Sequencing Ready Reaction in a PTC-100 Hot 
Lid reactor (Genetic Research Instrumentation Ltd). A typical reaction mix was set 
up as follows: 
Template DNA 	200 ng of plasmid DNA or 100-120 ng of PCR product 
Primer 	 1.6 pmol 
Terminator mix 	4 p.1 
Sterile, distilled water up to 10 p.1 
The following sequencing program was run for 25 cycles: 
Step 1: 96°C for 30 seconds 
Step2: 50°C for 15 seconds 
Step3: 60°C for 4 minutes 
The DNA was precipitated from the reaction mix by adding 25 p.1 of ice-cold 
ethanol (abs.) and 1 p.1 of 3 M NaOAc, pH 5.2, incubating on ice for 20 minutes 
followed by centrifugation (13,000 rpm, 30 minutes, 4°C). The pellet was washed 
with 250 p.1 of ice-cold 70% (v/v) ethanol and dried on bench for 1 hour. 
Alternatively, the sequencing reactions were purified on genCLEAN Dye Terminator 
Removal Columns (GENETIX), according to the producer's instructions. The 
samples were run by Jill Lovell (ICAPB, University of Edinburgh) on an ABI 
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PRISM® 377 DNA Sequencer and the resulting sequences were analysed using 
Sequencer TM4 computer program. 
2.3.3 RNA Methods 
2.3.3.1 Total RNA Preparation from Yeast 
Yeast total RNA was prepared using the modified protocol of Schmitt et al., 1990. 
Fifty millilitres of the appropriate medium (Table 2.2) was inoculated with a 
single colony of yeast strain and grown overnight at the suitable temperature. Upon 
reaching 0D600 of 0.5-0.7, the cells were sedimented by centrifugation at 3,500 rpm 
for 5 minutes (MSE Mistral 1000 centrifuge). The supernatant was removed and the 
cells resuspended in 400 p.1 of AE buffer. At this point the cells could be stored in 
AE buffer for 6 months at -70°C. Otherwise, 50 p.1 of 10% (w/v) SDS and 500 p.1 of 
phenol-AE were added to the cells, vortexed twice vigorously and incubated at 65°C 
for 4 minutes. The samples were snap-frozen in liquid nitrogen and allowed to thaw 
before being centrifuged at 14,000 rpm for 5 minutes. The aqueous phases was 
removed and extracted twice with phenol-AE: chloroform (1.2: 1) and once with ice-
cold chloroform. The aqueous layer was again removed in an Eppendorf and 
precipitated with ethanol (section 2.3.1.2). The precipitated RNA was dried under 
vacuum and resuspended in 40 p.l of ice-cold DEPC-treated water and the 
concentration measured at spectrophotometer (section 2.3.1.3). 
AE buffer: 	50 mM NaoAc, pH 5.2 
10mMEDTA,pH8 
Phenol-AE: 	Phenol equilibrated with AE buffer in a ratio of 4:1 and left to get 
separated overnight at 4°C. 
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2.3.3.2 RNA Gel Electrophoresis and Northern Blot Analysis 
Low molecular weight RNAs (shorter than 600nt) were separated on 
polyacrylamide-urea gels. The gels (6%) were prepared by mixing 20 ml Sequagel-6 
and 5 ml Sequagel complete buffer reagent (National Diagnostics), as well as adding 
300 j.tl of 10% (w/v) ammonium persuiphate (APS). 10 .ig of yeast total RNA 
(section 2.3.3) was mixed with three volumes of Sanger loading dye and heated to 
95°C for 3 minutes immediately prior to loading. Gels were run in 1X TBE buffer 
(Table 2.4) at room temperature (24W, 1 hour). 
The RNA was then transferred electrophoretically from the gel to a HybondTM-
N nylon membrane (Amersham Pharmacia) in 0.5X TBE (Table 2.4) for 3 hours at 
50V. Once the transfer complete, the membrane was blotted dry and the RNA was 
cross-linked to the membrane in a Stratagene UV Stratalinker using the 
'autocrosslink' function to immobilise the RNA on the filter. 
Sanger loading dye: 51% (vlv) Formamide 
20 mM EDTA 
0.3% (w/v) Xylene xyanol 
0.3% (w/v) Bromophenol blue 
High molecular weight RNAs (longer than 600nt) were separated on agarose 
gels. Agarose gels (2%(w/v)) were prepared by melting 4g of agarose in 200 ml of 
0.5X TBE buffer (Table 2.4). Total RNA (8 - 1 Ojtg) prepared as described in section 
2.3.3 was mixed with 5 volumes of RNA loading buffer and heated to 65°C for 15 
minutes immediately prior to loading. Electrophoresis was performed in 05X TBE 
buffer at 60V for approximately 16 hours. 
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RNA loading buffer: 	50% formamide 
6% formaldehyde 
0.1X HEPES 
10% (v/v) glycerol 
0.025% (w/v) bromphenol blue 
0.025% (w/v) xylene cyanol 
0.01% (w/v) ethidium bromide 
The agarose gel was washed twice in distilled water, 5 minutes each, with 
gentle agitation. The RNA was transferred in 6X SSC (Table 2.4) by capillary force 
to a HybondTM- N nylon membrane (Amersham Pharrnacia). Transfer was allowed to 
take place overnight and, following this, the RNA was immobilised on the membrane 
by cross-linking as above. 
2.3.3.3 Hybridisation of Northern Blots 
The membranes were hybridised with 5'end labelled oligonucleotides (section 
2.3.2.14). Two protocols of hybridisation were followed depending on the length of 
the radiolabelled oligonucleotide used. 
a) End-labelled oligonucleotides smaller than 35 nucleotides were hybridised as 
follows: the nylon membrane was pre-hybridised in 50 ml of hybridisation buffer-S 
(pre-warmed to 65°C) for at least one hour at 37C. 
The labelled probe was added to the membrane and the incubation continued 
overnight at 37°C. The following morning the probe was decanted off and stored at - 
20°C for possible re-use. The membrane was washed twice for 20 minutes in 6X 
SSPE buffer (Table 2.4) pre-warmed to 42°C. Following washings, the nylon 
membrane was blotted dry, wrapped in Saran wrap to prevent it drying out and 
subjected to autoradiography at -70°C. 
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b) For end-labelled oligonucleotides larger than 35 nucleotides, the pre-hybridisation 
was done in formamide hybridisation buffer (pre-warmed to 65°C) for at least one 
hour at 37°C. The protocol was similar to a) with the exception of the washings, 
which were done with 2X SSPE (Table 2.4). 
Hybridisation buffer-S: 
Formamide hybridisation buffer 
lox SSPE 
5X Denhardts solution 
0.5% (w/v) SDS 
200 tg/m1 Salmon Sperm DNA 
50% (vlv) Formamide 
5X SSPE 
5X Denhardts solution 
1% (w/v) SDS 
200 p.g/ml Salmon Sperm DNA 
50X Denhardts solution: 	 1% (w/v) BSA 
1% (w/v) FicoIl 400 
1% (w/v) Polyvinylpyrolidone (PVP) 
2.3.3.3.1 Membrane Stripping for Reprobing 
For successful removal of probes, membranes were never allowed to dry during or 
after hybridisation and washing. To strip, a boiling solution of 0.1% (w/v) SDS was 
poured onto the nylon membrane and allowed to cool to room temperature on a 
shaking platform. This was repeated twice. The membrane briefly rinsed with 
distilled water to remove the stripping solution, blotted dry and either re-probed with 
another end-labelled oligonucleotide as above or stored between Saran wrap for 
future use. 
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2.3.3.4 Microarray Analysis 
This analysis was performed in collaboration with our colleague David Barrass who 
optimised the conditions and perfected this method for its applications to examine 
splicing in yeast. 
2.3.3.4.1 Microarray slides 
Microarray slides were printed at SCGTI University of Edinburgh. They contain 
oligonucleotide probes corresponding to intron-containing genes of the yeast 
genome. Each gene has four probes: one probe is to detect the 3' exon, one to the 5' 
splice site, one to the mature junction formed on splicing and one to intron itself. 
There are some controls: probes against yeast intronless genes and some to 
snRNAs; all of these found within introns and some produced by RNA polymerase 
II. Each probe has 35 - 51 bases (average 41 bases), with a melting temperature of 
80-90°C. The probes were printed in triplicate onto the surface of the poly-lysine 
coated slides where they bind non-covalently. Labelled target eDNA (derived from 
yeast total RNA) hybridizes to these probes specifically. 
2.3.3.4.2 Target labelling 
Labelling the target was done as follows: total yeast RNA (section) was prepared 
from wild-type and temperature sensitive cell cultures matched in pairs having 
similar culture density. Between 20-50 tg of RNA was mixed with 9 .tl of gene 
specific primer mix (MWG) and the volume adjusted to 19 pA with DEPC-treated 
water. The specific primer mix consists of oligonucleotide primers (MWG) of 20 - 
24 bp that hybridises to the RNA species recognised by the microarray probes. They 
are designed to amplify an anti-sense target for each of the transcripts represented on 
the array. 
The RNA solution was denaturated at 70°C for 10 minutes and then placed on 
ice. To this, an equal volume of labelling mix containing the reverse transcriptase 
and Cy3 I Cy5 labelled deoxynucleotides was added. The labelling reaction was 
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incubated in the thermoblock (PTC- 100 Hot Lid reactor (MJ Research)) overnight at 
47°C. 
Labelling mix: 1X cDNA synthesis buffer 
0.2 M DU 
7.5 mM of each dATP, dCTP, dGTP and 3.5 mM dTTP 
0.01 M Cy3IC5 labelled dTTP (Amersham Pharmacia) 
20 U RNase inhibitors (Invitrogen) 
30 U Thermoscript reverse transcriptase (Invitrogen) 
5X cDNA synthesis buffer: 250 mM Tris-acetate, pH 8.4 
375 mM Potasium Acetate 
40 mM Magnesium Acetate 
2.3.3.4.3 Target purification 
After this incubation, the labelled cDNA (microarray target) was purified by adding 
RNA hydrolysis solution, followed by incubation at 65°C for 30 minutes and the 
neutralisation with Tris-HCI. pH 7.5 at 4°C for at least 5 minutes. Following this, 
Cy3 and Cy5 targets were combined (in order to form part of one hybridisation) and 
mix with 20 tg of human Coti DNA (Invitrogen). The mixture was applied to 
Microcon YM-100 purification column (Millipore) and spun to filter-purify the 
target with two washings of the column. 
RNA hydrolysis solution: 	0.5 M NaOH 
250 mM EDTA, pH 8.0 
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2.3.3.4.4 Pre-treatment and hybridisation 
Micro-array slides were treated in blocking solution for 15-20 minutes before being 
washed. Then they were incubated in pre-hybridisation solution for 45 minutes at 
46°C. The incubation step was followed by rinsing in water, dehydration in 95% 
ethanol and drying by spinning for 1 minute at 1000 rpm (MSE Mistral 1000 
centrifuge). 
The labelled target was added to slides, covered with cover-slips and the slides 
were tightly sealed in humidified hybridisation chambers. The hybridisation was 
performed overnight at 46°C. 
After hybridisation, the slides were washed for five minutes each in three 
washing solutions: wash solution 1 (1X SSC, 0.2% SDS), wash solution 2 (0.1X 
SSC, 0.2% SDS) and wash solution 3 (0.1X SSC). Finally the slides were rinsed in 
water and dried as before. 
Blocking solution: 	92% (v/v) 1 -methyl-2-pyrilidinone (NMP) 
8% (v/v) Boric acid, pH 7.0 
1.63% (w/v) Succinic Anhydride 
Pre-hybridisation solution: 5X SSC (Table 2.4) 
0.1% SDS 
1% (w/v) BSA 
2.3.3.4.5 Scanning and data analysis 
Arrays were scanned with a scanner Affymetrics 428. The conversion of 
fluorescence signals to numerical values and scatter plots were performed using 
Array ProAnalyser software. 
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2.3.3.5 In vitro Transcription of Actin pre-mRNA 
2.3.3.5.1 Preparation of DNA template 
Plasmid p283 containing the actin gene (Table 2.8) was used for T7 polymerase - 
directed in vitro transcription reaction. The plasmid (SOOng) was linearized with 
BamHI restriction enzyme in a total volume of 20 j.tl as in section 2.3.2.4. Following 
digestion, 1 p1 of the template DNA was directly used in in vitro transcription 
reaction. 
2.3.3.5.2 Transcription Reaction 
The transcription reaction was set up in a clean Eppendorf and incubated at 37°C for 
30 minutes. 
The reaction mix was as follows: 
Liniarised template DNA 	 I p.! 
T7 buffer 1.5 p.! 
10 mM CTP, GTP, UTP 1.t1 
400 p.M ATP I p.! 
[c.t-32P] ATP (-3000 Ci/mmol) 1 p.! 
sterile, distilled water 11.7 p.! 
RNasin 0.3 p.! 
T7 RNA polymerase 0.5 p.1 
T7 buffer: 0.4 M Tris-HCI, pH 8.0 
0.1 M M902 
0.2MDTT 
0.1 MNaC1 
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2.3.3.5.3 Purification of transcript 
The actin transcription reaction volume was increased to 100 M'  with DEPC-treated 
water and purified from proteins, unwanted nucleotides and salts by phenol: 
chloroform:isoamyl alcohol (25:24:1) extraction (section 2.3.1.1) and ethanol 
precipitation (section 2.3.1.2). The RNA pellet was dried under vacuum and 
resuspended in 50 jii of DEPC-treated water. The transcript could be stored at -20°C 
for up to 5 days. 
2.3.3.6 In vitro splicing 
In order to analyse if a whole yeast cell extract (see section 2.4.3) is able to splice 
(i.e. formation of spliced mRNA and splicing intermediates), in vitro splicing was 
performed using radiolabelled actin pre-mRNA transcript (section 2.3.3.5) as a 
substrate. 
The following reaction mix was set up in a sterile Eppendorf: 
1 Ox splicing buffer 	 1 p.1 
30% (wlv) PEG —8000 	 1 p.1 




In vitro actin pre-mRNA (1OOOcps) 	0.5 p.1 
The reaction was incubated at 24°C for 25 minutes and then terminated by placing on 
ice. Two microlitres of Proteinase K solution was added, and the contents were 
gently mixed and incubated at 37°C for 45 minutes. Following this incubation, 200 
p.1 of splicing cocktail was added and the resulting mixture extracted twice with 200 
p.1 of phenol: chloroform:isoamyl alcohol 25:24:1 (section 2.3.1.1) to remove the 
protein debris. The supernatant containing the RNA was precipitated by the addition 
of 600 p.1 of ethanol (abs.) (section 2.3.1.2) and centrifuged at 14,000 rpm for 20 
minutes at 4°C. The RNA pellet was washed in 70% (v/v) ethanol and dried under 
vacuum. Ten microlitres of Sanger loading dye (section 2.3.3.2) were added and the 
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samples boiled for 5 minutes. The prepared RNA was loaded on a 7% denaturing 
polyacrylamide gel (section 2.3.3.2) and run in IX TBE buffer (Table 2.4) at 24 W 
for 1 hour. The gel was vacuum-dried for 2 hours at 75°C and exposed to 
autoradiography film at -70°C. 
lOx splicing buffer: 600 mM KPO 4 , pH 7.5 
25 MM  MgC1 2 
20 mM ATP 
Proteinase K solution: 1 mg/ml Proteinase K 
50 mM EDTA, pH 8.0 
1% (w/v) SDS 
Splicing cocktail: 	50 mM NaoAc, pH 5.3 
1 mM EDTA, pH 8.0 
0.1% (w/v) SDS 
25 i.g/ml E. coil tRNA 
2.3.3.7 Native gel electrophoresis 
Native gel electrophoresis was carried out using an adaptation of the method of 
Pikielny et al. (1986). This system separates the three splicing complexes: pre-
spliceosome (complex III or A), inactive spliceosome (complex I or B) and active 
spliceosome able to support the two splicing steps (complex II or Q. 
Two 16 X 16 cm glass plates separated by 1.5 mm spacers were tapped 
together and pre-warmed at 65°C. To seal the plates. a 3-4 cm blocking gel was 
poured between the plates and the gel-assembly left to set at 65°C for 5 minutes. A 
separating gel was then poured on the top of the blocking gel up to the top of the 
plates and a 10 X 10 cm comb was inserted. The gel was allowed to polymerise at 
room temperature for 3-4 hours and then stored at 4°C overnight covered in Saran 
wrap. Non-denaturing gels were pre-run at 4°C for 1 hour in pre-chilled 1X Native 
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gel running buffer (80V). 
Splicing reactions were set up as in section 2.3.3.6 and terminated on ice. An 
equal volume of ice-cold Q buffer was added to each reaction and then incubated for 
10 minutes on ice. Five microlitres of ice-cold RNP loading dye were added to each 
sample then loaded on the gel. The gel was run at 4°C overnight at 30V until the 
xylene blue dye front had reached the blocking gel. Once the electrophoresis 
terminated, the gel was covered in Saran wrap and exposed to autoradiography film 
at -70°C. 
Blocking gel: 	lml 29.2% (w/v) acrylamide: 0.8% (w/v) bis-acrylamide 
100 pJ 0.5M EDTA 
250 p.1 1OXTB 
3.65 ml DEPC-treated water 
50 p.110% ammonium persuiphate (APS) 
20 p.1 TEMED 
Resolving gel: 0.25 g agarose was melted in 40 ml DEPC-treated water and then the 
mixture incubated to 65°C until use. Five mililiters of acrylamide [29.2% (w/v) 
acrylamide : 0.8% (w/v) bis-acrylamide] were mixed with 2.5 ml lOX TB buffer, 1 
ml 0.5 M EDTA and 2.5 ml glycerol and incubated at 65°C. The agarose mixture 
was added to the acrylamide mixture, the total volume was adjusted to 50 ml with 
pre-warmed DEPC-treated water (65°C). Four hundred microlitres of 10% 
ammonium persulphate (APS) and 50 p.1 of TEMED were added and the gel was 
poured immediately. 
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4XQmix: 	 1.6MKC1 
8 mM Magnesium Acetate 
80 mM EDTA 
64 mM Tris-HC1, pH 7.5 
Q buffer: 	 IX Q mix 
2.8 gItI yeast total RNA 
RNP Loading dye: 	 50% Ficoll 
2.5X TB 
50 mM EDTA 
0.2% Bromophenol blue 
0.4% Xylene cyanol 
lox TB: 	 1.2 M Tris-HC1, pH 7.5 
400 mM Boric acid 
lox Native gel running buffer: 	5X TB 
100 mM EDTA, pH 8.0 
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2.4 Protein methods 
2.4.1 Spectophotometric Quantification of Proteins 
Protein concentrations were determined by the Bradford method using the Bio-Rad 
Protein Assay and following the manufacturer's instructions. Briefly, a series of BSA 
standards were prepared by diluting 10 mg/ml BSA (NEB) in sterile, distilled water 
to give four to five dilutions between 0.2 and 0.9 mg/mi. One hundred microliters of 
each standard solution was mixed with 5 ml diluted (1:5) Bradford Dye Reagent 
(Bio-Rad), vortexed and allowed to stand for 5 minutes at room temperature. The 
0D595 of each sample was measured (with a 0 mg/ml solution as a blanc) and the 
values used to plot a graph of BSA concentration versus 0D 595 . The protein sample 
of unknown concentration was simultaneously treated in the same manner and the 
concentration was extrapolated from the standard plot. Each protein concentration 
was assayed in triplicate. 
2.4.2 Crude Extraction of Total Cellular Protein from Yeast 
Ten milliliters of the appropriate medium (section Table 2.2) was inoculated with a 
single yeast colony and incubated at the required temperature overnight. The 
following day the OD600 was measured and a total of 3 0D 600 units of cells were 
harvested by centrifugation for 5 min at 3500 rpm (Mistral 1000 centrifuge). The 
pellet was resuspended in 500 j.tl of 0.2 M NaOH, transferred to a clean Eppendorf 
and left on ice for 10 minutes. Fifty microlitres of 50% Tn-sodium acetate (TCA) 
were added and the precipitate incubated on ice for at least 10 minutes. The 
suspension was centrifugated for 5 minutes at 14,000 rpm and the supernatant 
disposed. The pellet was resuspended in 35 .tl of dissociation buffer and then 15 tl 
of IM Tris base were added to neutralise the TCA. The extract was stored at -20°C 
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until use. For SDS-PAGE followed by Western blotting, 5-8 pA of extract were 
heated to 95°C for 10 minutes prior to loading on a polyacrylamide gel (see section 
2.4.4). 
Dissociation buffer: 0.1 M Tris-CI, pH 6.8 




0.25% Bromophenol blue 
2.4.3 Large Scale Extraction of Yeast Total Cell Protein (Splicing 
Extract) 
One hundred milliliters of the appropriate medium (section Table 2.2) was inoculated 
with a single yeast colony and incubated overnight at the required temperature. This 
culture was used to inoculate 3-4 litres of medium to an 0D 600 of 0.1 and the cells 
were grown further until the 0D600 reached 0.5 - 1.0. The cells were harvested by 
centrifugation at 5000 rpm for 5 minutes (Beckman, JLA 10.5000 rotor) and the 
pellet was resuspended in 50 ml of AGK buffer. Cells were sedimented at 3500 rpm 
for 5 minutes (Mistral 1000 centrifuge), resuspended in 20 ml of AGK buffer and 
centrifuged once again as above. The supernatant was discarded, the pellet was 
weighted and resuspended in 400 pA of AGK buffer for each gram of cell pellet. To 
this suspension, DTT concentration was adjusted to 2 mM and then 10 Al of IOOX 
protease inhibitors (Sigma) was added. Using a sterile syringe or a 1 ml Gilson 
pipette, the cell suspension was transferred drop-wise in a 50m1 Falcon tube full of 
liquid nitrogen. This cell pellet could be either processed further immediately or 
stored at -70°C for at least one year with no loss of activity. 
Using a mortar containing liquid nitrogen the frozen cell pellet was ground to a 
fine powder with occasional addition of liquid nitrogen to ensure that the pellet did 
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not thaw. This frozen powder was then transferred to a chilled polycarbonate 
centrifuge tube and centrifuged at 17,000 rpm for 30 minutes at 4°C (Beckman JA 
25.50 rotor, pre-chilled to 4 0C). Without disturbing the lipid layer, the supernatant 
was transferred to a chilled Ultra plus polycarbonate tube (Nalgene) and centrifuged 
at 40,000 rpm for 1 hour at 4°C (Beckman 70.1 Ti rotor, pre-cooled to 4°C). The 
final supernatant was transferred to a dialysis membrane (10 kDa cut-off) and 
dialysed against two changes of 1.5 litres of ice-cold Buffer D at 4°C, for 3 hours. 
The splicing extract was then placed in pre-chilled Eppendorfs and centrifuged for 10 
minutes at 4°C. The resulting supemate was aliquoted into fresh pre-chilled 
microfuge tubes and stored at -70°C. The splicing extract was thawed slowly on ice 
prior to use. 
AGK buffer: 	10 mM HEPES, pH 7.9 
1.5 MM  MgC12 
200 mM KC1 
10% (vlv) Glycerol 
Buffer D: 	20 mM HEPES, pH 7.9 
50 mM KC1 
0.2 mM EDTA, pH 8.0 
20% (v/v) Glycerol 
0.4 mM DTT (added immediately before use) 
1 tablet of Protease Inhibitors (Roche) per 1.5 L of buffer D 
2.4.4 SIDS Polyacrvlamide Gel Electrophoresis (SDS-PAGE) 
2.4.4.1 Novex Mini Gels 
Protein samples to be analysed by SDS-PAGE were, unless otherwise stated, mixed 
with an equal volume of 2X SDS loading buffer, heated for 5-10 minutes at 70°C and 
centrifuged at 14,000rpm for 20 seconds. The samples were loaded onto a pre-cast 4- 
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12% polyacrylamide gel (Novagen), alongside a molecular weight protein marker of 
known size (SeeBlue Plus2 Pre-Stained Protein Standard, Invitrogen) for reference. 
The gels were run at 200V for 50 minutes, in a Novex Mini-cell (Novagen) with 1X 
MOPS (Table 2.4) as buffer. 
2X SDS Loading buffer: 	100 mM Tris-HC1, pH 6.8 
200 mM DTT (added immediately before use) 
4% (w/v) SDS 
0.2% (w/v) Bromophenol blue 
20% Glycerol 
2.4.4.2 Classic Gels 
In order to get a better resolution of the protein bands, the SDS-PAGE was 
performed using the classic gel system. The SDS polyacrylamide gel was poured 
between two taped 18 x 20 cm glass plates separated by 1 mm spacers. The 
resolving gel solution was prepared, poured between the plates and overlaid with 
isopropanol. The gel was then left to set at room temperature, the isopropanol was 
washed off with sterile, distilled water and the stacking gel was poured and an 
appropriate comb inserted to create the necessary loading wells. After polymerisation 
was complete, the sealing tape was removed from the plates and the comb was gently 
taken out. The plates were fixed into the electrophoresis aparatus (Cambridge 
Electrophoresis) and the chambers were filled with 1X Protein Running Buffer. 
Protein samples were treated as previously and loaded onto the gel along with the 
molecular weight protein marker (SeeBlue Plus2 Pre-Stained Protein Standard, 
Invitrogen). The gel was run at 180V for 7 hours. 
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10% resolving gel solution: 12 ml 30% (w/v) acrylamide 
2.34 ml 2% (w/v) bis-acrylamide 
9 ml 1.5M Tris-Cl, pH 8.8 
360 tl 10% (w/v) SDS 
12.3 ml sterile, distilled water 
360 p.! 10% (w/v) ammonium persulfate 
36 p.1 TEMED 
Stacking gel: 	 1.7 ml 30% (wlv) acrylamide 
650 p.1 2% (w/v) bis-acrylamide 
1.250 ml 1M Tris-Cl, pH 6.8 
6.4 ml sterile, distilled water 
100 p.! 10% (w/v) ammonium persulfate 
10 p.1 TEMED 
lox Protein Running Buffer: 250 mM Tris Base 
1.9M Glycine 
1% (w/v) SIDS 
2.4.5 Western Blotting 
2.4.5.1 Electrophoretic Transfer of Proteins to PVDF Membrane 
Proteins were transferred electrophoretically from SIDS polyacrylamide gel to 
Hybond-P membrane (Amersham Pharmacia) using the Bio-Rad transfer system and 
following the manufacturers' protocol. The transfer was performed in lx Western 
Transfer Buffer at 1 OOV for 2 hours or at 20V over-night. Completion of transfer was 
assessed by the pre-stained marker. 
lOX Western Transfer Buffer: 	1.5 M Glycine 
200 mM Tris-HC1, pH 8.3 
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2.4.5.2 Antibody Binding 
Non-specific protein interactions were blocked by incubating the membrane in 25 ml 
of fresh Blocking Buffer for 1 hour at room temperature, with constant shaking. The 
membrane was washed three times with 25 ml of IX TBS-T buffer (Table 2.4) 
before being incubated in 10 ml Blocking Buffer*  with the appropriate dilution of 
primary antibody (usually 1:1000). This incubation was performed overnight, at 4°C, 
with gentle agitation. The following day the membrane was washed four times in 50 
ml TBS-T buffer, each time for 10 minutes. The HRP-conjugated secondary antibody 
in 10 ml of Blocking Buffer (1:1000 dilution) was added and the incubation 
continued for 1 hour at room temperature, with gentle shaking. Finally, the 
membrane was washed for four times for 10 minutes each with 50 ml of 1X TBS-T 
buffer. 
Blocking Buffer: 	IX TBS-T buffer 
5% (w/v) non-fat dry milk 
For the polyclonal antibodies, the non-fat dry milk in the Blocking Buffer was 
substituted with Bovine Serum Albumin (BSA). 
2.4.5.3 Enhanced Chemiluminescence (ECL) 
Two millilitres of developer solution (Amersham) was prepared as described by the 
manufacturer, applied to the membrane and incubated for 1 minute at room 
temperature with gentle agitation. The membrane was drained of excess developing 
solution, wrapped in Saran wrap and exposed to X-ray film. Exposure times were 
varied depending on the strength of the signal. 
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2.4.6 In vitro Transcription/Translation of Proteins 
In vitro coupled transcription/translation systems (TNT systems) are cell-free protein 
synthesizing tools for the in vitro expression of proteins from cloned genes. Briefly, a 
DNA template is introduced in a rabbit reticulocyte lysate (as used in the present 
work) that contains the cellular components necessary for gene transcription and 
protein synthesis: RNA polymerases, transcription factors, tRNA, ribosomes, amino 
acids, and initiations, elongation and termination factors. The system also contains a 
variety of post-translational processing activities including acetylation, proteolysis 
and some phosphorylation. 
2.4.6.1 Preparation of DNA template 
The gene or gene fragment needed to be expressed was amplified by PCR (section 0) 
using oligonucleotide primers designed as follows: the 5' oligonucleotide primer, F, 
contained a T7 phage polymerase promoter required for transcription initiation from 
the DNA template (Figure 2.3). In this work to produce Prp45p, full length and 
truncated versions, PRP45-containing plasmid pRS-45 was used. When amplifying 
from an internal AUG (to produce internal regions of the protein of interest), a Kozak 
consensus sequence (CCACCATG) was also introduced in 5' primer to ensure 
efficient translation initiation. The 3' primer, R, should contain an in-frame 
termination codon (usually, TAA) if the native termination codon was not present. 
Following amplification of the desired sequence, the resulting DNA template was 
analysed by agarose gel electrophoresis (section 2.3.2.8) to ensure that the correct 
product had been amplified. Then PCR-generated DNA fragments were used directly 
in the TNT reaction without purification. 
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Figure 2.3 Schematic representation of in vitro transcription/translation 
reaction. 
2.4.6.2 In vitro coupled transcription-translation reaction 
Between 0.2 - 2 tg of DNA template were added to the components of Rabbit 
Reticulocyte TNT kit (TNT T7 Quick for PCR DNA, Promega) according to the 
manufacturer's instructions and incubated at 30°C for 90 minutes. L- [35S  ]Methionine 
(-1000 Ci/mmol) was included in the reaction in order to be incorporated in the in 
vitro translated protein and thus, to allow the protein detection by autoradiography 
(Figure 2.3). 
Following incubation, 5 pi of each reaction was mixed with 2X SDS Loading 
Buffer (section 2.4.4), heated at 70°C for 5 minutes and the samples were analysed 
by SDS-PAGE (section 2.4.4). The gel was then covered in Saran wrap, dried on a 
Gel-Vac vacuum gel drier (Hybaid) for 2 hours at 75°C. Then the gel was subjected 
to autoradiography by exposing to BioMax MR film (Kodak) at room temperature. 
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2.4.7 Co-immunoprecipitation of Proteins from Yeast Extract 
To show protein-protein interaction in vitro, co-immunoprecipitation assay was 
performed. 
Twenty-five microliters of HA2-tagged PRP46 splicing extract prepared as in 
section 2.4.3 was depleted of ATP (arid thus of splicing activity) by adding 2 mM 
glucose and incubating at 24°C for 20 minutes. Five microliters of 35 S-labelled 
polypeptides produced by TNT reaction (section 2.4.6) and 4 j.iI of anti-HA 
antibodies (1 2CA5, Roche, Table 2.10) were added and the total NaCL concentration 
was adjusted to 150 mM with 1P 300 Buffer. The reaction was incubated on ice for I 
hour. Protein A-Sepharose (PAS) beads (10 mg/sample) were swollen in 1 ml of 
NTN Buffer for 30 minutes, washed twice in 1 ml NTN Buffer and twice with ice-
cold 1P 150 Buffer before being suspended in 265 il of ice-cold 1P 150 Buffer per 
sample. PAS beads were then added to each sample and incubated on a rotating 
wheel for 2 hours at 4°C. Five microlitres of each supernate (1.6%) were then 
subtracted and used as 35S-labelled protein controls. The remaining suspension was 
washed three times with 1 ml of chilled 1P 150 Buffer and the pellets were finally 
resuspended in 25 p.1 of 2X SDS loading buffer (section 2.4.4). Samples were then 
heated at 70°C for 10 minutes, centrifuged at 1,000 rpm for 60 seconds and subjected 
to SDS-PAGE (section 2.4.4). The control supernates were mixed with an equal 
volume of 2X SDS loading buffer, heated as above and loaded alongside the 
immunoprecipitation samples. In order to visualise any co-immunoprecipitated [35 S]-
Methionine-labelled polypeptides, the gel was covered in Saran wrap and vacuum-
dried as in section 2.4.6.2. Then this was subjected to autobiography with BioMax 
MR film (Kodak) at room temperature. 
NTN Buffer: 	150 mM NaCl 
50 mM Tris-HC1, pH 7.5 
0.1% (v/v) Nonidet P40 
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1P300 Buffer: 	12 mM HEPES. pH 7.9 
300 mM NaCl 
5 MM MgCl2 
0.1% (v/v) Nonidet P40 
1P150 Buffer: 	6 mM HEPES, pH 7.9 
150 m NaC1 
2.5 MM  MgC12 
0.05% (vlv) Nonidet P40 
2.4.8 Phosphorylation Co-Immunoprecipitation 
In order to assay if the protein of interest (Prp45p in the present work) is post-
translationally modified by phosphorylation, a co-immunoprecipitation assay was 
performed followed by X-Protein Phosphatase Digestion. 
Fifty microliters of 13-Myc-tagged PRP45 splicing extract prepared as in 
section 2.4.3 was resuspended in 250 tl of Phosphatase and Protease Inhibitors (PPI) 
Buffer. The mixture was added to 40 p1 of agarose beads coupled with mouse 
monoclonal anti-c-Myc antibodies (Santa Cruz Biotechnology, Table 2.10). Prp45p-
Myc was immunoprecipitated for 2 hours at 4°C on a rotating wheel and 50 jtl of the 
supernatant was taken off and used as a protein loading control. The 
immunoprecipitate was washed three times with PPI Buffer, twice with 800p1 of IX 
PBS Buffer (Table 2.4) and then twice with 500[d of LPP reaction buffer. Half of the 
agarose beads were resuspended in 50 tl of LPP buffer and 400 U of X-Protein 
Phosphatase (New England Biolabs) were added. The Phosphatase digestion reaction 
was incubated for 45 minutes at 30°C. The agarose beads were than spun down and 
heated in 20 p1 of Dissociation buffer (section 2.4.2). The samples were separated on 
10% poly-acrylamide gel as described in section 2.4.4.2 and Prp45p was analysing 
by immunobloting with rabbit polyclonal anti-c-Myc antibodies (Table 2.10). 
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PPI Buffer: 	50 mM Hepes, pH 7.9 
75MKCI 
1 mM EGTA 
1 MM  MgC12 
0.1% (v/v) NP40 
1 mM Sodium Vanadate 
50 mM Sodium Fluoride 
1/2  tablet Protease Inhibitors per 10 ml of buffer 
LPP Buffer: 	1X X-Protein Phosphatase Buffer 
2 mM MnC12 
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3.1 Introduction 
The two—hybrid screens performed previously (Albers et al.. 2003) not only detected 
a mutual interaction between Prp45p and Prp46p but also mapped the regions of 
contact within each protein. Thus, Prp45p through a portion of the conserved SNW 
domain (amino acids 54-204) interacts with the Prp46p cluster of seven WD-repeat 
units (amino acids 127- 432). However, this kind of analysis does not ascertain if the 
interaction between the bait protein and the prey protein leading to the 
transactivation of the reporter gene is direct or if some other factor(s) contributes to 
it. So, to confirm a two-hybrid interaction, co-immunoprecipitation experiment must 
be employed and this is described in this chapter. The data obtained showed the 
importance of yeast N-terminal domain of Prp45p, which might confer extra 
functions to the yeast protein that are not complemented in a Prp45p-depleted strain 
by the human homologue, SKIP. 
Albers et cii. (2003) found Prp45p associated with the spliceosome before the 
first step of splicing but the exact timing of this association was not established. 
Therefore it was of interest to determine this by resolving spliceosome complexes 
that form in yeast splicing extract depleted of Prp45p. 
Throughout this work monitoring of PRP45 expression has been achieved using a 
PGAL regulated PRP45 strain named YMA45/2. This haploid yeast strain (Albers et 
al., 2003) has part of the PRP45 promoter substituted with a cassette containing: the 
L11S3 gene marker, the yeast Gall - lO promoter region (PGAL), and S. aureus Protein 
A epitope (see Table 2.6 and Figure 4.1). The presence PGA,, allows the expression of 
PRP45 to be turned on by growing the strain with galactose as sole carbon source 
and turned off in the presence of glucose in the growth medium. 
Chapter 3: Prp45p and the Spliceosome 
3.2 Prp45p and Prp46p interact in vitro 
In order to validate the two-hybrid interaction between Prp45p and Prp46p, co-
immunoprecipitation experiments were employed using yeast extract containing 
HA2-tagged Prp46p and in vitro translated Prp45p, full length or deletion derivatives, 
produced with TNT transcription/translation kit (Promega). The template DNA 
provided by PRP45—containing plasmid pRS-45 (see Table 2.9 and section 4.2.1) 
was amplified by PCR according to the protocol described in section 2.3.2.6. The 
primers were designed to produce the following peptides: WT representing full-
length Prp45p; R46 (amino acids 54-218), RI (amino acids 1-218), R2 (54-291) and 
R4 (54- 379) all include the minimum region of interaction with Prp46p found in 
two-hybrid screen (amino acids 54-204); R5 (218-379) is the C-terminal region of 
Prp45p and constitutes the negative control for the co-immunoprecipitation (Figure 
3.1.A). The PCR products were transcribed using T7 polymerase and translated into 
the corresponding peptides in the presence of 35S-methionine (see section 2.4.6) so 
that, after resolving by SDS-PAGE, they could be visualised by autoradiography 
(Figure 3.1.13). 
Following the TNT reaction, some of the peptides (WT, R2, R4) were resolved 
as multiple bands, a common problem with this system (Figure 3.1.13). The band 
corresponding to the correct peptide was the slowest migrating one while the others 
were caused by the incorrect initiation of translation at ATG codon downstream of 
the first one. Some of these fast migrating bands could also be breakdown products 
of the original peptide. 
Another feature of the synthesized peptides was their slower electrophoretic 
mobility that corresponded to a 5-8 kDa increase in their molecular weight. This 
migration behaviour was caused by the highly charged nature of Prp45p and is 
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WT Ri R2 R4 R46 R5 Luc -DNA 
Figure 3.1 Schematic diagram of different truncated forms of Prp45p 
synthesized in vitro by transcription and translation. 
A. Wild-type Prp45p (WT) is represented as a box and the conserved SNWKN as a 
blue bar. The Prp45p truncated derivatives (Ri - R5) are depicted below as black 
bars. R-M and R-H depicted as red bars are the minimum regions of interaction with 
Prp46p found in two-hybrid screens performed in our lab and at Hybrigenics, 
respectively. The numbers represent amino acid positions. B. The peptides depicted 
in A. were produced in vitro using Promega TNT T7 Quick for PCR DNA. Five 
microliters of the TNT reactions were mixed with an equal volume of 2X SDS 
Loading Buffer and loaded onto 4-12% PAA gel (Novex Minigel). The gel was dried 
and 35S  -labelled peptides were visualised by autoradiography. As a positive control, 
luciferase (Luc) was produced using the same protocol, while the negative control (-
DNA) was the reaction mix incubated without DNA template. The sizes in kDa of 










WT Al R2 R4 R46 R5 WT R1 R2 R4 R46R5 WTR1 R2 R4 R46 R5 
I 	 II 	 II 	 I 
Precipitates 	Control 	Supernates 
Figure 3.2 Analysis of the in vitro interaction between Prp46p and Prp45p. 
Yeast splicing extract containing l-1A 2 -Prp46p was ATP-depleted and incubated with 
monoclonal anti-HA antibodies and in vitro produced Prp45 polypeptides (Fi(yure 
3.2) for 1 hour on ice. Protein A-sepharose beads were added and the incubation 
continued for 2 hours at 4°C. As controls, the precipitations were performed without 
yeast extract. The precipitated proteins (Precipitates), controls and supernates (1.6%) 
were analysed by SDS-PAGE and the 35S-labelled polypeptides visualised by 
autoradiography. 
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Next, in vitro translated peptides were used to check the interaction with 
Prp46p. As shown in Figure 3.2, wild-type Prp45p and the N-terminal fragment, Ri, 
precipitated with HA2-tagged Prp46p from yeast extract. In contrast, the other 
peptides R46, R2 and R4, all containing the minimum region of interaction with 
Prp46p (amino acids 54-204), as identified in two-hybrid screen, failed to precipitate 
Prp46p. As expected, R5 did not show any association with Prp46p. This behaviour 
was not a result of peptide degradation, as the peptides were present in the supernates 
(Figure 3.2). 
These data confirmed the two-hybrid screens results of a physical interaction 
between the two proteins either directly or indirectly. To show a direct interaction 
between the two proteins experiments were done with His6-tagged Prp46p produced 
in E. co/i (A. Diment, this lab; data not shown). Unfortunately they were not 
successful, due perhaps to some post-translational modification(s) of Prp46p that in 
contrast to yeast, cannot take place in E. co/i. However a direct interaction between 
the two proteins was demonstrated performing the co-immunoprecipitation assay the 
other way around, with the in vitro synthesized Prp46p polypeptides and His6-tagged 
Prp45p produced in E. co/i on a pET19b vector (Novagen). These results are also 
presented in Albers et aL, 2003. 
3.3 Prp45p is involved in formation of the active splice osome 
In order to investigate at what specific stage of spliceosome assembly Prp45p 
functions, splicing extracts from YMA45/2 cells grown either under permissive 
conditions (galactose-based medium) or repressive conditions (glucose-based 
medium) were incubated under in vitro splicing conditions and the complexes that 
formed on pre-mRNA at different times were resolved on native gel electrophoresis 
(Figure 3.3.13). 
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Figure 3.3 Pre-mRNA splicing and time course of formation of splicing 
complexes in Prp45p-depleted cells. 
Yeast splicing extracts were prepared from YMA45/2 cells grown for 14 hours in 
permissive, galactose-based liquid medium (YMGRS-sup) (lane 2) and in non-
permissive, glucose-based medium (YPDA) (lanes 3-5). The splicing reactions were 
initiated by the addition of 32P-labelled ACT] pre-mRNA as described in section 
2.3.3.5. Splicing activity of Prp45p-depleted extract could be restored on addition of 
0.4 p.g of recombinant His 6-Prp45p or 1 tl of in vitro translated Prp45p (lane 5). The 
actin lane (lane 1) contains only the 32P-labelled actin pre-mRNA. The positions of 
the ACT] pre-mRNA, lariat intermediate and excised intron are noted on the right. 
Splicing reactions set up as in A., (as in lanes 2 and 3) incubated for the indicated 
times, then stopped on ice and incubated in the presence of 1.4 jtg/.tl of yeast total 
RNA for 10 minutes before loading onto a 3% polyacrylamide/0.5% agarose gel (see 
section 2.3.3.7). The positions of the splicing complexes (I, II, III) are indicated on 
the left. U represents the unassembled pre-mRNA. 
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In parallel it was tested whether Prp45p depleted extract was functional (Figure 
3.3.A) by the addition of recombinant His 6 tagged-Prp45p produced in E. coli (A. 
Diment, this lab) (lane 4) or Prp45p synthesized in vitro, in rabbit reticulocytes lysate 
by TNT reaction (see 2.4.6 and section 3.2) (lane 5). As shown previously (M. 
Albers, PhD Thesis), splicing extract prepared from YMA45/2 cells grown under 
non-permissive conditions (GLU) could not support splicing in vitro (lane 3) but 
extract prepared from the same strain grown under permissive conditions (GAL) 
could process actin pre-mRNA (lane 2). The splicing defect was partially 
complemented in vitro by the addition of recombinant Prp45p (0.4 j.tg) or 
radiolabelled Prp45p (1 j.tl), showing that Prp45p was the only factor required to 
make this splicing extract functional and that could be used for further analyses. A 
range of different concentrations of Prp45 protein (0.2, 0.8, 1.0, 1.2 i.g of 
recombinant protein or 0.5, 2.0, 2.5, 3.0 il of in vitro translated protein) was used to 
reconstitute the loss of splicing activity but the results did not show a better 
complementation (data not shown). 
The observed defect of Prp45p-depleted cells was associated with a specific 
defect in spliceosome assembly (Figure 3.3.13). Splicing reactions run on native gel 
were separated as described previously (Pikielny et al., 1986) into three discrete 
complexes named I, II and III (see section 2.3.3.7). As expected, pre-mRNA from the 
Prp45p-complete extract was rapidly assembled into the prespliceosome (complex III 
or A) that was converted into the to inactive spliceosome (complex I or B) and then 
to the final active spliceosome, complex II or C, that contains the intermediates and 
products of the splicing reaction (lane 1-3). In contrast, extracts prepared from 
glucose-repressed PGAL: PRP45 cultures failed to support the formation of active 
spliceosome while complexes III and I assembled but at a slow rate (lanes 4-6). 
In conclusion, it can be assumed that the absence of Prp45p did not 
significantly affect earlier steps in spliceosome assembly but was necessary for the 
formation of catalytically active spliceosomes. 
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3.4 Complementation of yeast Prp45p with the human 
SKIP/Sn wip fragments 
The human homologue of yeast Prp45p (Snwlp, SKIP or NCoA-62) was previously 
shown to substitute for the function of Prp45p in yeast cells depleted of this protein 
(M. Albers, PhD Thesis). Full-length Prp45p presents a 22.8% amino acid identity 
with full-length SKIP and the sequence homology within the SNW domains of these 
two proteins reaches 35.5%. Although there are studies revealing the presence of 
SKIP in spliceosome (Neubauer et al., 1998, Makarov ci al., 2002) a direct role of 
SKIP in pre-mRNA splicing has not been proved until recently (Zhang et al., 2003). 
Moreover, some conserved domains found in most of the SNW family members are 
required for different functions within the cell such as transcription, protein-protein 
interaction and signalling pathways (Zhang et al., 2001) (Figure 1.4.A). 
In order to find out which domain of SKIP is responsible for its ability to 
substitute for its yeast homologue, and thus the domain required for splicing, the 
complementation of the growth defect of the Prp45p-depleted strain YMA45/2 was 
attempted using four SKIP deletion constructs in pGBT9 (kindly gift of J. Figueroa). 
These plasmids (depicted in Figure 3.4.A) encode for the DNA-binding domain of 
GAL4 (GBD) fused with the following SKIP domains: 1-200 (corresponding to the 
prolyl-peptidase (PPIase) binding domain in S. pombe and D. discoideum); 1-300 
(containing the proline-rich domain as well as SNW domain with the conserved 
SNWKN motif); 201-537 (containing all the conserved regions of SNW family 
proteins: the proline—rich domain, the SNW domain, the SH2-like domain, the C-
terminal domain); 334-537 (containing SH2-like domain as well as the conserved C-
terminal domain found in all SNW members except S. cerevisiae and P. falciparum) 
(Figure 3.4.A). 
The strain YMA45/2 was transformed with these plasmids as well as with 
pGBT/SKIP and pMA45 (bearing the LexA-domain fused with PRP45 to detect the 
efficiency of complementation). As controls, plasmids pGBT9 (producing GBD 
domain) and pBTM1 16 (producing LexA domain) were tested in parallel. The 
transformants were grown on GAL-HW medium for 5 days. 
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Figure 3.4 Complementation of Prp45p depletion by the human SKIP protein. 
Proposed homology between human SKIP and yeast Prp45p and cartoons of SKIP 
truncated proteins used for complementation assay. Both proteins are depicted as 
boxes and the dashed and colored boxes indicate the conserved motifs/domains/ 
common regions among the SNW members. The numbers indicate the amino acid 
positions. 
Yeast strain YMA45/2 was transformed with either pGBT9 (producing the Gal4p 
DNA-binding domain, GBDp); pGBT9-derived fusion plasmids producing the fusion 
proteins: GBD :SKIP( 1-200), GBD :SKIP( 1-300), GBD : SKIP(20 1-536), GBD: SKIP 
(334-536); LAp (producing (LexA protein); pGBT9/SKIP (producing the human 
SKIP, N-terminally fused to GBDp, GBD:SKIP) and pMA45 (producing Prp45p 
fused to the LexA protein, LA:Prp45p). Transformants were selected on galactose-
based medium (GAL-HW), suspended in serial dilutions in microtiterplates and then 
transferred onto either galactose (YPGa1A-HW) or glucose (YMM-HW) based 
medium. The plates were incubated for 5 days at 30°C before being photographed. 
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It can be seen that, under non-permissive conditions (glucose-based medium) 
when Prp45p was depleted from the cells, none of the SKIP deletion constructs 
overcame the growth defect. Full-length SKIP complemented the growth defect but 
not as efficiently as the yeast Prp45p (Figure 3.4). 
It can be concluded that, although SKIP represents the functional homologue of 
Prp45p. none of its highly conserved domains are individually sufficient for yeast 
Prp45p function. One possible explanation could be the lack of the conserved 
proline-rich domain and the conserved C-terminal domain found in SKIP and other 
SNW proteins. These regions might be necessary for splicing in higher eukaryotes 
and redundant in yeast where their activity may be compensated by other factors. 
Another explanation might be given by N-terminal domain of yeast Prp45p. 
distinctive from its counterparts in respect of length (yeast Prp45p is much shorter) 
and structure, aspects that could provide extra features in folding and structural 
integrity. 
3.5 Discussion 
In recent years the existence of protein complexes has been suggested by different 
approaches, either genetic approaches, like two-hybrid screens, synthetic lethal 
screens and suppressor screens or biochemical analyses like imnuinoaffinity 
purification followed by mass spectrometry. These analyses proved to be successful 
in identifying protein complexes involved in splicing. It is noteworthy for the present 
work to mention the Cwc-rnultiprotein complex identified in budding yeast (Ohi et 
al., 2002) and its homologue in fission yeast, Cwf-complex (Ohi et al., 2002), the 
yeast penta-snRNP complex containing the five snRNAs and around 60 proteins 
(Stevens ci al., 2002) or the mammalian 35S U5snRNP complex (Makarov et al., 
2002). In all these complexes Prp45p/SKIP and Prp46p/PRLGI were always present. 
However, the first indication of an interaction between the two proteins (and others 
identified in the multiprotein complexes described above) came from the two-hybrid 
screens performed in our lab (Albers c/ al., 2003). 
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The data presented in this chapter confirmed this interaction in vitro and 
specified the Prp45p region of interaction within the N-terminal domain. The 
interaction requires not only the minimum portion found in two-hybrid screens but 
also an additional N-terminal end. In addition to this, a similar study (Martinkova et 
al.. 2002) found that the minimum region in Prp45p sufficient for cell survival lies 
within amino acids 1-190. Neither the N-terminal domain (amino acids 1- 119) nor 
the region within amino acids 53 - 190 (overlapping with the one found in two-
hybrid screens) could complement the loss of the yeast Prp45 protein in Prp45p-
depleted cells. In contrast with SNW domain, the N-terminal region (amino acid 1-
54) is poorly conserved. It does not contain special known motifs but might promote 
the correct folding and/or stability of the protein. These data could explain the failure 
of human SKIP N-terminal derivatives (amino acids 1-200 and 1-300) to 
complement the loss of its yeast homologue (Figure 3.4). The importance of this 
domain is reflected by the temperature-sensitive phenotype conferred by N-terminal 
truncated protein (1-47), as discussed in Chapter 4. However, to conclude the 
complementation experiment, it is necessary to test the stability of SKIP deletion 
derivatives in yeast cells by Western analysis of the GBD-tagged SKIP peptides. 
On the other hand, in the Prp46p two-hybrid screens all the preys are fused at 
their N-terminal end with the Gal 4p-transactivation domain, which provided the N-
terminal region (Albers et al., 2003). Similarly, co-immunoprecipitation experiments 
with 3 S-labelled Prp46 truncated forms and His 6-tagged Prp45p mapped the region 
of interaction in Prp46p within the portion identified in two-hybrid screens (amino 
acids 127-432) plus the N-terminal end (Albers et al., 2003). It would be interesting 
to determine if the Prp45p-Prp46p direct interaction is maintained for the human 
homologues of these proteins, SKIP and PRLG1, and also whether the N-terminal 
domain of SKIP contributes to these interactions. 
Additional two-hybrid screens were performed recently at Hybrigenics using 
Prp46p as a bait (A. Diment, unpublished data). The results not only confirmed that 
the main interactor of Prp46p is Prp45p, but also trimmed down the previously found 
Prp45p portion necessary for this interaction (amino acids 54 - 204) by around 110 
amino acids (residues 55 - 98) (see Figure 3.1.A). The interaction with Prp46p in a 
yeast extract proved to be stable and strong, as shown by increasing the stringency of 
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co-immunoprecipitation conditions, i.e. the salt concentration (NaC1) from 150 mM, 
as above, to 500 mM. These results are presented in Chapter 5 (section 5.4). 
The requirement for Prp45p in the formation of the active spliceosome is in 
agreement with data obtained for its human homologue, SKIP, for which it was 
determined that it enters precisely at the time of spliceosome activation after 
formation of complex B (inactive spliceosome stage) but before complex C (active 
spliceosome). This requirement was also determined for other members of the yeast 
Cwc-protein complex like PrpI9p (Tarn et al., 1993), Snt309p (Chen et al., 1998), 
Ceflp (Tsai et al., 1999), Ntc20p and Ntc30p (Chen et al., 2001), i.e. they associate 
with the spliceosome simultaneously or just after the dissociation of U4 snRNA, step 
in the assembly process that marks the transition from complex JiB to functional 
spliceosome (complex TI/C). 
Prp45p synthesized either in E.coli or in mammalian reticulocyte lysates partly 
reconstitutes the splicing activity in the Prp45p-depleted extract. Complementation 
with different range of protein concentrations did not lead to a better 
complementation, which demonstrated that Prp45p is not the only limiting factor for 
the reaction. Initial experiment with recombinant protein gave the same phenotype, 
i.e. inefficient reconstitution of the Prp45p-depleted splicing activity (M. Albers, 
PhD Thesis) possibly explained by the improper folding or post-translational 
modification of the protein produced in E.coli. This situation is similar with the ones 
observed for other members of Prpl9/Ntc-protein complex: Prpl9p (Tarn et al., 
1994) or Snt3 O9p (Chen et al., 1999) that failed to complement the Prp l9p /Snt3 09p 
—immunodepleted extracts. However the splicing activity was restored in these cases 
by the addition of the entire Prpl9p-associated complex. Therefore it is possible that 
this protein complex functions as a whole and the depletion of one of its components 
triggers the inactivation of other(s). Indeed, in vitro depletion of Cefi p from cell 
extracts by the addition of anti-Cefi p antibodies specifically inhibited the association 
to the spliceosme of the other components of Ntc/Cwc-protein complex (Tsai et al., 
1999). 
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4.1 Introduction 
In order to understand the function of PRP45 in S. cerevisiae, temperature-sensitive 
(Ts) lethal mutants of this gene were created and analysed. 
Chromosome I of S. cerevisiae where PRP45 is located has been extensively 
studied in order to identify essential genes and to characterize their physical and 
genetic organisation (Coleman etal., 1986; Steensma etal., 1987; Diehl and Pringle, 
1991). For these purposes two approaches were used. Firstly, molecular analyses by 
northern blotting of transcripts encoded by different segments of chromosome I, and 
gene-replacement/complementation experiments led to the identification of the 
essential gene PRP45 (Diehl and Pringle, 1991). 
Secondly, various attempts to obtain temperature-sensitive mutations of the 
genes on this chromosome failed to identify a Ts allele of PRP45. Three different 
approaches were used to try to get Ts mutations on this chromosome. In 1984, 
Kaback et al. mutagenized a strain monosomic for chromosome I, using either ethyl 
methanesulphonate (EMS) or N-methyl-N'-nitro-N-nitrosoguanidine (NG) as 
mutagen. In this way 32 independent mutations that mapped to chromosome I were 
isolated, and localised to three genes. When the study was repeated using different 
mutagens like ultraviolet light and nitrogen mustard (Harris and Pringle, 1991), 
nearly all of the mutations obtained fell into the same few genes. A more specific, 
third attempt was made by Harris et al., 1992. This study tried to generate Ts lethal 
mutations in three genes that had not been affected during the previous Ts mutant 
hunts, but had been identified and shown to be essential during molecular analyses of 
chromosome I. One of these three genes was FUN20 or PRP45. Briefly, this 
approach involved passing a plasmid containing PRP45 through a mutD mutator 
strain of E. co!i, followed by screening for Ts lethal mutations using the plasmid 
shuffle technique. As all types of base substitutions are induced at high frequencies 
in the mutD strain (different from the first two methods which yield only a limited 
number of amino acids substitutions) this approach should generate more mutants. 
Unfortunately, the results suggested PRP45 could not yield Ts lethal mutations. The 
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situation was the same for one of the other genes analysed in the same study 
(FUN12) while in the case of the third gene, FUN53, they succeeded in recovering 
Ts lethal alleles but only at a very low frequency. As the sequencing analysis done 
during this study revealed one single base-pair substitution within the Ts alleles 
obtained, the authors conclude that "many of the single-copy essential genes on 
chromosome I cannot be rendered temperature-sensitive by single or simple 
combinations of substitutions" and "the genes that can yield Ts lethal alleles by 
single substitutions do so at extremely low frequency". 
In the present work a more specific mutagenesis of PRP45 was carried out, 
with a rate of mutagenesis higher than in the other studies, an approach that yielded 
temperature-sensitive alleles of this gene. As concluded above, the mutations found 
were located in two regions of PRP45 within its SNW domain. These mutations were 
re-created within the wild-type gene by site-directed mutagenesis in order to identify 
which mutation is responsible for the temperature-sensitive phenotype. In this 
chapter, analysis took the form of examination of growth rates at permissive and 
non-permissive temperatures. 
4.2 Random muta genesis of PRP45 
4.2.1 Random PCR mutagenesis 
The strategy for mutagenesis used in this work is based on the skewed nucleotide 
PCR method described in the report of Leung et al., 1989. In this protocol (section 
2.3.2.12), random mutations were generated within PRP45 using a modified PCR 
procedure. In order to get a high rate of mutagenesis consisting of both transitions 
and transversions, the dATP concentration added to the reaction mixture was five 
times lower than the concentration of the other three deoxynucleotides (dCTP, dGTP 
and dTTP). In this way one of the over-represented deoxynucleotides was 
occasionally misincorporated instead of dATP into the extended DNA strand. During 
the amplification steps these misincorporations were propagated as well as new 
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errors being created. 
Initially, a plasmid that provided the template for mutagenic PCR was created. 
This plasmid, named pRS-45 was engineered by cloning the entire chromosomal 
PRP45 gene flanked by 500 nucleotides from its promoter region (P) and by 500 
nucleotides from its terminator region (T), into the centromeric pRS314 vector. 
Oligos PS&5-45M and TXHO-45M (Table 2.7) that annealed in P region and T 
region, respectively, were used as primers for skewed nucleotide PCR (Figure 4.1). 
Then, the mutagenized PCR product was co-transformed with a linearised plasmid, 
pRS-PT, that contains P and T regions in a PRP45 conditionally regulated strain, 
YMA45/2. 
4.2.2 Construction of pRS-PT vector 
Plasmid pRS-PT was created in a 3-way ligation. Firstly 0.5 kb containing the 
promoter region of PRP45 (P region) and 0.5 kb with the terminator region of the 
same gene (T region) were amplified from chromosome I by PCR. The primers used 
contain restriction sites at the 5' ends so that, when joined, the P region and T region 
are separated by an NcoI restriction site and can be ligated in the centromeric 
plasmid pRS3I4 (TRPI is its selectable marker). Plasmid pRS314 was cut with SpeI 
and PstI, the P region was digested with SpeI and NcoI and the T region digested 
with NcoI and PstI. Then the three fragments were ligated and the resulting plasmid 
was designated pRS-PT. Prior to transformation pRS-PT was linearised by digestion 
with NcoI. 
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Figure 4.1 Schematic representation of the four screens performed to identify 
Ts mutants of PRP45. 
Oligonucleotide primers PS&5-45M (S) and TXHO-45M (X) were used in a skewed 
nucleotide PCR to amplify PRP45 ORF (together with its Promoter (P) and 
Terminator (T) regions) from plasmid pRS-45. Five hundred nanograms of 
mutagenised PCR product and 250 nanograms of NcoI/BsmI digested pRS-PT 
plasmid were co-transformed in PRP45 conditionally regulated strain, YMA45/2, 
and plated on either YMGRS -His, -Trp or YMM -His,-Trp media. Four days after 
transformation the cells were replica plated onto YMM-Trp (Glc-Trp) at different 
temperatures to select for temperature-sensitive or cold-sensitive mutants and then 
verified by re-streaking the Ts candidates on YPDA. From the cells grown at 23°C 
that were defective at 37'C, the pRS-45-derived plasmids were isolated (plasmid 
rescue procedure) and their identities checked by digestion with PvuII. Then they 
were re-transformed in YMA45/2, the transformants selected directly on YMM-Trp 
plates and the Trp colonies re-streaked in duplicates onto YPDA plates and grown at 
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4.2.3 Co-transformation of PGAL: PRP45 conditionally regulated strain 
The transformed YMA45/2 (Albers et al., 2003) cells with randomly mutagenized 
PRP45 gene and the linearised pRS-PT were plated or replica plated (in case that the 
initial plating was done on galactose-based media) on glucose - Trp (YMM - Tip). 
In this way the chromosomal PRP45 is turned off and the cells rely on the episomal 
copy which is "provided" if the homologous recombination occurred between the 
mutagenized PRP45 and NcoI digested pRS-PT (Figure 4.1). 
In order to optimise the transformation efficiency and the selection of 
transformants, small-scale transformation experiments were done to figure out the 
optimum ratio between the PCR product and linearised vector. The number of 
transformants was greatest when YMA45/2 strain was transformed at an 0D60 0 of 0.6 
with a ratio of 500 ng PCR product: 250 ng liniarised vector. Furthermore, when a 
negative control of NcoI-digested pRS-PT was included in transformation, Trp 
transformants were recovered on selective plates that indicated that the digestion was 
not complete. This situation was overcome by double digestion of pRS-PT with NcoI 
and BsmI, the latter having a unique restriction site situated in the T region 28 bases 
down-stream of the NcoI site. 
Five randomly picked Trp colonies were had their plasmids rescued (section 
2.3.2.2) and sequenced to determine the frequency of mutations. The mutagenesis 
rate was 0.5% (28 mutations in 5700 bp). This figure was lower than the value of 
1.0% reported by Leung et al., 1989, but presented an advantage when identifying 
the mutations responsible for the Ts phenotype. Most point mutations examined 
represented transitions A:T to G:C and T:A to C:G, figures that are in concordance 
with the fact that dATPs were significantly less incorporated during mutagenic PCR. 
The figure of 0.5% that represents 6 changes per 1.1kb (the size of PRF45) is higher 
than 0.16% obtained by Harris et al., 1992, when mutagenizing FUN53 (see section 
4.1). The rate of mutagenesis of PRP45 in the same study was not reported. 
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4.2.4 Screening for 1s lethal mutations 
After transformation, the cells were grown on —Trp plates (YMGRS-Trp or YMM-
Trp) at 23°C for 3 days, at which point the colonies were counted and replica plated a 
few times onto glucose (YMM-Trp) to ensure that the chromosomal copy of PRP45 
was completely switched off. This was indicated by the negative controls: YMA45/2 
cells transformed with plasmids pRS3 14 and pRS-PT that do not contain the PRP45 
gene (see Figure 4.1). 
Four Ts screens designated Primo, Secundo, Terto and Quatro were performed 
that differ from each other in terms of cell density plated onto -Trp plates, selection 
and number of replica platings done. The characteristics and the results of these 
screens are shown in Table 4.1. 
After the selection, the transformants were replica plated onto YMM—Trp 
plates and incubated at 14°C (for 6 days), 37°C (for three days) and 23°C (for 4 
days). The latter replica plating was done last to ensure that the putative temperature-
sensitive mutants did not result from poor transfer of cells during this procedure. 
Transformants able to grow on YMM-Trp at 23°C but not at 37°C were scored as 
presumptive Ts mutants. In these screenings 93 temperature-sensitive candidates and 
no cold-sensitive mutants there were identified. 
All the putative Ts mutants were re-checked by streaking 2 colonies from each 
candidate from the YMM-Trp (23°C) plate onto YPDA plates at 37°C and 23°C 
alongside positive control strain YMA45/2 containing wild-type PRP45 in the same 
vector (pRS-45). This analysis at different temperatures was performed on YPDA in 
order to avoid the selective pressure of —Trp media on the mutants and to optimise 
the growth of the cells. After 3 days on YPDA, 31 clones displayed a similar growth 
to the wild-type at non-permissive temperature and therefore they were discarded. 
The remaining 62 candidates with the growth completely abolished at 37°C had the 
plasmids rescued and verified by restriction digestion (data not shown). 
In order to confirm that the Ts lethal phenotype was plasmid dependent, these 
vectors were re-transformed into strain YMA45/2, transformants plated directly onto 
YMM-Trp plates and, after 4 days of growing at permissive temperature (23°C), the 
positive Trp clones had the Ts analyses re-done as before on YPDA (Figure 4.2.A). 
Table 4.1 Summary of the PRP45 Ts screens 
replica Ts 	after 
No. 	of 
2nd replica plating 	@ Putative Ts checking in Re- Ts Ts 	mutants' 
Screen Selection   transformants replica 
screened plating" 
plating" different mutants duplicate analysede mutants nomenclature 
OCC on YPDAd 
YMGRS- YMM- YMM- p-I 
Primo 13.140 YMM-Trp 11 8 8 2 





YMM-Trp 15 5 5 1 S-57 
Trp, His  Trp Trp  (prp45-57) 
Terto YMM- 7,453 - - YMM-Trp 34 16 16 1 T-113 
Trp (prp45-113) 
Quatro YMM- 7,520 - - YMM-Trp 33 33 16 1 Q-9 
Trp  
' The medium the cells were olated on after transformation - 
b The replica platings necessary to completely switch off the chromosomal PRP45 gene controlled by PGAL  promoter. 
Replica plateed on YMM-Trp and incubation at 14°C, 37°C and 23°C. 
d The putative Ts mutants were checked by re-streaking each in duplicate on YPDA and incubating at 14°C, 37°C and 23°C. 
e Strain YMA45/2 was transformed with the plasmids containing PRP45 mutants to check the maintenance of the phenotype. 
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4.2.5 Sequencing the Mutants 
The confirmed prp45 Ts mutants were sequenced (section 2.3.2.15). In comparison 
with the wild-type PRP45 sequence, the nucleotide exchanges and the corresponding 
amino-acid alterations within the Prp45 protein were mapped and the results are 
presented in Figure 4.2.13. 
As can be seen, the Primo and Quatro Ts mutants are truncated forms of 
Prp45p that retained the NI-12-terminal end of the protein. The shortest one. P-3, 
which consists only of the first 47 amino-acid residues of Prp45p, supported growth 
at 23°C but not at 37 0C. This result is contradictory with the report of Martinkova et 
al., 2002, who found that truncated Prp45p (1-119) is incompatible with the survival 
of cells, while the first 190 amino-acids are sufficient for growth even at 37C. 
Similarly, mutant P-i, spanning the first 142 amino acids is viable and does not 
contain the SNWKN motif. An interesting situation concerns the mutant Q-9, that is 
also a truncated form of Prp45p, with 186 amino acids, and is similar in length to P-
5, a Primo candidate found initially to be Ts mutant but, as Figure 4.2.A. illustrates, 
did not maintain the phenotype after re-transformation. Both P-S and Q-9 contain 
frame-shift mutations downstream of the SNWKN motif at positions 179 (for P-5) 
and 176 (for Q-9), which led to the premature termination of the coding region 
(Figure 4.2.13). However, Q-9 contains additional substitutions (especially a mutation 
of the conserved position 164 in front of SNWKN motif (lysine to glutamate)) that 
perhaps enhance the Ts phenotype. The P-8 mutant that lacks the C-terminal 38 
amino acids was previously found as a putative Ts candidate in the Primo screen and 
subsequently showed a growth rate at 37°C similar to the wild-type. This is 
compatible with the results of Martinkova et al., 2002, who showed that the last 49 
amino-acid residues of Prp45p were dispensable for growth at 37°C. 
The remaining temperature-sensitive mutants, S-57 (or prp45-57) and T-1 13 
(or prp45-113) were chosen as the main objects of further study. There are many 
reasons behind this decision: first of all, given the number that have been checked on 
plates, only these were very stable regarding the Ts phenotype. 
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Figure 4.2. Schematic diagram summarizing the phenotype and mutations 
generated by random PCR mutagenesis in PRP45. 
pRS-45-derived plasmids carrying prp45 Ts alleles (P-i, P-3, Q-9, S-57 and T-
113) and wild type (WT) were re-transformed in GAL-regulated PRP45 strain, 
YMA45/2, to check for the reproducibility of the Ts phenotype. Mutant P-5 (similar 
in lenght to Q-9) and mutant P-8 (similar to a previous study) were analysed 
alongside. The transformed cells were plated onto glucose-based media lacking 
tryptophan. The Trp cells were re-streaked onto YPDA plates and incubated at 23°C 
and 37°C for 3 days before being photographed. 
Wild-type Prp45p is illustrated as a bar with N-terminal amino acid at position 1 
and C-terminal amino acid at position 379 and below are shown the mutant protein 
products. The regions A and B are shown in green as well as the amino acid position 
they range within. The highly conserved SNWKN motif is depicted as a blue vertical 
bar. The substituted amino acids and their positions are shown; conservative changes 
shown in red and semi-conserved are orange. (*) represents a frame-shift mutation 
and STOP indicates nonsense mutations that give rise to the truncated proteins (P-i 
and P-3). The names of these protein products are shown on the right. 
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Secondly, the mutations within these alleles are in two conserved regions of 
Prp45p, located in the SNW domain, flanking the SNWKN motif. For ease of 
characterisation, these regions were denominated A, the one situated upstream of 
SNWKN motif, spanning amino acids 120 - 136 and, B, situated downstream of 
SNWKN motif between amino acids 190 and 211. 
Within region A, both mutants share the same change in residue 130 (lysine to 
glutamate), which was found in other sequenced Ts mutants including T-104 where 
this was the only mutation but did not determine the Ts phenotype. Lysine at 
position 130 is moderately conserved among the homologues of Prp45p, being 
substituted with another positively charged amino-acid, arginine, in D. melanogasrer 
and S. pombe. Apart from this, the prp45-57 allele contains a change in position 135: 
the semi-conserved amino-acid valine to glutamate while the prp45-113 mutant has a 
mutation affecting the highly conserved lysine (position 133) substituted by a 
glutamate. Thus the positively charged consensus sequence 103KKARKVV1O9 of 
region A becomes less charged due to the presence of two negatively charged amino 
acids. 
Regarding region B, the changes are not so dramatic: prp45-57 has an 
asparagine to aspartic acid substitution in position 192, a highly conserved leucine 
(position 208) changed into serine, and asparagine (position 210) into aspartic acid. 
As for prp45-113, there is only one mutation affecting the semi-conserved leucine in 
position 204 that changes to proline. 
These conditional mutants along with the wild-type strain were grown in liquid 
culture (YPDA) at 23°C and 37°C and the growth rates were monitored by 
measuring the optical density (0D600; section 2.2.8). As depicted in Figure 4.3, at 
23°C there is no difference between the cell growth of mutant strains prp45-57 and 
prp45-113 and of wild-type strain (PRP45). 
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Figure 4.3. Growth curves of the Ts mutants prp45-57 and prp45-113 alongside 
wild-type (PRP45). 
Overnight cultures of these strains were grown at 23°C in YPDA to mid-logarithmic 
phase and aliquots were used to inoculate 50 ml of YPDA at 23°C (upper panel) or 
37°C (bottom panel) to 0D 600 of 0.1. Aliquots were removed every hour and the 
0D600 was read. Upon reaching 0D 600 of 0.7, the cultures were diluted (with media 
pre-warmed at the appropriate temperature) to maintain log growth. 
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When the temperature was shifted to 37C, growth of the mutant strains slowed 
after 2 hours and was arrested after 8 —9 hours at the restrictive temperature. 
Overall, this experiment validates the results obtained on solid media that show that 
the prp45 mutants have growth defects at elevated temperature. 
4.3 Site-directed Muta genesis of PRP45 
In order to understand which of the mutations obtained by random mutagenesis was 
responsible for the Ts phenotype, i.e. to identify residues essential for Prp45p 
function, site-directed mutagenesis was performed. 
All the individual mutations obtained in both Ts mutants prp45-57 and prp45-
113 were re-created separately in the wild-type gene using the two-stage PCR 
overlap extension method. Plasmid pRS-45 (CEN TRPJ PRP45) was used as the 
template for the first amplification step as described in section 2.3.2.13.1. Residues 
targeted for mutagenesis were situated in region A, B or in both of these. The 
mutated DNA products of the second-step amplification were digested with 
restriction endonucleases and inserted into pRS-45 in lieu of the corresponding wild-
type restriction fragments. These constructs were sequenced before being 
transformed into the PRP45 conditionally regulated strain, YMA45/2 to check for 
the Ts phenotype. 
Figure 4.4 shows all the changes inserted to re-build the mutations found in 
prp45-57, in so-called region A - 57A (K130E, V135E), region B - 57B (L208S, 
N21OD), 57B1 (L208S), 57-201 (N192D) and in A and B - 57AB2 (K13OE, V135E 
and N210D) and 57AB (K130E, V135E and L208S). Similarly, for mutations found 
originally in prp45-113: in region A - 113A (KI30E and K133E), in B - 113B 
(L204P), at position 273 - 113C (L273P) and AB - 113AB (KI30E, K133E and 
L204P). 
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Figure 4.4. Amino acid substitutions within Prp45p created by site-directed 
mutagenesis. The amino-acid sequence of Prp45p is schematically shown as a 
horizontal bar ranging from residue I (N-terminus) to residue 379 (C-terminus) and 
so-called conserved regions A and B are depicted in green and the highly conserved 
SNWKN motif is illustrated as a blue vertical bar. prp45-57 and prp45-113 are the 
temperature-sensitive (ts) mutants found in random mutagenesis screens, while the 
others, 57A to 57AB and 113A to I 13AB are mutant alleles of PR.P45 generated by 
site-directed mutagenesis (SDM). The conserved amino acids are depicted in red and 
the semi-conserved ones in orange, and their corresponding position in the wild-type 
Prp45p is shown. After transformation in YMA45/2, only 57AB and 1 13AB mutants 
kept the Ts phenotype. The extra mutations in constructs 57-192-9 and 113-C are 
errors generated during amplification and cloning. 
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Incubating the transformants at 37°C on glucose-based media (i.e. when the 
chromosomal PRP45 allele is shut off and the viability of the cells depends on the 
presence of the plasmid) showed that only mutants 5 7A and 11 3AB which have the 
conserved/semi-conserved amino acids substituted in both regions, conferred the 
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Figure 4.5 Growth of Prp45p mutants generated by site-directed mutagenesis at 
permissive and non-permissive temperatures. 
The plasmids containing wild-type PRP45 (pRS-45) and the mutant prp45 constructs 
p57A, p57AB, p1 I3AB depicted in Figure 4.4 were transformed into YMA45/2 and 
plated on Glc-Trp. After four days at 23°C one colony from each transformant was 
re-streaked on YPDA and incubated for 3 days at 23°C (permissive temperature) and 
at 37°C (restrictive temperature) before being photographed. 
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All the constructs generated by site-directed mutagenesis were thoroughly 
sequenced. During the SDM some un-wanted mutations were found in constructs 57-
201 and 113C, probably generated during the PCR by Taq polymerase. The use of 
this enzyme was discontinued and the proofreading Pfu polymerase was utilized in 
subsequent work. 
This data not only confirm the theory of Harris and Pringle, 1992, which 
stipulated that more than one mutation is necessary to get temperature-sensitive 
alleles of PRP45 but also showed that the two conserved domains A and B are 
essential for the Prp45p function. 
4.4 Construction of c-Myc tagged PRP45 /prp45 strains 
In order to rigorously show that the mutations within the prp45 gene caused the 
temperature-sensitive phenotype, chromosomal tagged prp45 Ts alleles were 
generated. This would allow further investigation of the consequences of these prp45 
mutant alleles on the splicing and I or transcription processes. At the same time the 
tagged alleles (wild-type and mutant) would represent a tool for the examination 
whether the Ts phenotype is due to the loss of function of Prp45 mutant proteins or 
is a result of the instability of these proteins. 
First of all, a tagged version of the wild-type PRP45 was constructed in the 
pRS-45 plasmid. Using site-directed mutagenesis by whole plasmid amplification 
(section 2.3.2.13.2), a unique NcoI restriction site was generated exactly at the last 
codon of the PRP45 open reading frame. Thus, the TAG stop codon of PRP45 was 
changed into ATG and the sequence become CCATGG, which represents the NcoI 
restriction site (Figure 4.6). The plasmid created was referred as to pRS-45N. 
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Figure 4.6 Construction of c-Myc tagged versions of PRP45 alleles. 
1) Site-directed mutagenesis by whole plasmid amplification was used to introduce 
an NcoI restriction site in lieu of the STOP codon, TAG, of PRP45 ORF and thus a 
new plasmid, pRS-45N was created. 2) Oligonucleotide primers c-Myc-TRP-Nco-F 
and c-Myc-TRP-Nco-R were used to amplify a cassette from plasmid pFA6a-
13 Myc-TRP I of approximately 1.8 kb containing 13 c-Myc epitopes (13 Myc) fused 
with ADHJ terminator (the black box) and TRPJ marker gene (TRPJ). 3) The 
amplified cassette was then cut with NcoI (N) and ligated into plasmid pRS-45N, 
previously linearised by NcoI (N) digestion, to produce plasmid pMM45. 4) A DNA 
fragment of 2.3 kb that contains this cassette and the 500 bp of the PRP45 terminal 
region (T) was isolated from pRS-45N by digestion with SfoI (S), located upstream 
of NcoI site, and XhoI (X). 5) This fragment was then ligated into p57AB and 
p1I3AB, previously cut with SfoI and )cliol, producing plasmids pMM57 and 
pMM1 13. Restriction digestion and DNA sequencing were used to check the identity 
of the newly created plasmids. 
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The manufactured restriction site allowed the integration downstream of 
PRP45 ORF of a cassette of 1.8 kb, containing a sequence that encodes thirteen c-
Myc epitopes followed by the terminator region of ADHI gene and TRPJ marker 
gene. The cassette was amplified from vector pFA6a-13Myc-TRP using 
oligonucleotide primers c-Myc-TRP-Nco-F and c-Myc-TRP-Nco-R that contain 
NcoI restriction sites in the 5'end. The PCR product was gel purified, digested with 
NcoI and ligated into NcoI digested pRS-45N. In this way the PRP45 open reading 
frame lacking the STOP codon was fused in-frame to the DNA sequence of the c-
Myc tag. This new plasmid was called pMM45. 
To tag the prp45 Ts mutants, 5 7A and 113 AB, the cassette was excised from 
pMM45 by restriction digestion with SfoI and XhoI. SfoI has a unique restriction site 
4 nucleotides upstream of the 3 'end of PRP45 ORF, while k7ioI was used to 
construct pRS-45 at the 3'end of the PRP45 terminator region. The SfoI / JOwl 
restriction fragment was ligated into SfoI / )OioI digested plasmids p57AB and 
p 1  1 3AB. Thus the two prp45 mutant alleles, 57AB and 11 3AB become tagged with 
c-Myc. The newly created plasmids were called accordingly: pMM57 and pMM 113. 
Subsequently, the complete PRP45—c-Myc coding sequence with 0.5kb of upstream 
and downstream DNA were amplified from plasmid pMM45, gel purified and 
transformed into the haploid yeast strain BMA38a (Figure 4.7). The 0.5 kb flanking 
regions were included in order to allow homologous recombination of the PCR 
product with the chromosomal PRP45 gene and thus, its replacement with the tagged 
gene (see section 2.2.7). As the c-Myc cassette contains the TRPJ marker, the 
selection of transformants was done onto medium lacking tryptophan (YMM-Trp). 
After 4 days at 23°C, tryptophan prototrophic transformants were obtained. This 
strain was referred to as YMM45. 
The same protocol was applied for pMM57 and pMM1 13 to create 
chromosomal c-Myc tagged versions of prp45 mutants 57AB and 113AB. The 
mutants were amplified and transformed into strain BMA38a with selection for Trp 
transformants to produce strains YMM45-57 and YMM45-1 13. 
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Figure 4.7 Construction of c-Myc-tagged Prp45p strains, YMM45, YMM45-57 
and YMM45-1 13. 
A. PCR products containing PRP45-c-Myc-TRPI or 57AB-c-Myc-TRPJ or 1 13AB-
c-Myc-TRPJ flanked by 0.5kb sequences homologous to the sequences upstream and 
downstream of the PRP45 ORF, were used to replace the chromosomal copy of 
PRP45 gene in BMA38a haploid yeast strain. The amplifications were done on 
pMM45, pMM57 and pMM1I3 using the primers PS&5-45M (1) and TXHO-45M 
(2). B. PCR on cells from strains YMM45, YMM45-57 and YMM45-1 13 as well as 
wild-type BMA38a as control. The annealing positions of the primers, 3 and 4 are 
shown (in panel A.) as well as the length of the amplified DNA. 
I \-  
A. 	 P PRP45 13Mw TRPI 
' 2 
pMM45I pMM571 pMMII3 
PCR and Transformation 




on Chromosome I 
3. 




YMM45/ YMM45-57/ YMM45-113 
B. 	 M 
- 2.4 kb 
110 
Chapter 4: Construction ofprp45 Temperature-sensitive Mutants 
The integration of the prp45 alleles into the chromosomal locus was verified by 
PCR on one of the yeast colonies from each strain constructed (Figure 4.7.13). The 
oligonucleotide primers used were PRP45-522-F and 13-Myc-R. A single product of 
the expected size of 2.4 kb was amplified from the transformed cells but not from the 
wild-type strain, suggesting that the integration occurred at the desired locus. 
The cloned alleles were thoroughly sequenced to confirm not only their correct 
integration but also to exclude the acquisition of unwanted mutations during 
amplification or cloning (Figure 4.8). At the same time this step confirmed the 
presence of the desired mutations in YMM45-57 and YMM45-1 13 as they were 
generated for 5 7A and 113 AB. 
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Figure 4.8 Schematic representation of DNA sequences of YMM45, YMM45-57 
and YMM45-1 13. A. The PRP45 ORF in yeast haploid strains YMM45, YMM45-
57 and YMM45-1 13 was sequenced using the oligonucleotide primers: S (PS&5-
45M), P (PRP45-F-PROMOTER), A (PRP45-F1), B (PRP45-F2), M (13-Myc-.R), N 
(c-Myc-TRP-Nco-R) and X (TXFIO-45M). The annealing position of these primers 
is also shown. B. and C. Sequencer TM4 graphs showing the results of the 
sequencing analysis within the regions A and B of YMM45-57 and YMM45-1 13. 
YMM45 alignment in the same regions represents the control. The position number 
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4.5 YMM45-57 and YMM45-113 present a growth defect at non-
permissive temperature 
Having confirmed the presence of the desired mutations in these strains, it was of 
interest to test their ability to grow at the restrictive temperature. The Trp 
transformants from which the DNA sequences were analysed were streaked on 
YPDA medium and growth of the mutant strains YMM45-57 and YMM45-1 13 at 
23°C and 37°C was compared with wild-type strain (YMM45) grown under the same 
conditions (Figure 4.9.A). As with the results previously obtained when analysing 
the same mutants on plasmids (section 4.3), both YMM45-57 and YMM45-1 13 
present temperature-sensitivity at 37'C, with the latter having a stronger Ts 
phenotype. This demonstrates that the mutations created in PRP45 are indeed 
responsible for the growth defect at the non-permissive temperature. 
This was further confirmed by growth of these three strains in YPDA liquid 
medium at 23°C and 37°C. By comparing these growth rates at 23°C to the ones 
obtained for untagged PRP45 alleles (wild-type and mutants) presented in Figure 4.3, 
one can conclude that there is no difference between them, the doubling time being 2 
hours in both situations. Thus the addition of the c-Myc tag at the C-terminal of 
Prp45p alleles does not affect the function of these proteins under these conditions. 
However, at 37'C, growth starts to slow down after 5 hours for YMM45-57 and after 
1 hour for YMM45- 113, and then is arrested after about 10 and 6 hours, respectively. 
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Figure 4.9 Growth of mutant strains YMM45-57 and YMM-113 at permissive 
and restrictive temperature. A. PRP45 yeast strain, YMM45 and the derivate 
mutants with temperature-sensitive prp45 alleles, YMM45-57 and YMM45-1 13 
were streaked on YPDA plates and incubated for 3 days at 37°C and 4 days at 23°C. 
B. The same strains were grown overnight in YPDA liquid media at 23°C to mid-
logarithmic phase before their growth was monitored at 23°C and 37°C. Aliquots 
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The reason why these two mutants are behaving slightly differently at 37C, 
perhaps relies on the differences between the amino acid residues mutated in region 
A: two conserved lysines changed in YMM45-1 13 versus one conserved lysine and 
one semi-conserved valine in YMM45-57. It is possible that the positively charged 
region A (with the consensus sequence RFVGKKARKVVA) is involved in forming 
salt bridges with a negatively charged protein sequence, or in nucleic acids binding. 
The presence of two extra negatively charged amino-acid residues (glutamate) may 
disturb these interactions, more in YMM45- 113 where two lysines are affected and 
the sequence becomes less positively charged. As for region B. two leucine residues 
are affected in both mutants, in YMM45-113 one being changed with a proline 
residue. Proline is a cyclic amino acid that usually creates a turn in the amino-acid 
chain with consequences for protein folding. 
4.6 Discussion 
Previous studies of chromosome I of S cerevisiae and especially of PRP45 
suggested that this gene is difficult to get Ts mutants regardless of the mutagen used. 
Indeed, the use of muiD E. coil strain, defective in the proof-reading activity of DNA 
polyrnerase proved to produce a high rate of spontaneous mutations, around 104  more 
than the wild-type but not for PRP45 or its neighbours: FUN12 and FUN53 
Here, using a PCR-based random mutagenesis protocol. 63 Ts mutants were 
obtained. When 45 of these mutants were re-analysed, only 5 seemed to preserve the 
Ts phenotype. This discrepancy could be due to some un-wanted recombinational 
events that took place initially not only between the mutagenized PCR product and 
the liniarised plasmid, but also with the chromosomal copy of PRP45. So the initial 
defect observed was in fact due to cooperation between the mutations located on the 
plasmid and on the chromosome. A better strategy would have used a PRP45 
knockout strain (to avoid any subsequent recombination) that hosts a URA 3—based 
plasmid carrying the wild-type PRP45. The mutagenized PCR product and the 
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linearised plasmid should have been transformed as before and the screen for Ts 
mutants performed using plasmid shuffle technique on 5-FOA plates. 
Three of the five Ts mutants are truncated forms of Prp45p that contain the N-
terminal region of the protein up to at least 47 amino acids. The N-terminal region of 
Prp45p (1-47) does not contain significant stretches of amino acids nor conserved 
residues among the other Prp45p homologues but proved to have an important role 
for the protein folding and/or function. First, it seemed to be important for cell 
viability: a truncated form of Prp45p containing the N-terminal 190 amino acids 
supports cell growth in a haploid strain while the same fragment without the first 53 
amino acids is incompatible with cell survival (Martinkova et al., 2002). A second 
line of evidence is given by the results presented in Chapter 3 and Annex I regarding 
the interaction of Prp45p with Prp46p. Co-immunoprecipitation experiments showed 
that the N-terminal region of Prp45p is essential for the in vitro interaction with 
Prp46p while the minimum region of interaction found in two-hybrid screens (54-
208) is not sufficient in vitro. However, before drawing any conclusion it is 
necessary to fully analyse this truncated protein in another background, as YMA45/2 
host strain seemed to pose problems and to affect the phenotypes determined by the 
prp45 mutants located on plasmids. 
Another interesting trait of the mutants is that certain sites of the PRP45 gene are 
susceptible to mutagenesis. Regions A and B seemed to have more than one 
mutation; an identical A:T to G:C transition in position 87 (resulting in a silent 
mutation) as well as the A:T to G:C in position 388 (K104E) were found in many 
independent mutants. This clustering was also observed in the early study (Harris et 
al., 1992) for PUN53 where mutations that determined the Ts phenotype are 
preferentially located in a certain region. These regions do not contain stretches of 
adenine that could have determined the substitutions and perhaps there are more 
relaxed and prone to mutagenesis due to the nucleotide context or constraints in 
DNA repair. 
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5.1 Introduction 
The availability of the tagged versions of temperature-sensitive alleles of PRP45 
allowed the study of the functions and interactions of the encoded proteins. To date, 
two different roles for Prp45p have been proposed and demonstrated: as a splicing 
factor in yeast (Albers et al., 2003) and as a co-regulator in many transcription 
pathways in mammalian cells (Zhou et al., 2000, Leong et al., 2001, Zhang et al., 
2001). 
By making use of the two Ts mutants described previously, the work presented 
in this chapter attempts to shed more light on the relationship between the structure 
and the function of Prp45 protein. 
5.2 prp45 Ts mutant proteins are stable at non-permissive 
temperatures 
As the wild-type and the mutant alleles of the PRP45 gene were tagged, the next step 
was to examine the proteins encoded by them. Protein samples were taken at 
different time points after the shift to 37°C when, according to the growth curve 
experiment (Figure 4.9) the growth started to slow, and when it levelled off. Total 
protein extracts were prepared from similar numbers of cells (3 0D 600 units; as 
described in section 2.4.2) and analysed by SDS-PAGE and Western blotting using 
monoclonal anti-c-Myc antibodies (section 2.4.5). 
The results of this experiment (Figure 5.1) show, first of all, the production of 
the c-Myc-tagged Prp45p with a molecular mass of- 64-66 kDa (and even slower on 
SDS-10% PAA gels; see later in Figures 5.2 and 5.3), which is slightly higher than 
the calculated molecular weight of 59 kDa (42.5 kDa for Prp45p plus 16.5 kDa for 
the thirteen c-Myc epitopes). A previous study in our lab revealed the same 
decreased electrophoretic mobility of the recombinant His 6-Prp45p and a Protein A-
tagged Prp45p on SDS-polyacrylamide gels indicating an apparent molecular weight 
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of 50-55 kDa instead of 42.5 kDa. The highly charged nature of this polypeptide 
could explain this discrepancy between the calculated molecular weight and its 
migration in gels. 
Secondly, the Western blot showed that the two mutant proteins are quite 
stable at elevated temperature. Unlike the wild-type protein, the levels of the mutant 
proteins are slightly reduced in the samples taken at the last time points, 15 hours for 
YMM45-57 and 9 hours for YMM45-1 13 (Figure 5.1.A-lane 6 and B-lane 6). This is 
most likely due to the cessation of growth of the mutant strains by these late time 
points, which results in general proteolysis. 
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Figure 5.1 Western blot analysis of the Ts mutant strains after the shift to 37°C. 
Strains YMM45, YMM45-57 (A.) and YMM45-1 13 (B.) were grown on YPDA 
liquid media at 23°C and 37°C, aliquots (3 0D 600 units) were removed at specific 
time points and approximately 0.3 - 0.5 0D600 unit equivalents of cell extracts were 
analysed by SDS-PAGE. Protein extract prepared from wild-type strain (BMA38a) 
served as negative control. The gels were blotted onto PVDF membrane and probed 
with mouse monoclonal anti-c-Myc antibodies. The positions and the sizes of the 
marker proteins are indicated on the left of each gel by arrows. 
Interestingly, the Prp45-1 13 protein seemed to migrate slower on this type of 
gel (Novex Minigel). To elucidate this migration behavior, the experiment was 
performed on another system: SDS-10% polyacrylamide gel electrophoresis (see 
section 2.4.4.2) of protein samples derived from crude extracts or splicing extracts 
were compared (Figure 5.2). Splicing extract was made from each strain of interest 
(YMM45, YMM45-57 and YMM45-1 13, grown on liquid YPDA at 23°C) as 
described in section 2.4.3 and the total protein concentration was estimated by 
Bradford Assay (section 2.4.1). Equivalent amounts of protein (170 j.tg) were 
electrophoresed. 
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Figure 5.2 Different electrophoretic mobilities of proteins expressed in prp45 Ts 
mutants. Total protein prepared by TCA precipitation of crude extracts (lanes 1 - 4) 
or derived from splicing extracts (lanes 5 - 7) of the indicated strains were loaded 
onto a 10% polyacrylamide gel. The gel was run for about 7 hours at low voltage to 
allow a good separation of the protein species and then it was analyzed by 
immunoblotting using monoclonal anti-c-Myc antibodies. BMA38a protein extract 
(lane 1) served as a negative control. The position and sizes (in kDa) of marker 
proteins are indicated at the left. (*) represent the breakdown products of c-Myc-
Prp45p as results of the proteolytic activity within the splicing extracts. 
The results presented in Figure 5.2 strengthened what was determined 
previously, that both mutant proteins have a retarded migration behavior compared 
with the wild-tyDe. with Prp45-57 being retarded less than Prp45-1 13 protein. 
121 
Chapter 5: Analysis ofprp45 Ts Mutant Proteins 
5.3 Analysis of the phosphorylation status of Prp45p 
The previous experiment also revealed the existence of three bands corresponding to 
the Prp45 protein, possibly three putative isoforms generated by post-translational 
modifications. In 1998. Neubauer el al. purified and identified the spliceosome-
associated proteins in mammals using gel filtration and affinity chromatography 
followed by two-dimensional gel electrophoresis. One of the spliceosornal proteins 
identified was the mammalian homologue of Prp45p, SKIP, which separated as three 
spots possibly corresponding to three different phosphorylation states. The extensive 
two-hybrid screens done in our lab that involved Prp45p (Albers et al., 2003), 
showed the interaction of this protein with protein kinase C protein, Pkclp, 
suggesting possible phosphorylation events on Prp45p may occur. This is 
strengthened by the presence of 7 putative Protein kinase C phosphorylation sites and 
7 putative Casein kinase II phosphorylation sites on Prp45p, as predicted by the 
PROSITE motif search programme (littp://npsa-pbil.ibcp.fr/cgi-
bin/pattern_prosite.pl).  
Considering this, plus the extensive work done on SKIP as a factor involved in 
regulation of different transcription pathways - that is known to involve 
phosphorylation / dephosphorylation mechanisms - plus the results obtained in this 
study on the SDS-10% polyacrylamide gel electrophoresis, it was reasonable to 
examine the phosphorylation status of Prp45p. To achieve this, a co-
immunoprecipitation of Prp45p-c-Myc fusion protein from YMM45 splicing extract 
was performed. The incubation of the splicing extract with the mouse anti-c-Myc 
antibodies was done in the presence of phosphatase inhibitors and protease inhibitors 
in order to maintain the phosphorylation state and the integrity of the protein and 
thus the multi-band pattern specific for phosphorylated protein. This step was 
followed by SDS-PAGE on 10% polyacrylamide gel and Western blotting with 
rabbit anti-c-Myc antibodies. As a control, the precipitate was digested with ?-













Figure 5.3 Analysis of the phosphorylation state of Prp45p. c-Myc-tagged 
Prp45p was immunoprecipitated from 50 il of YMM45 splicing extract using mouse 
monoclonal anti-c-Myc antibodies. Half of the precipitate (P +) was treated with ?-
protein phosphatase before being loaded onto 10% polyacrylamide gel (lane 4). This 
was run alongside the untreated precipitate (P -), an aliquot of the YMM45 splicing 
extract containing —170 .tg total protein (I - lane 1 and 5) and 3% of the total 
immunoprecipitation supernate (SN). An equivalent amount of protein derived from 
YMM45-57 splicing extract served also as control (lane 7). The samples were 
immunoblotted with rabbit polyclonal anti-c-Myc antibodies. On the left are 
indicated the positions of putative Prp45p isoforms as well as the sizes of the marker 
proteins. (*) represent breakdown products of Prp45p present in the splicing extracts. 
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This dephosphorylation treatment would determine a band shift in the 
migration of Prp45p, i.e. the retarded bands that correspond to the phosphorylated 
isoforms would disappear and more protein would migrate like the unphosphorylated 
form. In Figure 53 the results of the co-immunoprecipitation experiments are 
presented. The untreated Prp45p precipitate migrated as previously as three bands 
(lane 3). The two slowly migrating species, which probably correspond to 
phosphorylated isoforms of Prp45p. are very weak, maybe due to intrinsic 
phosphatase / protease activity in the splicing extract which is not completely 
abolished. This is confirmed by the absence of these species in the supernate and the 
presence of breakdown products. The A.-phosphatase treatment eliminated the 
slowest migrating band, while the intermediate one had a fuzzy appearance, maybe 
as a result of proteolytic activity. 
Different modified protocols were used to demonstrate Prp45p 
phosphorylation, among which it is worth mentioning the use of different amounts 
and incubation times for X-phosphatase, the use of Calf Intestinal Phosphatase or 
different immunoprecipitation buffers. Unfortunately, the results have not been more 
convincing. Thus it can not be concluded that, under these experimental procedures, 
Prp45p is phosphorylated and perhaps other protocols could be tried like two-
dimensional gels or phosphorylation assays using [y- 32P] ATP, for which there was 
no time. 
5.4 Prp45p mutant alleles and Prp46p interact in vitro 
The mutations in regions A and B that confer the temperature-sensitive phenotype to 
prp45 alleles lie in the region RI proved to interact in vitro with Prp46p (section 
3.2). Therefore it was of interest to find out if these mutations affect the interaction 
with Prp46p and to achieve this, the same method was used as previously presented. 
The prp45 Ts alleles containing the engineered mutations mutations in regions 
A and B were amplified from plasmids p57AB and p1I3AB (see section 4.3). 
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Figure 5.4 Analysis of the interaction between Prp46p and prp45 Ts mutant 
proteins. 
35 S-labelled Prp45p, wild-type (lane 1) and RI truncated form (lane 4) and Ts 
mutant proteins, Prp45-57p and Prp45-1 l3p (lanes 2 and 3) as well as the Prp45-
I 13p truncated form RI (lane 5) were in vitro synthesized using reticulocyte TNT 
extract (section 2.4.6). The TNT reaction was also performed with luciferase 
template (Luc) as a positive control or without DNA template (-DNA) as a negative 
control. Five microlittres from each reaction were mixed with 5 tl of 2X SDS-
loading buffer and migrated onto a 4-12% PAA gel (Novex minigel, Novagen). The 
gel was dried and the radiolabelled proteins visualised by autoradiography. 
HA2-Prp46p from yeast extract was mixed with [35 S]-methionine—labelled Prp45p, 
Prp45-57p or Prp45-1 13p and with anti-HA antibodies and incubated in a buffer 
containing 150 mM, 300 mM or 500 mM of NaC1 (as described in section 2.4.7). The 
reactions were added to Protein A-Sepharose beads and incubated for 2 hours at 4°C. 
The beads, Precipitates, (lanes 1-3) were washed in buffer containing the same 
concentration of NaCl, then resuspended in 2X-SDS protein loading buffer and 
resolved on a 4-12% PAA Novex minigel. After electrophoresis, the gel was dried 
and the labelled proteins visualized by autoradiography. Samples without HA 2-
Prp46p-containing yeast extracts (lanes 4-6) were included as negative controls. To 
check for the stability of the proteins, supernates from each immonoprecipitation 
(1.6%) (lanes 7-12) were loaded alongside. The marker protein sizes and positions 
(in kDa) are indicated on the left. 
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The PCR products were used in TNT reactions (as described in section 2.4.6) 
with added 35S-methionine to get radiolabelled Prp45 proteins. For Prp45- 113 mutant 
protein, an RI region containing the N-terminal 218 amino acid residues was also 
synthesized. The results of the in vitro transcription/translation reactions are 
presented in Figure 5.4.A. Note the different electrophoretic behaviour of the mutant 
proteins (lanes 2 and 3) compared with the wild-type (lane 1), which is supported by 
the differential migration of the truncated derivatives RI (lanes 4 and 5). These 
results confirmed those obtained previously on immunoblots with anti-c-Myc 
antibodies (Figure 5.2), namely that the different migration pattern is due only to the 
substitutions generated in PRP45 ORF. 
Co-immunoprecipitation experiments were performed with HA 2-Prp46p from 
yeast extract. In order to estimate the strength the in vitro interaction, the experiment 
was performed at different salt concentration of the co-immunoprecipitation buffer 
ranging from 150 to 500 mM NaCl. The analysis was performed in parallel with the 
wild-type Prp45p. 
As shown in Figure 5.4.13, HA 2 :Prp46p co-precipitated fill-length wild-type 
Prp45p even at 500 mM NaCl, which indicated a very strong interaction between the 
two proteins (Figure 5.4 B, upper panel). This supported the results obtained in vivo 
by two—hybrid screens that identified a strong Prp45p-Prp46p interaction resistant to 
20 mM triaminotriazole, 3-AT, a HIS3 inhibitor used to evaluate the strength of two-
hybrid interactions. 
Surprisingly, both Prp45-57p and Prp45-1 l3p co-precipitated with Prp46p 
even at higher salt concentrations, like the wild-type, which means that the mutations 
they carry are not involved in this association and might affect the cell wellbeing 
through different interactions (Figure 5.4.13, middle and bottom panels). 
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5.5 Discussion 
Following the construction of two temperature-sensitive mutants of PRP45, it was of 
interest to analyse how their mutations affect the stability, folding and interactors of 
the proteins they encoded. 
The different migration behaviour on SDS-PAGE of Ts mutant proteins compared to 
the wild-type Prp45p is possibly due to the additional negative charges of these 
proteins. Data in the literature on HPV E7 protein from two different strains of 
human papillomavirus. HPVI6 and HPV6, showed the same anomalous 
electrophoretic behaviour of these two proteins although the theoretical molecular 
mass is the same for both (Armstrong et al., 1993). The analysis of the two proteins 
showed that the different migration on SDS-PAGE was due to the presence of one 
aspartic acid residue in HPV16 E7 instead of one lysine as in HPV6 E7, this change 
being necessary and sufficient for the HPV 16 E7 protein to have a slower 
electrophoretic mobility. As in the study presented here, in the prp45 Ts mutant 
proteins the extra glutamate residues in region A. perhaps create a repulsion with the 
negatively-charged SDS, so there are less SDS bound than for the wild-type Prp45p. 
The overall charge is less negative for the mutant proteins and therefore, they will 
migrate more slowly towards the positively-charged electrode (anode) during 
electrophoresis. To support this theory, an extra experiment would be needed in 
which the protein samples are treated with a neutralising agent, for example, 1-ethyl-
3-(3-dimethylarninopropyl)-carbodiimide (EDC) which converts the negatively 
charged carboxylates of amino-acid residues to neutral amides. It is also possible that 
the different negative charge of these proteins caused differences in the shapes of the 
proteins or SDS-protein complexes. To clarify this aspect, the experiment should be 
performed in the presence of a strong denaturing agent, like urea, which is known to 
destroy the secondary structure of the proteins. 
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The co-immunoprecipitation assay showed that mutations in regions A and B of the 
conserved SNW domain did not affect the interaction with Prp46p although they 
impaired the cell growth at elevated temperature. There are some explanations of this 
phenomenon. One could be that the mutations in regions A and B affect the 
interaction with different partners. Indeed, subsequent two-hybrid screens results 
(performed at Hybrigenics) narrowed down the minimum region of interaction with 
Prp46p within amino acids 55 and 98, approximately 30 amino acids upstream of 
region A (see Figure 3. LA). 
Another explanation is that the co-immunoprecipitation conditions might not 
alter the folding of the mutant proteins to the same extent as the in vivo conditions, 
namely the growth at 37°C, might do. For this reason it would be worth analysing the 
interaction between the Ts mutant proteins and Prp46p in vivo, by two-hybrid assay. 
Both mutants could be cloned in bait plasmids and the interaction with Prp46p 
produced from a prey plasmid should be assessed by growing the transformed yeast 
cells at 37°C and on different concentrations of 3AT. 
Although there was much data that suggested a phosphorylated state of Prp45p, the 
experiments performed in this direction have not given a conclusive result. However, 
it is possible that other post-translational modifications could affect Prp45p. In this 
respect, the PROSITE motif search of Prp45p predicts the existence of three putative 
N-glycosylation sites on three asparagine residues, two of them being situated 
upstream of region A (position 107) and of region B (at position 194). 
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6.1 Introduction 
Previous work has demonstrated the role of Prp45p in pre-rnRNA splicing in vivo 
and in vitro (Albers et al. 2003). The analyses were done on a galactose-regulated 
PRP45 strain, in which the expression of PRP45 and consequently its function could 
be switched off by the addition of glucose. Northern blotting and primer extension 
analysis showed that pre-mRNA started to accumulate after 8 hours in glucose-based 
medium, indicating Prp45p requirement for splicing in vivo. Following metabolic 
depletion of Prp45p, cell extracts could not support the formation of splicing 
intermediates and products from actin pre-mRNA and, as shown in Chapter 3, the 
formation of active spliceosome was inhibited. Further work involving co-
immunoprecipitation of RNA species by proteinA: Prp45p showed the association of 
Prp45p with the splicing machinery in both steps of splicing. 
Considering these data, it was of interest to determine the involvement of 
newly identified prp45 Ts mutants in pre-rnRNA processing and further, at what 
particular catalytic stage these mutants are deficient. The analyses presented in this 
chapter include not only classic experiments (Northern blotting, in vitro splicing 
assay) but also reporter gene assays and newly developed microarray assays. 
6.2 Effect of prp45 Ts mutants on pre-mRNA splicing in vivo 
RNA from prp45 mutant strains YMM45-57 and YMM45-1 13 grown at non-
permissive temperature was analysed for the accumulation of pre-rnRNA. indicative 
of a splicing defect in vivo. Both strains were grown at 23°C until mid-logarithmic 
phase and then shifted to 37°C for 1, 2 and 4 hours. Total RNA was isolated and 
analysed by agarose gel electrophoresis and Northern blotting with a probe to exon 2 
of the ACT] gene. PRP45 strain, YMM45, was used as a negative control. 
Ii 
1-, 
YMM45 YMM45-57 YMM45-113 sP" 	? 
01 24 0 1 24 01 24061202 
ACTINI-exon 2 
AL 	 pre-mRNA 
IqPF.qwSS 	 mRNA 
PGKI 
liSUS*SSUSUL 	mRNA 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
Figure 6.1. The prp45 temperature-sensitive yeast strains do not accumulate 
actin pre.mRNA in vivo. Northern analysis of the total RNA extracted from WT 
(YMM45) (lanes 1-4), YMM45-57 (lanes 5-8), YMM45-1 13 (lanes 9-12), and 
prp16-2 (lanes 16 and 17) grown at 37°C in YPDA liquid media for the specified 
time. YMA45/2 was pre-grown at 30°C in galactose-based media to mid-logarithmic 
phase before being transferred to glucose (YPDA) for 6 and 12 hours (lanes 13-15). 
Time 0 represents the point when the shift was done from permissive to non-
permissive conditions. Ten micrograms of RNA was run on a 2% (w/v) agarose gel 
and then blotted onto Hybond-N membrane (Amersham). The blot was hybridised 
with a radiolabelled oligo complementary to exon 2 of the ACT] gene. The position 
of the ACT] pre-mRNA and mRNA are indicated. The same filter was stripped and 
reprobed with a PGKI gene probe as a control for loading (bottom lanes). 
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Two splicing-defective strains were positive controls: 1) YMA4512 strain 
grown in glucose-based medium for 6 and 12 hours to allow the full repression of 
PRP45 expression; 2) prpl6-2 temperature-sensitive strain grown at 37°C for 2 
hours. Prp l6p is a member of the DEAH-box family and is an ATP-dependent 
helicase required for the second step of splicing - cleavage at the 3' splice site and 
exon ligation (Schwer and Guthrie, 1991). 
Figure 6.1 shows that no pre-mRNA was detected in either YMM45-57 or 
YMM45-113, nor a decrease in the level of mRNA (lanes 6-8 and 10-12). This is not 
the case for YMA45/2 that, after 12 hours in glucose-based medium, accumulated 
precursor actin RNA while the level of spliced mRNA decreased (lane 15). This is a 
known behaviour of the strains defective in splicing that have rapidly degraded pre-
mRNA and mRNA species in the nucleus (Bousquet-Antonelli et al., 2000). prpl6-2 
showed no pre-mRNA accumulation but the level of mRNA decreased, as expected 
for a defect in the second step of splicing while the amount of the loading control, 
PGKJ mRNA, (bottom panel, lane 17) remained unaffected. 
6.3 /3-Galactosidase Assay 
To extend this analysis, a more sensitive method was employed that detects 
reductions in the level of splicing not visible using Northern blotting. The assay also 
detects transport of the unspliced pre-mRNA from the nucleus to the cytoplasm. 
Briefly, the 3-gaIactosidase assay involves three lacZ-based reporter genes 
placed under the control of a galactose-inducible promoter (Figure 6.2.A). Plasmid 
pLGSD5 contains the PGAL-CYC1-1aCZ hybrid gene and allows detection of defects 
in transcription / translation of the 3-galactosidase gene. Plasmid pJC5 1 contains a 
synthetic sub-optimal RP51A intron flanked by short exons. The intron has to be 
spliced out for the production of 3-ga1actosidase as the 3-gal coding sequence is out-
of-frame with CYC] AUG in the unspliced RNA. 
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Figure 6.2. Effect of prp45 Ts mutants on pre-mRNA export, pre-mRNA 
splicing and transcription! translation. 
A. Constructs used in f3-galactosidase assay. The star symbol represents frame-shift 
mutation. On the right is shown their ability to express -ga1actosidase. B. YMM45 
(wild type PRP45), YMM45-57 (prp45-57), YMM45-1 13 (prp45-113) and prp8-1 
strains were grown in liquid GGL-U media. Upon reaching an 0D60 0 of 0.5, J3-
galactosidase expression was induced for 2 hours at non-permissive temperature 
(37°C) by 2% (v/v) galactose. Aliquots of 1 ml were removed from each culture, the 
cells were broken and the -galactosidase activity was estimated using a colorimetric 
assay as describe in section 2.2.9. Four independent transformants were analysed in 
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The last construct, pJC 1, resembles pJC5 I except that the -galactosidase ORF 
is in frame with the CYCJ AUG only for the unspliced pre-mRNA, so that - 
galactosidase is produced only when the intron is not removed. 
This plasmid is a tool for detecting pre-mRNA export into the cytoplasm. prp 
mutants that are deficient in the early steps of spliceosome assembly may permit the 
exit of unspliced pre-mRNA from the nucleus and, subsequently, their translation 
into protein in the cytoplasm. This method also gives information on the putative 
effect that these Ts mutants have on transcription / translation. This is of particular 
interest, as certain homologues of Prp45p like human SKIP and D. melanogaster 
NcoA-62, have been shown to have roles as transcription co-regulators. 
The three constructs were transformed into the YMM45-57, YMM45- 113 and 
YMM45 (wild-type) strains and the splicing-deficient strain prp8-1. The splicing 
factor Prp8p is a U5 snRNP specific protein required for splicing in vivo and in vitro 
(Larkin et al., 1983, Lustig et al., 1986). The transformants were grown in glycerol / 
lactate-containing medium at 23°C and -galactosidase activity was measured 2 
hours after the addition of galactose and a shift to 37°C (see section 2.2.9). The 
results are presented in Figure 6.2.13. 
The pLGSD5-transforrned cells gave rise to significant 3-galactosidase activity 
and no major difference could be seen between the prp45 Ts mutants and the wild-
type cells. These results mean that the substitutions in regions A and B of Prp45p did 
not affect the transcriptional or translational activity, at least not in the case of this 
reporter gene. The level of f3-galactosidase in prp8-1 mutant is much lower, around 
42% of level of the wild-type. This indicated a possible role Prp8p might have in 
transcription. Links between transcription and splicing are known (for reviews, see 
Proudfoot et al., 2002; Hirose and Manley, 2000). 
As expected for the splicing reporter assay (pJC5 1), the prp8 mutant strain 
displayed very low 3-galactosidase activity, about thirty-fold less than YMM45. The 
level of the enzyme activity in YMM45-57 and YMM45-1 13 after the galactose 
induction was 70% and 52%, respectively, compared to wild-type, indicating a mild 
splicing defect in vivo, with one stronger than the other. 
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With pJC 1, the prp8-1 cells showed a 5-fold increase in translation compared 
to wild-type, and about 15% of the 3-ga1actosidase activity of pLGSD5 transformed 
in the same strain. The latter result was similar to that reported previously by Legrain 
and Rosbash, 1989, for the same mutant, then known as rna8-1, while, analysing 
strains defective in the early steps of spliceosome assembly (rna6), the relative 3-
galactosidase activity was about 80%. As for the prp45 mutants, the -galactosidase 
activities as percentage of pLGSD5 activity were: 5.6% and 2.7%. Therefore this 
experiment re-confirmed the results of Lustig et al., 1986 and those reported in 
Chapter 2, that both Prp8p and Prp45p are dispensable for the early steps of 
spliceosome assembly. 
The 50% reduction in splicing activity indicating an in vivo splicing defect 
stronger than for YMM45-57 (with 30% reduction) was a good reason to focus only 
on YMM45-113 mutant strain for further analysis. In the following section this 
mutant was investigated to determine at which step the splicing inhibition occurred. 
6.4 Effect of prp45 Ts mutants on pre-mRNA splicing in vitro 
To analyse pre-mRNA splicing in vitro, splicing extract was prepared from strain 
YMM45-113 (Ts) grown continuously at 23°C and in vitro splicing reaction was 
performed as described in section 2.3.3.6. In order to establish the optimal conditions 
to detect a splicing defect in vitro, the reactions were incubated at different 
temperatures, i.e. at 23°C (25 mm), 28°C (15 mm), 30°C (15 mm), 32°C (12 mm) 
and 34°C (12 mm) (Figure 6.3). To avoid some errors that could arise due to elevated 
temperature that is known to activate nucleases; therefore an extract derived from 
wild-type PRP45 strain YMM45 was prepared and analysed alongside. To eliminate 
a potential defect caused by the limiting amount of splicing factors, the protein 
concentration of both extracts was measured by Bradford Assay and the same protein 
amount was used in the assay. 
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Figure 6.3 In vitro splicing assays of prp45 mutant strain performed at different 
temperatures. 
YMM45 (WT) and YMM45-113 (113) yeast strains were grown in YPDA at 23°C. 
Upon reaching an OD60 of 0.7, splicing extracts were prepared. Five microliters of 
splicing extract plus splicing buffer, ATP and radiolabelied actin pre-mRNA 
(substrate, lane 2) were mixed and the splicing reactions were incubated at the 
indicated temperature for different times. The splicing reactions were stopped, 
deproteinised and the RNA species were extracted with 
phenol/chorophormlisoamylic alcohol (P/C/1) and then ethanol-precipitated before 
being loaded on a 7% polyacrylamide gel. A radiolabelled DNA marker (Mspl 
digested pBR322) was loaded alongside (lane 1). The splicing species that result 
from the first and the second step of splicing are indicated on the right side. 
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It can be noticed from Figure 6.3 that, according to the amount of mRNA 
formed, the two extracts started to display different activities upon heat treatment at 
28°C. The 15 minutes incubation of prp45-113 at 30°C (lanes 7 and 8) caused a 
stringent reduction in the splicing intermediates and products, especially second step 
ones, lariat intron and mRNA. It is clear from the results in lanes 9 and 10 that the 
incubation above 32°C triggered the action of nucleases in both wild-type and mutant 
(a smearing appearance of RNA species). 
Although the block was not complete (i.e. the production of second-step 
splicing intermediates was not abolished) these results indicated that the prp45 Ts 
mutant displayed a mild splicing defect in vitro, apparently affecting the second step 
of splicing more than the first. Other heat-inactivation conditions were applied to get 
a stronger in vitro splicing defect for the prp45 mutant. Unfortunately they did not 
lead to a more conclusive result. One example is the heat-treatment of both extracts 
at 32°C in the absence of ATP and pre-mRNA substrate followed by their addition 
and incubation at 15°C for 1 hour, or performing the splicing reaction at 37°C for 20 
minutes. The latter experiment caused complete degradation of pre-mRNA species. 
So far the 30°C incubation of splicing reactions seemed to get the most obvious 
defect for prp45 strain, and to confirm this finding, a time course was done. Splicing 
reactions were set up as previously and incubated at 30°C for 1.5, 5, 10 and 15 
minutes. The results are depicted in Figure 6.4. Wild-type extract produced 
intermediates of the splicing reaction within 1.5 min and mature RNA formation, 
detected after 5 minutes exponentially accumulated up to 15 minutes. In contrast, 
extract from prp45 cells displayed a slower kinetics: the splicing intermediates 
started to accumulate after 5 mm. (lane 7). The 15 minutes incubation limited the 
splicing of the actin pre-mRNA to less than 7% of that observed for the wild-type 
extract, as calculated for mRNA species by Phosphorlmager quantification (lanes 5 
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Figure 6.4 Time-course of the in vitro splicing of the actin pre-mRNA performed 
at 30°C. 
Five microliters of splicing extracts from wild-type and YMM45-1 13 strains 
prepared from cells grown at the permissive temperature of 23°C were mixed with 
splicing buffer, ATP and radiolabelled actin pre-mRNA. The reactions were 
incubated at 30°C for the indicated periods of time and then were P/C/I extracted and 
ethanol precipitated. The precipitated RNA was fractionated on a 7% denaturing 
polyacrylamide gel and the results were visualised by autoradiography. RNA species 
are cartooned on the right. In the first lane, a radiolabelled size marker, MspI-
digested pBR322 was loaded. 
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Taking together, the results presented in this section were compatible with 
those from the 3-galactosidase assay, namely the prp45 Ts mutant had a mild 
splicing defect. At that moment a question was posed: if the splicing defect was mild 
then what determined, at a molecular level, the strong growth defect of prp45 
mutants at 37"C? A possible explanation could be that the mutant protein affects the 
splicing of other transcripts more severely; therefore a more global assay for pre-
mRNA splicing analysis was employed using microarray technology and is presented 
in the following section. 
6.5 YMM45-57 and YMM45-113 accumulate intron-encoded 
snoRNA species at non-permissive temperature 
6.5.1 Microarray analysis of YMM45-57 and YMM45-1 13 
Contrary to the traditional use of a small number of reporter genes to characterize a 
splicing defect, the microarray method analyses all yeast intron-containing 
transcripts. 
The method consists of two parts: 1) designing the microarray (biochip), that 
was achieved by our colleague, David Barrass; 2) generating the fluorescent labeled 
cDNA, hybridizing it to the microarray and analyzing the data (see section 2.3.3.4). 
1) The microarray contains four probes engineered to recognize and bind 
specifically sequences from each yeast intron-containing transcript: one for the 5'-
splice site (V), one for the intron (I), one for the 3' exon (E) and one for the mature 
junction that forms between linked cxons. All these probes are transferred from a 
micro-well plate onto a glass surface by a printhead containing microspotting pins. 
To avoid errors, each set of probes is transferred in triplicate; therefore there will be 
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Figure 6.5 Microarray design and pre-mRNA splicing pathway for normal 
transcript (A.) and snoRNA-intron containing transcripts (B.) 
The microarray contains four probes for each intron-containing transcript: intron 
probes (red) detect pre-mRNA and lariats 5'-splice site (pink) detect pre-mRNA: 
mature junction (green) probes detect mRNA and exon 2 probes (orange) detect both 
pre-mRNA, lariat intermediate and mRNA. The arrays for snoRNA-intron containing 
transcripts have an additional probe corresponding to the mature snoRNA (purple) 
and detect snoRNA-containing species. 
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2) Yeast total RNA was extracted from YMM45 and YMM45-57 or YMM45-1 13 
strains grown at 37°C for a period of time determined from the growth curves 
(Figure 4.3). 
A reverse transcription reaction was set up with the RNA and two florescent-
labeled dTTP, namely Cy3 for the wild-type RNA and Cy5 for the mutant RNA were 
included (forward labeling reaction). They were incorporated during extension into 
the DNA strand so that the resulting cDNA molecules would absorb and emit light at 
distinct and separable wavelengths. In order to minimize differences that could affect 
the final results, care was taken to ensure that the genetic background of the strains 
analyzed was the same: YMM45, YMM45-57 and YMM45- 113 are all derived from 
BMA38a and the only difference between them is the mutations in the PRP45 ORF. 
Moreover, the growth conditions (the media, temperature, shaking speed), final 
0D600 at which the cells were collected and the RNA extractions and manipulations 
were similar for the wild-type and mutant strains. Finally, any variance that could 
result from different dye incorporation or fluorescence was ruled out by swapping 
the dyes between the wild-type and mutant cDNA (reverse labeling reaction) for all 
samples. 
The two fluorescent cDNA pools corresponding to the wild-type and to the 
mutant strain were purified, mixed and hybridized to the microarray overnight, at 
47°C. After the hybridization, the unbound material was removed by successive 
washings and the fluorescent DNA bound to each probe on the biochip was 
visualized by fluorescence detection. The glass slide was subjected to white light 
excitation and the light emitted from the two fluorescent samples at each location 
was converted to a digital output, quantified and interpreted. More specifically, in an 
ideal situation, the light emitted by the wild-type cDNA (Cy 3) would hybridize 
differentially to the four probes of a transcript resulting in a certain pattern of 
intensities from spots, namely signals from M (green) and E (orange) probes (Figure 
6.4). If the mutant does not affect splicing, i.e. there are no intron species 
accumulating, the pattern of intensities would be approximately the same, between 
the mutant and the wild-type. 
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Figure 6.6 Scatter plots of probe intensities for prp45 Ts mutants at different time points after shift to non-permissive temperature 
(37°C). 
YMM45-57 and YMM45-1 13 temperature sensitive strains were grown in YPDA at 23°C until mid-log phase and shifted to 37°C. At the 
indicated time points, total RNA was prepared and used in microarray analysis. The intensities of probes were plotted on logio graphs 
where x axis represents the wild-type (Cy3) and y axis represents the mutant (Cy5). The results presented are for the direct labelling 
reaction. The intensities of the spots are coloured as in Figure 6.5: red for intron probes, pink for 5' splice-site probes, green for mature 
junction and orange for exon 2 probes. The purple spots correspond to the intron encoded-snoRNA probes and are different from the intron 
probes of the same transcript. The ellipses delimit the spots characteristic for a certain species and are colour-coded as before. 
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Conversely, if the mutant is fully splicing-defective, the Cy5 signals are 
detected for I (red), V (pink) and E (orange) probes. The pattern that results after the 
combination of the signals would be different than in wild-type and is indicative of a 
splicing defect. In reality it would be a gradient of intensities in both cases. 
The probe intensities are plotted on a graph: YMM45 (Cy3 on x axis) versus 
YMM45-57 or YMM45- 113 (Cy5 on y axis) for different time points in accordance 
with the growth rates (Figure 4.9.13). Figure 6.5 show the scatter-plots for the two 
mutant strains at permissive (Oh) and non-permissive temperature. It can be seen that 
there is no widespread accumulation of the intron probes (red spots) or 5'splice site 
probes (pink spots) in the mutant strains relative to the wild-type even after longer 
exposure at the non-permissive temperature. The Cy5/Cy3 ratios (representing the 
correlation between the mutant and wild-type) remained unaffected for the other two 
probes, mature junction (M) and exon (E) for almost all genes. This indicates that 
there is no detectable splicing defect caused by the two prp45 mutants at elevated 
temperature and the results validated what was found in the previous sections of this 
chapter. The reverse labeling reactions confirmed these results were accurate. 
However, two interesting things were conspicuous in these scatter-plots: firstly, 
the specific accumulation in both mutants of intron probes of transcripts like 
YMR116C, RPL7A and RPL7B - in the case of the YMM45-1 13 strain the red spots 
are obvious even at 23°C. Transcript, YMR116C (ASCJ, BELl) encodes for a WD-
repeat protein (G-beta like protein) and is believed to interact with the translational 
machinery. RPL7A (YGL076C) encodes for the ribosomal protein L7A and RPL7B 
(YPLI98W) encodes for the ribosomal protein L713. Null mutants of either RPL7A or 
RPL 7B are viable but disruption of both is lethal (submitted information to SGD). 
Secondly, the plots showed the accumulation of the small nucleolar RNA specific 
signals. They are colored in purple in order to distinguish them from the other intron 
probes (see Figure 6.4.13). This effect can be seen at 23°C for YMM45-1 13 and then 
in both mutants at later time-points. Small nucleolar RNAs (snoRNAs) represent an 
abundant and diverse class of non-coding RNAs that play a major role in 
posttranscriptional covalent modifications (2'-O-methylation, pseudouridylation and 
cleavage) of different groups of RNA (rRNA, tRNA and snRNA) (Ailmang et al., 
1999; for review see Kiss, 2002). In yeast, the majority of snoRNA are derived from 
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independently transcribed units either mono- or poly-cistronic, possessing their own 
promoter and transcribed by RNA Pol II (like U3, U13. U14) or RNA Pol III (like 
MRP). Apart from these, seven snoRNAs (U18, U24, snR38, snR44, snR39, snR54 
and snR59) are encoded in introns of protein-coding genes. 
In the scatter-plots illustrated in Figures 6.5 all the intron-encoded snoRNAs 
were identified; YMR116C is the host gene for snR24 (U24), RPL7A accommodates 
snR39 while RPL7B is the host for snR59. Interestingly, there is no accumulation of 
snR17A (U3 snoRNA) either intron probe or 5' splice site probe. The non-intron 
encoded snoRNA, snRlO, that served as control as well as snRNAs (U I, U2, U4. U5 
and U6) were not affected (their signals were on the median). Microarray analysis 
performed in our lab for various Ts mutants showed that this defect depends on the 
function of the defective protein within the cell. For example, the exosome Ts 
mutant rrp6 strongly accumulated snoRNA-containing species after 30 minutes at 
37°C, the second step mutant prpl6-2 showed a similar pattern to prp45 mutants 
while the splicing mutant prp8-1 accumulated intron probes but not snoRNA 
containing ones (David Barrass, personal communication). 
An important step of microarray analysis is generating dendrogram clusters 
that identify the relationship between different mutants with respect to their effects 
on different probes, in this case intron probes (Figure 6.6, left panel) and 5'-splice 
site probes (Figure 6.6, right panel) of all the microarray transcripts. So far the 
mutants analyzed in our lab clustered into two major groups: one, located in the top 
left side formed by the exosome mutants (rrp6, ski® and a very large group in the 
middle of the clusters consisting of prp mutants prp2, prp8, prpl6, prp18 (David 
Barrass and Jean Beggs, unpublished data). Both prp45 mutants are clustering with 
the latter group. Interestingly, according to the intron index clustering, prp45-57 
seemed to behave similarly with the prpl6-2. However the number of transcripts 
whose splicing is affected in prp45 mutants is lower than for the other splicing 
mutants and further analysis is needed to identify the nature of these transcripts. 
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Figure 6.7 Dendrograms clustered by two indexes: the mtron accumulation and 5'splice-site accumulation, 5'SS. 
prp45 mutants and other temperature-sensitive mutants analysed in our lab were clustered using the Average Linkage (UPGMA) cluster 
method according to the similarities in the effects they have on the intron accumulation indices (left panel), and 5'splice-site accumulation 
indices (right panel). The resulting dendrograms align the analysed mutants on the horizontal axis, and on the vertical axis all the intron 
containing transcripts. The corresponding red boxes represent the extent of index accumulation in the mutants compared with the wild-
type. 
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6.5.2 Northern blot of YMM45-57 and YMM45-113 confirmed the 
microarray analysis 
There are two ways the in which intron-containing snoRNAs are produced. One is 
the splicing-dependent pathway that involves the formation of the snoRNA-
containing intron lariat. Following the splicing reaction, the lariat is linearised by a 
debranching enzyme (Prp26p/Dbrl) and it is processed into a mature snoRNA by 
trimming at the ends by nuclear 5'-*3' exonuclease Rati and components of the 
nuclear exosome (3'-*5' exonucleases) (Petfaiski et al., 1998, Ooi et al., 1998). An 
alternative, minor pathway is the splicing-independent one involving the activity of 
some endonucleases like Rntl on the snoRNA-containing pre-mRNA and then the 5' 
and 3' trimming at the ends (Giorgi et al., 2001). 
In order to confirm the results obtained in the microarray experiments, 
Northern Blotting analyses were performed. The filter shown in Figure 6.1 was 
successively hybridized with oligonucleotides complementary to three intron-
containing snoRNA genes, YMR116C (the host gene for U24), EFBJ (the host gene 
snR18) and TEF4 (the host gene for snR38) that constantly accumulate snoRNA 
signals in the prp45 mutants (Figure 6.7, top panel). 
Under non-permissive conditions, GAL:PRP45 and prpl6-2 strains (lanes 13-
17) showed, as for ACT] gene, accumulation of very low amounts of pre-mRNA and 
loss of the mRNA as well as the accumulation of 3'-truncated intermediate A (blots 
la, 2b, 2c, 3a) and of 5'-truncated intermediate B (blot 3a). Primer extension 
analysis in a previous study (Bousquet-Antonelli et al., 2000) identified the nature of 
these species: A extends to the 5 'end of the transcript and is the result of a defective 
5'-3' degradation pathway (Rati exonuclease defect), while B extends to the 3' end 
of the transcript and accumulated in the absence of 3'-*5' exonucleases (exosome 
components). The same work showed data compatible with one presented here, i.e. 
the accumulation of A intermediates is stronger than B-forms (detectable here only in 
case of TEF4) due to a 3'-*5' degradation more active than 5'->3'. 
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Figure 6.8 Analysis of pre-mRNA processing of the snoRNA-intron encoding 
genes YMR116C, EFBJ and TEF4. 
In the upper panel it an intron-encoding snoRNA gene and the truncated 
intermediates A and B generated by nuclear pre-mRNA degradation are 
schematically illustrated. Strains were grown in non-permissive conditions for the 
indicated times and total RNA was prepared as described for Figure 6.1. Ten 
micrograms of RNA was fractionated either on a 2% (v/v) agarose gel (panels 1 a, 1 b, 
2a, 2b, 2c, 3a) or on 6% denaturing polyacrylamide gel (panels ic, 2d and 3b) to 
visualise the low molecular weight RNA species. The gels were hybridised with the 
oligo probes shown in brackets and their annealing position is illustrated in the upper 
panel. The names of the genes followed by the name of the intron-encoded snoRNA 
are on the left. The names and the positions of the RNA species generated by pre-
mRNA splicing or degradation are indicated on the right. 
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In contrast with the ACT] gene, at 37°C the prp45 Ts mutants (Figure 6.7, 
lanes 5-12) had reduced levels of mRNA (panels la, lb. 2a, 2b) and also 
accumulated A-forms of all tested snoRNA containing transcripts even at permissive 
temperatures, especially in the case of prp45-113 which is a tighter Ts mutant. The 
result is in agreement with the microarray data that showed that snoRNA-containing 
species are accumulating in this mutant even at permissive temperature (Figure 6.5. 
upper panel). 
It was also observed that, when probing with primers annealing to exon 2, 423 (blot 
lb) or 484 (blot 2a), the prpl6-2 strain strongly accumulated one species smaller 
than the corresponding pre-mRNA. This also appeared (but not so obvious) for prp45 
mutants at elevated temperatures and after 6 hours of metabolic depletion of Prp45p 
in GAL-regulated strain. This specific band did not appear with hybridization against 
exon 1. The position of the band compared to the molecular markers run alongside 
(High Molecular Weight RNA Marker, Helena Biosciences) suggested that this 
species might correspond to the lariat-intron exon 2 intermediate that normally 
accumulates for step 2 splicing mutants. To validate this finding, and to rule out that 
this was a result of cross-hybridization, the filter was probed by an oligo against 
mature U 1 (panel 2c). 
Alternatively, the RNA samples were run on a 6% polyacrylamide gel that 
separates low molecular weight RNA species and blotted with oligonucleotides 
corresponding to mature U18 (205 - panel 2d) or mature U24 (214 - panel lc). In 
prpl6-2 cells (lane 17), upon probing for U18, there were two slower migrating 
bands besides mature snoRNA, the slowest one corresponding to the lariat intron-
exon 2. Although the size of EFBJ pre-mRNA is 81 nucleotides larger than the 
corresponding lariat intron-exon 2 (987 nt versus 906 nt), the latter one, being 
circular, will be retarded. This migration pattern is common to RNA species 
fractionated on polyacrylamide gels. As for YMR116C, one single band assumed to 
correspond to lariat intron-exon2 (625 nt) accumulates in prpl6-2 mutant. The pre-
mRNA species are longer (1233 nt) and could not be resolved. Indeed, prp45 Ts 
mutants seemed to modestly accumulate lariat intron-exon 2 intermediate at non- 
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permissive temperature (lb. Ic, 2a, 2d - lanes 6-8 and 10-12). This supports the in 
vitro splicing assay results showing that prp45-1 13 mutant (section 6.2) caused a 
mild step 2 splicing defect (Figure 6.3). In addition to this, analysis of Prp45p-
depleted cells showed that, after 6 hours in glucose, EFBJ and YMR116C lariat 
intron-exon 2 intermediates could be detected as a smearing band due perhaps to 
degradation (panels Ic and 2d, lane 14) while EFB1 pre-mRNA was increasingly 
accumulating (blot 2d). 
In all the strains analyzed, the mature snoRNAs formation was little affected 
by the mutant proteins (panels 1c, 2e, 3c). Processing towards a mature U18 or 
snR38 is done by the alternative endonucleolytic cleavage of the intron by Rntl 
endonuclease (Giorgi et al., 2001) or, as for U24 by exonucleolytic activity on the 
debranched intron lariats (Petfalski et a!, 1998; Ooi et al., 1998; Ailmang et al.. 
1999). 
It can be concluded that the prp45 mutants presented the characteristics of splicing 
mutants defective in the second step of splicing. Accumulation of snoRNA-truncated 
intermediates suggested that unspliced pre-mRNA species are present but cannot be 
identified due to the rapid degradation by the 5'-+3' and 3'-*5' nuclear exonucleases 
(Bousquet-Antonelli et al., 2000). 
6.6 Discussion 
In this chapter the effects of prp45 Ts mutants on pre-mRNA splicing and 
transcription were investigated. 
The lack of a strong splicing defect in the prp45 temperature-sensitive strains 
suggests that the growth arrest these cells exhibit at elevated temperature may not 
result directly from a defect in pre-mRNA splicing. It is therefore possible that these 
mutant proteins are involved in other cellular processes, which are disrupted under 
the restrictive conditions. One process is transcription and the Prp45p role as a 
transcriptional co-regulator in other organisms, has long been discussed (Zhang et 
a!, 2001, Leong et al., 2001, Zhou et al., 2002, Barry et al., 2003). However, the 
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reporter gene expression assay employed here did not support such a role, at least for 
the prp45 mutants analyzed here. 
On the other hand, although it was demonstrated that Prp45p is a general 
splicing factor (Albers et al., 2003), it is possible that these mutant proteins are 
involved in the splicing of a subset of transcripts with specific features. To clarify 
this, a microarray analysis was employed and the results confirmed by Northern 
blottings. 
The microarray clustering data for 5'splice site probes and intron probes 
showed similarities between prp45 mutants and other splicing factors in processing 
different transcripts. However, the number of the transcripts affected is smaller than 
for prp8 or prpl6 mutants and further statistical analysis of the data is required in 
order to identify these transcripts. 
A key question is why the truncated forms of snoRNA-containing genes 
accumulated as a result of a splicing defect. This finding is supported by the 
experiments on different splicing mutants like prp45 and prpl6-2 in this chapter, and 
of prp2-1 in the study of Bousquet-Antonelli et al. (2000). The degradation 
intermediates A and B resemble those accumulating for Ratl/Xrnl mutants defective 
5'—*3' exonuclease activity and the exosome mutants defective in 3'—*5' 
exonucleolitic activity, and a question arises: why are this truncated forms are 
accumulating in splicing-defective strains? One answer could be that, by the time 
these splicing factors are entering the spliceosome machinery, the pre-mRNA is 5' 
capped and associated with different splicing factors that hinder the access of 
exonucleases to 5' or 3'ends and, considering that these two events, pre-mRNA 
splicing and nuclear pre-mRNA decay, are in competition (Bousquet-Antonelli et al., 
2000), the exonucleolytic degradation occurs with different rates. 
Given that prp45 mutant strains appear to show a partial second-step splicing 
defect affecting the snoRNA intron-containing transcripts and the ACT] gene in in 
vitro splicing assays, it is possible that Prp45p is involved in regulation at this stage. 
To date, different studies showed that Prp45p is a member of U5 snRNP/Prpl9 joint 
protein complex required for the formation of the active spliceosome and involved in 
both catalytic steps (Makarov et at., 2002, Ohi et at., 2002). Some proteins found in 
this complex are involved in second-step splicing like Prp22p, Slu7p, Prpl 7p and 
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Prp8p (Schwer and Gross, 1998; Umen et al., 1995) but whether or not they directly 
interact with Prp45p is not known. So far, two-hybrid screen analysis (Albers et al., 
2003) has suggested an interaction in vivo between Prp22p and Prp45p, which, given 
the fact that it is uni-directional, it has been assumed to be indirect. Considering this 
result, it is possible that Prp45p could regulate the second step of splicing through an 
interaction with Prp22p. As Prp22p is required for the splicing of transcripts with the 
distance between the branchpoint and the 3'splice site, [BP-3'SS], larger than 21 
nucleotides (Schwer and Gross, 1998), one could assume that this interaction with 
Prp45p might occur only for such transcripts and that this interaction is affected in 
prp45 mutant strains. This is not the case for snoRNA-containing genes (for whom 
the second step splicing defect was observed) whose [BP-3'SS] are variable, from 19 
nucleotides as in YMR116C/snR24 to 35 nucleotides as in EFBJ/snRl8. This is also 
improbable taking into account the fact that Prp45p is required to splice transcripts 
with [BP-3'SS] as small as 7 nucleotides (Albers et al., 2003). All these observations 
could imply that Prp45p might affect the second step of splicing for different 
transcripts through different pathways and further work would be needed to 
demonstrate them. 
Overall, given the abundance of snoRNA-containing species within a cell and 
their stability due to association with many proteins, the use of snoRNA-intron 
encoding probes proved to be an important tool to detect pre-mRNA splicing defects 
in vivo. 
151 
Chapter 7 	Final Discussion and Future Work 
152 
Chapter 7: Final Discussion and Future Work 
7.1 Introduction 
Prp45p was isolated as a main interactor of Prp22p in a two-hybrid screen and 
subsequent analyses showed that it is a bonafide splicing factor required for nuclear 
pre-mRNA splicing both in vivo and in vitro (Albers et al., 2003). Co-
immunoprecipitation experiments found Prp45p associated with the spliceosome 
before the first catalytic step and until the end of the splicing process when it leaves 
with the lariat intron. This study shows that this association occurs before the 
formation of the active spliceosome (complex C) but post complex B formation 
(inactive spliceosome) (Figure 1.3), most probably after Ui and U4 snRNAs have 
already left the spliceosome. Several lines of evidence are supporting this finding. 
Firstly the co-immunoprecipitation of spliceosome snRNA with Prp45p that showed 
its association with U2, U5, and U6 snRNAs, but not with UI and U4 snRNAs 
(Albers et al., 2003). Secondly, the latest analyses demonstrated Prp45p to be a 
member of a large protein complex, Cwc/Ntc/35S complex, identified both in yeast 
and in human (Ohi et al., 2002; Chen et al., 2002; Makarov et al., 2002). These 
complexes were demonstrated to enter the spliceosome just after U  and U4 snRNA 
dissociation and before the first catalytic step. These complexes include other 
proteins like Cefip, Prp46p, Isyip, Syfip, Syf2p, Syf3p that were shown to interact 
with each other in two-hybrid screens and by co-immunoprecipitation analyses 
(Albers et al., 2003; Dix et al.; 1999; Ben-Yehuda et al., 2000). The data presented 
here confirmed the Prp45p-Prp46p interaction found in two-hybrid screens and in 
addition to this, mapped the region of interaction within the N-terminal domain of 
Prp45p. 
In order to get more insights into the function/structure relationship of Prp45p, 
random mutagenesis of PRP45 gene was employed. Contrary to the theory that 
PRP45 could not render temperature-sensitive mutations (Harris et al., 1992), two 
Ts mutants were obtained, prp45-57 and prp45-113, and subjected to further 
analyses. Sequencing analyses revealed that the mutations are mainly located into 
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two discrete regions A and B of the conserved SNW domain and affected 
conserved/semi -conserved amino acid residues. In order to determine the cause of 
the temperature-sensitive phenotype, site-directed mutagenesis was used to re-create 
the amino acid substitutions at the A and B regions of PRP45. The results revealed 
that changing the Prp45p structure by introducing mutations in both specific regions, 
disrupts this protein's ability to function at elevated temperature. The need to alter 
two regions simultaneously while modifications in either region are not sufficient for 
the Ts phenotype, could be explained by the cooperative nature of these regions in 
supporting the function of Prp45p. More specifically, both regions could be parts of 
the same catalytic site/ binding interface for nucleic acids or proteins and mutations 
in both of them determine a conformational modification that abolishes the biological 
function of the protein at elevated temperature. 
prp45 Ts mutants display only a mild step 2 splicing defect in vivo and in vitro at 
non permissive temperature. This does not seem to explain the observed growth 
defect at 37°C, suggesting that the mutations in regions A and B affect the protein's 
function in other cellular processes. There are many reports of Prp45p homologues 
involvement in transcription pathways (Zhang et al., 2003; Zhou et al., 2000). 
However, the gene reporter assay employed here to analyse a possible effect on 
transcription of prp45 did not show that these mutants caused such a defect. 
Further investigations of these mutants included microarray analyses that detected 
accumulation of snoRNA-containing species in both mutants at the non-permissive 
temperature. Moreover, subsequent Northern blottings confirmed the results and 
showed for these specific snoRNA host gene transcripts that they accumulate as 
intron lariat-exon 2 intermediates, a phenotype specific for mutants defective in the 
second step of splicing. 
Following the analyses described here, other investigations will aim to add additional 
clues to the role of Prp45p in splicing, transcription and other cellular processes. 
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7.2 Prp45p role in the second step of splicing 
Although the splicing defect was not very strong in prp45 Ts mutants, it provided a 
first clue of PRP45 involvement in the second step of splicing: results are confirmed 
by analyzing the splicing defect of the snoRNA-containing genes in vivo. The defect 
in vivo should be further examined using a more sensitive method. primer extension 
assay, with primers complementary to exon 2 and intron of the snoRNA-intron 
encoded genes. 
Furthermore, the analyses should be extended to the whole yeast intron-
containing transcripts by using the microarray assay with different primers called 
"branchmers" (Spingola el al., 1999). They prime across the 2'-5' junction of the 
lariat and the cDNAs resulting from the reverse transcription correspond only to the 
lariat intron containing species, i.e. lariat-intron exon 2 intermediate or lariat intron. 
These species would specifically hybridize on the microarray to the intron probes 
and, if it is the case, to the intron contained-snoRNA probes. In this way the 
microarray assay would distinguish between step I mutants and step II! post-step 11 
splicing mutants. Step I mutants accumulate pre-mRNA species in which signals are 
emitted by 5' splice site probes (V), step II mutants (and after) accumulate lariat 
intron—exon 2 and lariat intron species. The method has already been used in our lab 
for a Ts mutant of Prp26p/ Dbrlp which is the lariat debranching enzyme (Chapman 
and Boeke. 1991) (D. Barrass, personal communication). 
The effect of Prp45-113p/Prp45-57p inactivation on the second step of splicing could 
be further examined by determining whether c-Myc-tagged mutant proteins could co-
immunoprecipitate, upon heat inactivation, the splicing intermediates. Previous 
analyses showed that Prp45p co-precipitated the pre-mRNA, the lariat intron-exon 2. 
and exon 1 intermediates as well as the excised intron (Albers el al., 2003). 
Therefore it would be interesting to investigate whether the mutants are unable Co 
precipitate these species, indicating a defect. 
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7.3 Additional interactors of Prp45p 
Subsequent two-hybrid screens performed at Hybrigenics with Prp46p as bait 
identified Prp45p as a main interactor, confirming the previous results of Albers et 
al. (2003), and narrowed down the minimum region of interaction, within Prp45p 
amino acid boundaries 55 and 98, quite distant from regions A (spanning between 
amino acids 120— 130) and B (located within amino acids 190-211). Further in vitro 
analyses performed in this work showed that Prp46p co-precipitated with the two 
Prp45p Ts mutants, indicating that the regions A and B are not involved in this 
interaction. Therefore it is quite likely that other interactors of Prp45p are still 
needed to be identified and this could be done using the two Prp45p Ts mutants in 
genetic screens. 
One possibility is to screen for suppressors by subjecting the mutant strains to 
chemical mutagenesis and look for colonies that lose the Ts phenotype at elevated 
temperature but which confer another phenotype that is independent of the initial one 
(for example, cold-sensitivity). The identity of the suppressors can be established by 
transforming the mutant strains with a library and selecting for the loss of cold-
sensitivity at 16°C. 
Dominant suppressors constitute another option to identify putative interactors. 
Over-expressing a wild-type gene located on a high-copy number plasmid either in 
prp45-113 or prp45-57 strain and looking for the loss of temperature—sensitivity at 
37°C, is an indication that the interaction with a wild-type protein has been restored 
or the need for this interaction has been bypassed. 
Another genetic approach to identify Prp45p interactors is to isolate synthetic 
lethal mutants to prp45 Ts mutations. This technique was used successfully in 
isolating Snt309p in aprpl9 Ts synthetic lethal screen (Chen el al., 1998) and lately 
mutants synthetically lethal with cl/i Ts mutant (Vincent et al., 2003). 
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7.4 Further muta genesis of PRP45 
Alignment of the amino acid sequences of SNW proteins revealed that SNWKN 
motif is not 100% conserved as was considered previously. Indeed the first 
asparagine residue of this motif seemed to be substituted for a methionine in the 
simple parasite E. cuniculi (Figure 1.). In an attempt to determine the functional 
significance of this motif, Martinkova et al., (2003) mutagenized the yeast SNW 
sequence to AAA and found that the modifications did not alter the protein function 
or, as present work demonstrated, mutations only in one domain of Prp45p were not 
incompatible with cell viability. Therefore, additional site-directed mutagenesis on 
yeast Prp45p could be used to make other modifications (substitutions with alanine 
residues) in motifs that are 100% conserved among the members of the SNW family 
(prp45-113 and prp45-57 contain mutations affecting absolutely conserved amino 
acids, KI33E and L208S). 
Solving the Prp45p crystal structure would provide further information about the 
positions where these mutations could be engineered. The crystal could be obtained 
with recombinant Prp45 protein produced in E. coil from an expression vector 
constructed in our lab (M. Albers, PhD Thesis). This crystallisation could give 
information about the secondary and tertiary structure and would also give clues 
about how different mutations might affect the protein conformation. For example it 
could clarify the functional significance of region A and region B within the general 
conformational structure of Prp45p. 
To date this analysis has not been done for any member of the SNW family 
therefore solving the crystal of Prp45p would open new possibilities for the 
investigation of this protein family. 
The random mutagenesis screen identified one Prp45p Ts mutant (P-3) that is an N-
terminal truncated form of the protein retaining the first 47 amino acid residues. To 
investigate the biological importance of the N-terminal domain, a tagged version of 
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this truncated Prp45p could be constructed in BMA38a and analyses similar to the 
one performed for prp45-11 3/prp45-57 could be employed. 
7.5 Prp45p role in transcription 
prp45 mutants studied here did not confer a transcription defect to the cells, at least 
for the -galactosidase transcript which was tested in section 6.3. To extend this 
analysis, the mutants could be used in a microarray assay having PAN Array slides 
provided by MWG which contain all the yeast transcripts, to look for a gene-specific 
effect. 
Prp45p is definitely a very interesting protein with a structure different from its 
orthologs and having at least one function besides pre-mRNA splicing as found for 
its homologues. The presence of SH2 domain, the putative phosphorylation sites and 
interaction with Pkc 1 found in two-hybrid screens make it worthy of further study as 
a potential target for regulation of splicing and/or transcription. 
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Identification and characterization of Prp45p and Prp46p, 
essential pre-mRNA splicing factors 
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ABSTRACT 
Through exhaustive two-hybrid screens using a budding yeast genomic library, and starting with the splicing factor and 
DEAH-box RNA helicase Prp22p as bait, we identified yeast Prp45p and Prp46p. We show that as well as interacting in 
two-hybrid screens, Prp45p and Prp46p interact with each other in vitro. We demonstrate that Prp45p and Prp46p are 
spliceosome associated throughout the splicing process and both are essential for pre-mRNA splicing. Under nonsplicing 
conditions they also associate in coprecipitation assays with low levels of the U2, U5, and U6 snRNAs that may indicate their 
presence in endogenous activated spliceosomes or in a postsplicing snRNP complex. 
Keywords: Protein interaction; snRNP; spliceosome; two-hybrid; yeast 
INTRODUCTION 
The excision of introns from precursor messenger RNAs 
(pre-mRNAs) occurs by two consecutive trans-esterification 
reactions in the spliceosome, a large and highly dynamic, 
ribonucleoprotein complex. In many in vitro studies, spli-
ceosomes have been observed to assemble de novo on each 
substrate pre-mRNA in an ordered stepwise manner. In a 
series of ATP-dependent steps, five small RNAs, the Ui, U2 1  
U4, U5, and U6 snRNAs, in the form of small ribonucleo-
protein particles (snRNPs), plus a variety of non-snRNP 
proteins associate with the pre-mRNA (for review, see 
Burge et al. 1999; Will and Luhrmann 2001). Prior to acti-
vation of the spliceosome and during the splicing process, a 
number of conformational rearrangements take place, in-
cluding critical changes to RNA—RNA interactions (for re-
view, see Nilsen 1998). These rearrangements include dis-
sociation of an extensively base-paired U4/U6 snRNA bet-
erodimer, displacement of a Ul snRNA:5' splice site 
interaction, and a consequent loosening of the associations 
of the UI and U4 snRNPs with the spliceosome immedi-
ately prior to the initiation of the splicing process. Follow- 
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ing the completion of the two splicing reactions, the spli-
ceosome appears to dissociate, at least in vitro. 
The splicing factors have been identified through genetic 
approaches in the budding yeast Saccharotnyces cerevisiae 
(for review, see Beggs 1995), fractionation of HeLa cell 
nuclear extracts and reconstitution of activities (Caceres 
and Kramer 1997), two-hybrid screens (e.g., Fromont-
Racine et al. 1997) or by affinity purification of complexes 
under mild, nondenaturing conditions and identification of 
the protein components by mass spectrometry (Neubauer 
et al. 1997, 1998; Stevens and Abelson 1999). Using the 
latter approach, Stevens et al. (2002) isolated a large penta-
snRNP complex that contains all five spliceosornal snRNAs 
andover 60 protein splicing factors. This complex supports 
pre-mRNA splicing when complemented with soluble fac-
tors, and it was proposed that the spliceosomal snRNPs may 
associate to form a penta-snRNP complex independently of 
the substrate pre-mRNA (for review, see Nilsen 2002). 
In addition to aiding the identification of novel splicing 
factors, two-hybrid screens provide information about in-
teractions between known splicing factors, and can also 
define regions of interaction between two binding partners 
(e.g., Fromont-Racine et al. 1997; Ben-Yehuda et al. 2000). 
Through exhaustive two-hybrid screens using a budding 
yeast genomic library and starting with the DEAH-box RNA 
helicase Prp22p as bait, we identified yeast Prp45p and 
Prp46p. We show that Prp45p and Prp46p interact with 
each other in vitro. We demonstrate that Prp45p and 
Prp46p are spliceosome associated throughout the splicing 
process and both are essential for pre-mRNA splicing. Un- 
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der nonsplicing conditions they associate in coprecipitation 
assays with a low level of U2, U5, and U6 snRNAs that may 
indicate their presence in endogenous activated spliceo-
somes or, more likely, in a postsplicing snRNP complex. 
These data are compatible with the recent detection of these 
proteins in the penta-snRNP complex (Stevens et al. 2002) 
and in another high molecular weight complex that con-
tains a subset of spliceosomal proteins (Ohi et al. 2002). 
RESULTS 
Two-hybrid analysis of Prp45p 
With the aim of identifying novel splicing factors and to 
shed light into the myriad of protein—protein interactions 
within the spliceosome, a number of two-hybrid screens of 
a yeast genomic library (FRYL; Fromont-Racine et al. 1997) 
were performed. Using the full-length Prp22 protein of S. 
cerevisiae as bait, 47 million potential interactions were 
tested, and a total of 20 clones were identified as positive for 
activation of both of the reporter genes used (Table 1). Ten 
isolates encoded five independent fragments of Prp45p 
(ORF YAL032c). All the Prp45p prey fragments share a 
small common region between amino acids 262 and 291 
(Fig. 1A), which therefore corresponds to a minimum re-
gion of interaction although it is not clear that this is suf-
ficient for the interaction. 
A second candidate interactor, Syf3 protein, was isolated 
in the Prp22p two-hybrid screen a total of five times as three 
independent fusions. The C-terminal region, consisting of 
amino acids 628 to 687, corresponds to the minimum re-
gion of Prp22p interaction in Syf3p (Fig. lB). Syf3p (also 
called Clflp) was shown earlier to be involved in spliceo-
some assembly as well as in cell cycle progression from G2 
to M phase (Chung et at. 1999; Russell et al. 2000). 
Full-length Prp45p was used in turn as bait to screen the 
FRYL genomic library, and 34 million potential interactors 
were tested. By far the most statistically significant interac-
tor was the protein Prp46 encoded by ORF YPLI51c (Table 
1); 19 plasniids encoding six independent protein fragments 
were isolated (Fig. 1C). The Prp45p interacting region ap-
pears to be within the amino acid boundaries 127 and 432 
of Prp46p, as deduced from the overlapping region of the 
isolated fragments. This region encodes seven copies of a 
conserved WD repeat motif that is thought to mediate pro-
tein—protein interactions (Smith et al. 1999). None of the 
other prey isolated in this two-hybrid screen corresponds to a 
WD repeat protein. Prp46p is the yeast homolog of the re-
cently identified human splicing factor Pl.RGI and the Schizo-
saccharo:nyces pombe protein prp5, for both of which asso-
ciation with subspliceosomal complexes and their requirement 
for pre-mRNA splicing has been demonstrated (Potashkin 
et al. 1998; McDonald et al. 1999; Ajuh et al. 2000, 2001). 
Intriguingly, the Prp45p bait also found a total of six 
isolates of Syf3p. These represented two independent frag- 
ments of Syf3p that are situated close to the N terminus, 
sharing a common region between amino acids 35 and 156 
(Fig. lB). Notably, this region is different from the Prp22p 
interacting region, which is located at the extreme C termi-
nus of Syf3p. 
In addition, another known splicing factor with a cell 
cycle link, namely the SyfI protein (Russell et al. 2000), was 
found to interact with the Prp45p bait. This interaction is 
statistically less significant, possibly indicating that this in-
teraction is weaker or indirect (Table I). 
In conclusion, these results suggest an association of 
Prp45p with four known or potential splicing factors, al-
though this two-hybrid assay may not distinguish between 
direct and indirect interactions. 
In this iterative approach to identify interacting factors, 
full-length Prp46p was used next as bait in a two-hybrid 
screen, testing 21 million potential interactors. Reassur-
ingly, among the 13 identified positive clones (Table 1), 
Prp45p was the most statistically significant, occurring as 
five distinct fusions. Interestingly, Prp46p interacts with a 
region of Prp45p that is not required for the Prp22p inter-
action (Fig. 1A), indicating that the Prp46p and Prp22p 
interactions with Prp45p are distinct. Furthermore, two dis-
tinct fusions of Syf3p were found as prey with Prp46p (Fig. 
lB). The Prp46p-interacting region in Syf3p overlapped the 
region for interaction with Prp45p. Thus Syf3p may interact 
indirectly with Prp45p and/or Prp46p (or cooperatively 
with both), but the interaction with Prp22p is distinct. The 
fact that in a previous screen with Syf3p as bait (Ben-Ye-
huda et al. 2000; Fig. 1A,C) the prey fusions of Prp45p and 
of Prp46p that were isolated contained almost the full-
length proteins may also reflect indirect or cooperative in-
teractions. The other Al category (and therefore statistically 
significant) prey with Prp46p was Hfmlp/Mer3p, a DEAH-
box protein and putative helicase that is implicated in mei-
otic recombination (Nakagawa and Ogawa 1999). 
Depletion of Prp45p causes a splicing defect in vivo 
The two-hybrid associations of Prp45p with a set of splicing 
proteins led us to ask whether Prp45p is also required for 
pre-mRNA splicing. Because it was reported earlier (Harris 
et al. 1992) that PRP45 (FUN20) is a gene essential for cell 
viability, we constructed strain YMA45/2 with a galactose-
inducible and protein A-tagged chromosomal PRP45 allele. 
Cultures of YMA45/2 and of the parental wild-type strain 
BMA38a were transfered to either permissive (galactose) or 
nonpermissive (glucose) conditions, and growth and pre-
mRNA splicing were monitored. About 8 h after the trans-
fer of the cultures to the nonpermissive conditions, the 
growth rate of YMA45/2 cells started to decline, and growth 
stopped at around 12 h (data not shown), unlike wild-type 
cells and YMA45/2 cells grown under permissive condi-
tions, which continued to grow logarithmically. Northern 
analysis (Fig. 2A) showed that unspliced RP28 RNA acdu- 
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TABLE 1. Interactions identified in the yeast two-hybrid screen? 
Protein ORF Protein length (amino acids) MRf' Isolates' Category" 
Prp22p two-hybrid screen isolates 
Prp45p YAL032c 379 262-291 10 Al 
Syf3p YLR117c 687 628-687 5 Al 
YNL274c 350 33-350 1 A3 
Pmi40p YER003c 460 342-460 1 A4 
Dbp7p YKR024c 742 327-621 2 A4 
Prp45p two-hybrid screen isolates 
YDR141c 1698 580_* 2 Al 
Firip YER032w 925 709-831 4 Al 
YGR198w 817 748-817 3 Al 
Yta7p YGR270w 1379 835-1198 4 Al 
Ubr2p YLR024c 1872 834- 4 Al 
Syf3p YLR1I7c 687 35-156 6 Al 
Vac 141) YLR386w 880 331- 5 Al 
Sgslp YMR19Oc 1447 503-739 2 Al 
Prp46p YPH51c 451 127-432 19 Al 
Cdc27p YBLO84c 758 30-412 2 A2 
YLR424w 708 31_* 1 A2/A3 
YMR031c 843 I_. 1 A2 
Vps75p YNL246w 264 26- 1 A2 
Ahcl p YOR023c 566 1 A2 
Pkclp Y131_105c 1151 301- 1 A3 
Syflp YDR416w 859 442-827 2 A3 
Ade6p YGRO61c 1358 792- 1 A3 
YGR071c 860 301- 1 A3 
Sechp YIL068c 806 100-s 1 A3 
Apllp YJR005w 700 159_* I A3 
YJR061w 935 395_* 1 A3 
Dynlp YKRO54c 4092 690_* 2 A3 
Mms22p YLRJ20w 1454 611_* 2 A3 
Nup188p YMLI03c 1655 1291- 1 A3 
Ecm5p YMRI76w 1411 790_* 1 A3 
Sla2p YNL243w 968 114-* I A3 
Ski3p YPRI89w 1432 463_* 1 A3 
Radlbp YBRII4w 790 59_* 1 A4 
YDLI)Olw 430 362_* I A4 
Nup84p YDLI16w 726 170- I A4 
Ngglp YDR176w 702 508-k I A4 
Trp5p YGL026c 707 61 7-* 1 A4 
Yapl801 YHR161c 637 112_* 1 A4 
YJLIO3c 618 219_* 1 A4 
YILI49w 663 508_* 1 A4 
YLRI87w 1026 167_* 3 A4 
Nis 11) YNL078w 407 270_* 1 A4 
Bnilp YNL271c 1953 1481-1 1 A4 
MnI4p YNRO59w 580 195_* 1 A4 
Niflp YORI56c 726 361- 1 A4 
Eaf3p YPR023c 401 228- 1 A4 
Prp46p two-hybrid screen isolates 
Prp45 YAL032c 379 54-204 5 Al 
Syf3 YLRII7c 687 10-243 2 Al 
HFMI YGL251c 1046 699-880 2 Al 
Pkcl YBLI05c 1151 301-801 1 A3 
YLR426w 202 202 1 A2 
VAF YBR069c 619 290-574 1 A4 
PEP12 YOR036w 288 288 1 A4 
The open reading frames that were identified as prey in two-hybrid screens with full-length Prp22p, Prp45p, and Prp46p bait fusions. Indicated 
are systematic protein and ORF names as given in the Saccharomyces Genome Database. 
'MRI: minimal region of interaction—amino acid boundaries of the region shared by all isolates of a given protein ( C termini of these inserts 
have not been determined). 
'Isolates: total number at prey isolates. 
"Category: Prey fusions were classified as defined by Frornont-Racine et al. 1997). Al (statistically the most significant): multiple coding fusions 
that share a common region; A2: fusion starts close to the translation initiation codon; A3: contains a large coding insert; A4: single coding 
fusion not represented in A2 or A3 category, and possibly the least significant, although this may also indicate that only a precisely defined 
peptide can mediate an interaction. 
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FIGURE 1. Protein—protein interactions involving Prp45p, Svtllp, 
and Prp46p. (A) Prp45p; (B) Svf3p; (C) Prp46p. Numbers represent 
amino acid positions. Vertical lines delineate minimal regions found 
in common in overlapping prey fusions. 
mulated in YMA45/2 cells at 8 h, just as the growth rate 
started to decline, whereas under permissive growth condi-
tions, strain YMA4512 behaved like wild type. Thus cells 
depleted of Prp45p display a clear splicing defect, indicating 
that Prp45p is indeed required for pre-mRNA splicing. 
As Prp45p was identified as a Prp22p-interacting protein, 
the question arises whether it is a general splicing factor, 
required for splicing of all introns, or whether its require-
ment might he dictated by the distance between the branch-
point and the 3' splice site, as reported for the second-step 
splicing factors Prp22p, Slu7p, and Prpl8p. Prp22p, for 
instance, is only required for splicing of introns in which 
the hranchpoint-3' splice site distance is larger than or 
equal to 21 nt (Schwer and Gross 1998). If Prp45p inter-
acted with Prp22p during 3' splice site recognition and 
cleavage, it would not be surprising to see a similar pattern 
of selective Prp45p requirement. 
The RP28 pre-mRNA intron, which was assayed by 
Northern analysis, has a branchpoint-3' splice site distance 
of 39 nt. To test whether Prp45p might be dispensable for 
splicing of introns with very short branchpoint-3' splice site 
distances, splicing of U3 pre-snoRNA was investigated, in 
which the distance between the branchpoint sequence and 
the 3' terminal GAG is only 7 nt. Figure 2B shows the 
results of primer extension analysis of U3 RNA and, as a 
control, of UI snRNA. Already after 6 h growth under 
nonpermissive conditions, there was a strong accumulation 
of the two U3 precursor RNAs in strain YMA45/2, but not 
in the control cultures. Thus Prp45p may be required for 
the splicing of all spliceosomal introns. 
Spliceosomal association of Prp45p 
To determine whether and at what particular stage of the 
splicing process Prp45p interacts with spliceosomes, the as- 
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FIGURE 2. it)t o Pi j , L1 ,i. pii on p 	'\ pIng in vivo. 
(.4) Northern analysis ot splicing. RNA was extracted from aliquots of 
the cultures grown for the indicated times under permissive or non-
permissive conditions. RNA (10 pg) was fractionated on a 1% (w/v) 
formaldehyde gel, blotted to Hybond - N membrane (Amersham). 
probed with a radiolaheled DNA fragment complementary to exon I 
of the RP28 gene, and analyzed by autoradiography. The positions of 
the RP28 pre-mRNA and mRNA are indicated. The blot was stripped 
and reprobed for the intronless PGK gene as a control for loading. (B) 
Primer extension analysis of splicing of U3 precursor RNA. RNA (10 
pg) was used in a primer extension reaction with a radiolaheled oh-
gonucleotide primer complementary to the extreme 5' end of exon 2 
of the U3 snoRNA. As a control, a primer for the intronless UIsnRNA 
was used in the same reaction. The products were resolved on a 6% 
(w/v) polyacrylanlide gel and visualized by autoradiography. The po-
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sociation of protein A-tagged Prp45p (protA:Prp45p) with 
pre-mRNA, intermediates, or products of splicing was 
tested by coprecipitation. Whole-cell extract produced from 
strain YMA45/2 grown under permissive conditions (i.e., 
producing protA:Prp45p) was incubated under splicing 
conditions with radiolabeled actin pre-mRNA. An aliquot 
(10%) of each sample was analyzed for splicing activity 
("splicing"), while the remainder was incubated with IgG-
agarose ("I") or, as controls, agarose beads ("B") or anti-
Prp8p antibodies ("C"). Prp8p is a U5 snRNP protein that 
is associated with the spliceosomes throughout the splicing 
reactions and should therefore precipitate the pre-rnRNA, 
intermediates, and products of the splicing reaction as 
shown previously by Teigelkamp et al. (1995b). To assess 
background precipitation by the protein A epitope, extract 
was prepared from strain BMA38a (pNOPPATAIL) in 
which the protein A epitope alone ("protA") was produced. 
To aid the determination of the particular stage of the splic-
ing process at which Prp45p associates with the spliceo-
some, the precipitations were also performed with extracts 
to which a purified recombinant form of dominant negative 
(dn) Prp2p (c+Prp2Tp)  had been added, which stalls 
splicing prior to the first step (Plumpton et al. 1994). 
Compared with the Prp8p control (Fig. 3, lane 6), 
protA:Prp45p 	protA:Prp45p 	protA 
- 	 + Prp2Tp - 
I 	 I. II 
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FIGURE 3. Coprecipitation of spliceosomes by Prp45p. Whole yeast 
cell extract (splicing extract) was prepared from cells of strain 
YMA45/2 grown in galactose-based medium, producing 
protA:Prp45p. As a control, extract was prepared from the parental 
wild-type strain carrying vector pNOPPATAIL, producing a double 
protein A epitope (protA). Splicing (50 pl. total volume) was per -
formed using 32 P-laheled actin pre-mRNA. The reactions were 
stopped and 3 pL were removed as splicing controls (ulpul). The 
remaining 45-4 samples were mixed with an equal volume of pre-
cipitation buffer containing either lgG-agarose beads (I), agarose 
beads without antibody (B) or protein A-Sepharose beads with pre-
bound anti-Prp8p antibodies (C) and incubated at 4°C for 2 h. Beads 
were washed in buffer containing 150 mM NaCl, deproteinized, and 
the RNAs precipitated. The samples from the immunoprecipitations 
(coIP) as well as from the input samples (5 iL; splicing) were then 
resuspended in formamide loading buffer, resolved on a 6% (wfv) 
polyacrylamide gel, and labeled RNAs were visualized by autoradiog-
raphy. In additional samples, recombinant dominant negative Prp2p 
was added to the extract prior to splicing (+ Prp2 ' p) and the 
samples were treated as above. The positions of the RNA species are 
indicated. (lariat l-E2) Lariat intron-exon2; (LI) Lariat-intron; (El) 
exon I. 
protA:Prp45p efficiently coprecipitated ("coIP"; Fig. 3, lane 
4) the pre-mRNA, the lariat intron-exon 2 (LI-E2), and 
exon I (El) intermediates as well as the excised intron (LI; 
lane 4). As also observed for Prp8p, spliced mRNA was not 
enriched in the protA:Prp45p precipitate, although some 
coprecipitation of mRNA cannot be ruled out, as detection 
of the mRNA was poor. In both negative controls, using 
agarose beads without antibody (Fig. 3, lane 5) and provid-
ing the protein A epitope but no Prp45p (Fig. 3, lane 21), 
only very low levels of pre-mRNA were found in the pre-
cipitate, demonstrating specific precipitation by Prp45p. 
These findings showed that Prp45p is associated with the 
spliceosome throughout the splicing reactions and that it 
stays associated with the spliceosome until after the second 
catalytic step, when it is found associated with the excised 
intron. 
When splicing was stalled due to prior addition of 
Prp2 1 p to the extracts (Fig. 3, lanes 7-9), the Prp45 pro-
tein still precipitated almost equivalent quantities of pre-
mRNA compared to untreated extracts (Fig. 3, lane 10 com-
pared to 4). Therefore, Prp45p is already in the spliceosome 
before Prp2p acts to promote the first transesterification 
reaction. Small amounts of precipitated splicing intermedi-
ates and excised intron from these stalled extracts must be 
the result of a low residual splicing activity in the extracts 
due to the presence of wild-type Prp2p. 
These data demonstrate that Prp45p associates with the 
splicing machinery throughout the splicing process, and 
upon dissociation of the spliced mRNA, Prp45p may seg-
regate with the excised intron. 
Coimmunoprecipitation of spliceosomal snRNAs 
with Prp45p 
To investigate whether Prp45p is snRNA associated, coim-
munoprecipitation of the spliceosomal UI, U2, U4, U5, and 
U6 snRNAs with protA:Prp45p was tested. Splicing extracts 
of strain YMA45/2 producing protA:Prp45p and, as a nega-
tive control, strain BMA38a-pNOPPATAIL were either in-
cubated with IgG-agarose (I), or, as controls, with agarose 
beads (B) or anti-Prp8p antibodies, prebound to protein 
A-Sepharose beads (C). After the immunoprecipitation 
with IgG agarose, the coprecipitated snRNAs were detected 
by Northern analysis. 
As shown in Figure 4, lanes 5 and 8, under normal pre-
cipitation conditions, washing with 150 mM salt, Prp8p 
strongly coprecipitated U4, U5(L and S), and U6 snRNAs, 
as expected for this U5 snRNP protein that is also present in 
U4/U6.U5 tri-snRNPs. Significantly, under these condi-
tions, protA:Prp45p pulled down approximately equal 
amounts of the U2, U5, and U6 snRNAs, but no UI or U4 
snRNAs (Fig. 4, lane 6). Low amounts of Ul and U4 
snRNAs were only detected when the precipitates were 
washed at lower stringency (75 mM salt; Fig. 4, lane 9). This 
suggests that Prp45p associates with U2, U5, and U6 
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FIGURE 4. (oprecip!tation of snRNAs by Prp4Sp. Whole yeast cell 
extract (splicing extract) was prepared from cells of strain YMA45/2 
grown in galactose-based medium, producing protA:Prp4Sp. As a con-
trol, extract was prepared from the parental wild-type strain carrying 
vector pNOPPATAIL, producing a double protein A epitope (protA). 
Extracts (50 p1.) were mixed with an equal volume of precipitation 
buffer containing either lgG-agarose beads (I; lanes 3, 6, 9), agarose 
beads without antibody (B; lanes 4, 7), or protein A-Sepharose beads 
with prebound anti-Prp8p antibodies (C; lanes 5, 8) and incubated at 
4°C for 2 h. The beads were washed in buffer containing 150 mM NaCI 
(or 75 mM where indicated), deproteinized, and the RNAs precipi-
tated. The samples were resuspended in forniamide loading buffer, 
resolved on a 6% (w/v) polyacrylamide gel, clectroblotted to a Hy-
bond-N nylon membrane (Amersham), and probed for Ui, U2, U4, 
U5, and U6snRNAs. Total RNA extracted from 20 1iL of extract is 
shown in lanes I and 2. 
snRNAs under nonsplicing conditions (no ATP was added 
to the extracts), and has a lower level of salt-sensitive in-
teraction with UI and U4 snRNPs. 
Analysis of the Prp46p knockout 
The finding that Prp46p interacted with Prp45p as well as 
with Syf3p in the two-hybrid screens and considering the 
link with splicing for the putative human and fission yeast 
hoinologs, PRLGI and prp5, respectively (Potashkin et al. 
1998; McDonald et al. 1999; Ajuh et al. 2000, 2001), an 
involvement of Prp46p in splicing seemed likely. 
To approach a functional analysis of Prp46p, a gene 
deletion experiment was performed. A diploid strain, 
YMA151KO1, was constructed in which the ORF of one 
allele of PRP46 was entirely replaced by the HIS3 marker 
gene and the PRP461prp46::HIS3 strain was sporulated. 
Among 14 spore tetrads that were dissected, none produced 
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more than two viable spores, all of which were His (data 
not shown), demonstrating that PRP46 encodes an essential 
gene in S. cerevisiae. 
To facilitate further functional characterization of the es-
sential Prp46 protein, strain YMA151/2 was constructed in 
which the chromosomal PRP46 gene was transcribed under 
control of the regulatable MET3 promotor, which is re-
pressed by niethionine. Cultures ofYMAI51/2 and parental 
strain BMA64cs were grown either in the absence (permis-
sive conditions) or in the presence (nonpermissive condi-
tions) of 7 mM methionine. At various time points, RNA 
was extracted and assayed by primer extension analysis for 
splicing of precursor U3 snoRNA (Fig. 5). 
Already after 4 h growth of strain YMA45/2 under non-
permissive conditions, just as the growth rate began to de-
cline compared to the permissive state (Fig. 5A), accumu-
lation of the U3A and U313 precursor RNAs was detectable 
(Fig. 513, lane 2). Thus, repressing PRP46 expression, 
thereby depleting the protein from the cells, leads to a splic-
ing defect that causes the accumulation of unspliced pre-
cursor RNAs. Therefore, we conclude that Prp46p is re-
quired for pre-mRNA splicing in S. cerevisiac. 
Prp45p and Prp46p interact in vitro 
To test whether the two-hybrid interactions between 
Prp45p and Prp46p could he reproduced in vitro, a coupled 
in vitro transcription—translation system was used to pro-
duce 35S-labeled Prp45p or fragments thereof and these 
were incubated with yeast extract containing HA,-tagged 
Prp46p. As shown in Figure 6, HA,:Prp46p coprecipitated 
full-length Prp45p as well as an N-terminal fragment, RI, 
that contains amino acids 1 to 218, but not fragments R2, 
R4, or R46, all of which include the minimum region of 
interaction (amino acids 54-204) determined in the two-
hybrid screen. To investigate the region of Prp46p required 
for this interaction and to determine whether these proteins 
interact directly, 35S-labeled fragments of Prp46p were pro-
duced in vitro and incubated with His-tagged Prp45p that 
had been produced in Escherichia coli and affinity purified. 
As shown in Figure 7, His 6:Prp45p coprecipitated full-
length Prp46p as well as fragments "a" and "b" that lack the 
C-terminal 19 and 24 amino acids, respectively. Neither 
fragments "c" nor "d" was coprecipitated with His,-Prp45p, 
although they contain all seven WD repeats, and "d " cor-
responds to the minimum region of interaction determined 
in the two-hybrid screens. Other fragments "e," "f," "g," 
and "h" that start at the N terminus, are truncated at the C 
end, and contain 6, 5, 3, or no WD repeats also failed to 
coprecipitate with Prp45p (data not shown). 
DISCUSSION 
Prp45-like proteins have been identified and characterized 
in other organisms, including SKIP/SNW I /NCoA-62 in hu- 
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FIGURE 5. Effect of Prp46p depletion on cell growth and pre-niRNA 
splicing. (A) Effect of Prp46p depletion on cell growth. Strains 
YMAI5I/2 and BMA64 (WI') were grown at 30°C in minimal me-
dium lacking methionine (inducing conditions for Prp46p production 
in YMA15I/2) or with 7 mM methionine (repressing condition) as 
indicated. The O.D. 10 was monitored and cultures were diluted at 
intervals to maintain logarithmic growth. The indicated O.D.,, () is 
therefore the calculated theoretical O.D. (B) Effect of Prp46p depletion 
on in vivo splicing. RNA (10 pg)  extracted from aliquots of the cul-
tures shown in A was used as template in a primer extension reaction 
using radiolabeled oligonucleotide primers complementary to the ex-
treme 5' end of CXOfl 2 of the U3 snoRNA and to the (intronless) U I 
snRNA as control. The products were resolved on a 6% (w/v) poly-
acrylamide gel and visualized by autoradiography. The positions of the 
extension products are indicated. (time [h]) Time point of sample. 
(Lanes 1,4,7) YMAI5I/2 minus methionine; (lanes 2,5,8) YMAI5I/2 
plus 7 mM methionine; (lanes 3,6,9) BMA64s plus 7 mM methioninc. 
(Lariat 1-E2) lariat intron-exon2. 
mans (Dahl et al. 1998), Bx42 in Drosophila nwlanogaster 
(Wieland et al. 1992), SnwA in Dictyosteliurn discoiileuui 
(Folk et at. 1996), and Cwfl3p/spSNWl in fission yeast 
(Ambrozkova et al. 2001; Ohi et at. 2002). All these proteins 
share a conserved SNW domain (Baudino et al. 1998) that 
contains a 100% conserved SNWKN motif (Fig. 6A). Ex-
perimental data have shown the involvement of SKIP as 
either an activator or a repressor for a number of different 
transcription pathways (Zhou et al. 2000; Leong et al. 2001; 
Zhang et at. 2001). On the other hand, SKIP has been dem-
onstrated to be a component of human spliceosomes (Neu-
bauer et al. 1998) although, until now, a role for SKIP! 
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Prp46p is a member of the ancient family of WD repeat 
proteins that have diverse functions in a variety of cellular 
processes (Smith et al. 1999). Prp46p shares greatest simi-
larity with a subset of these proteins that are likely to be 
functional homologs. This includes the human protein 
PLRGI, which was demonstrated to be a component of 
human spliceosomes (Neubauer et al. 1998) and essential 
for splicing in HeLa nuclear extract (Ajuh et al. 2001), and 
the S. pombe prp5 protein. Mutation of the prp5 gene results 
in pre-mRNA splicing defects as well as a block to cell cycle 
progression at the G2IM phase (Potashkin et al. 1998; Mc-
Donald et al. 1999). The related Arabidopsis thaliana PRLI 
protein regulates glucose and hormone responses (Nemeth 
et al. 1998). All these proteins contain a C-terminally lo-
cated cluster of seven WD repeat units that are thought to 
cJ ate protein—protein interactions. 
he interactions described here of Prp22p with Prp45p, 
it 1i-p45p with Prp46p, and of both Prp45p and Prp46p 
with Syf3p in two-hybrid screens also suggested possible 
roles for budding yeast Prp45p and Prp46p in the splicing 
process, and we demonstrate that metabolic depletion of 
either Prp45p or Prp46p results in a splicing defect (Figs. 2 
and 5). Compatible with a role as a splicing factor, 
protA:Prp45p and HA-tagged Prp46p coprecipitated low 
levels of U2, U5, and U6 snRNAs (Fig. 4; data not shown); 
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FIGURE 6. Prp4Sp coprccipitates with Prp46p in vitro. (A) 'S-me-
thionine-labeled full-length Prp4Sp or fragments of the regions indi-
cated were produced in vitro. (B) The in vitro-produced polypeptides 
were incubated with ATP-depleted yeast splicing extract containing 
HA,-tagged Prp46p and with anti-HA antibodies on ice for I h before 
adding protein A-Sepharose beads. The pellets and supernates (1.6%) 
were analyzed by SDS-PAGE and the 35S-labeled Prp45 polypcptides 
were visualized by autoradiography. 
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FIGURE 7. Prp46p coprecipitates with Prp15p iii itru. -I 
thionine-labeled full-length Prp46p or fragments of the regions indi-
cated were produced in vitro. (B) His-Prp45p affinity purified from 
E. co/i extract was incubated with the in vitro produced Prp46 poly -
peptides on ice for 1 h before adding antipentahistine antibodies 
bound to protein A-Sepharose heads, or beads alone as a control. The 
pellets and supernates (1.6%) were analyzed by SE)S-PAGE and the 
35S_ labeled Prp45 polypeptides were visualized by autoradiography. 
however, the amounts of these coprecipitated snRNAs were 
significantly lower than the levels of U4, U5, and U6 
snRNAs coprecipitated with Prp8p, a component of U5 
snRNPs and U4/U6.U5 tri-snRNPs. Because protA:Prp45p 
could be efficiently precipitated by IgG-agarose (confirmed 
by Western analysis; data not shown), and strongly copre-
cipitated spliceosomes, these data suggest that only a por-
tion of the total pool of Prp45p or Prp46p was associated 
with the snRNAs under these conditions. 
A number of proteins including Cefip, Isylp, Syflp, 
Syf2p, and Syf3p have now been shown to interact with each 
other and with Prp45p and Prp46p in two-hybrid screens 
and coprecipitation assays (Dix et al. 1999; Ben-Yehuda et 
al. 2000; this work) and have been detected together with 
Prp45p and Prp46p in large protein complexes, including 
the Ceflp-associated "Cwc" complex (Ohi et al. 2002) and 
a peiita-snRNP complex that may represent a form of re-
cycled spliceosome (Stevens et al. 2002). In a high-through-
put mass-spectrometric analysis (Gavin et al. 2002), Prp45p 
and Prp46p were detected in multiple complexes that con-
tained overlapping subsets of these and other proteins; 
however, both proteins were rarely present in the same 
complex, and the functional significance of these different 
complexes is unclear. 
It was previously reported that Isyip, Syfip, Svf2p, and 
Syf3p associate with low levels of U5 and U6 snRNAs, and 
under some conditions also with U2 snRNA (Dix et al. 
1999; Russell et al. 2000), and it was proposed that this  
might indicate an association with a postsplicing complex 
(Dix et al. 1999). The salt-sensitive association of Prp45p 
with lower levels of Ui and U4 snRNAs supports this hy-
pothesis, as following activation of the spliceosome, these 
two snRNAs are less strongly associated with this complex. 
Like Prp8p, Prp45p coprecipitated the excised intron lariat 
(Fig. 3). Thus, these data may indicate the presence of 
Prp45p and Prp46p in a postsplicing complex that contains 
the excised intron and the U2, U5, and U6 snRNPs, al-
though the coexistence of all these factors in a single com-
plex is not demonstrated here. Interestingly, the Cell p-as-
.cociated "Cwc" complex that includes Prp45p and Prp46p 
also contains U2, U5, and U6 snRNAs, which was reported 
to indicate spliceosome association (Ohl et al. 2002). 
significantly, Prp45p and Prp46p found each other as the 
'edominant binding partners in two-hybrid screens, and 
Koth found Syf3p as a highly significant interactor (Al cat-
egory; Fromont-Racine et al. 1997). We have shown that in 
addition to their interaction in two-hybrid screens, Prp45p 
and Prp46p interact in vitro, most likely through direct 
protein—protein contact. In addition, the use of truncated 
forms of these proteins produced in vitro confirmed the 
approximate region of the proteins required for the inter -
action. In each case, however, the interaction required more 
of the in vitro produced proteins towards the N termini 
compared to the minimum regions found in the two-hybrid 
screens. As the two-hybrid prey are fusion proteins, fused at 
their N-terminal ends, this might simply reflect a require-
ment for additional sequence at the N termini of these 
proteins to promote correct folding and/or stability. 
Ajub et al. (2001) demonstrated that PLRGI interacts 
with CDC5L, the human homolog of S. cerevisine Ceflp (Xu 
et al. 1996). The interaction of PLRGI with CDC5L was 
localized to the WD40 domain of PLRG1, the same region 
that in the yeast Prp46p interacts with Prp45p. Similarly, 
Cefip has been shown to interact with the WD repeat re-
gion of Prp46p in budding yeast (Ohi and Gould 2002). 
Thus, Prp46p might act as a platform for protein—protein 
interactions at different stages in the splicing reaction, ex-
plaining why it has been found in several complexes. 
Cefip was not found as a binding partner in our two-
hybrid screens with l'rp45p or Prp46p, although it was 
identified in two-hybrid screens with Isylp, Svflp, Syf2p, 
Syf3p, and Ntc20p, which form a network of two-hybrid 
interactions that is compatible with the existence of a com-
plex (Ben-Yehuda et al. 2000). The results presented here 
extend this network of interactions to include Prp45p, 
Prp46p, and Prp22p. Indeed, these correspond to a subset 
of the Cwc complex of proteins (McDonald et al. 1999; Ohi 
and Gould 2002; Ohi et al. 2002) and some of these proteins 
were identified as components of a Prpl9p-associated (Ntc) 
complex (Chen et al. 2002). 
The presence of Prp45p and Prp46p in a salt-sensitive 
penta-snRNP complex (Stevens et al. 2002) could explain 
the salt-sensitive snRNA associations observed here. Curi- 
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ously, Prp22p was not present in the penta-snRNP complex, 
although it was detected by mass spectrometry as a potential 
Cwc component (Ohi et al. 2002). Thus the two-hybrid 
interactions that we detected between Prp22p as bait and 
Prp45p and Syf3p may represent transient interactions of 
Prp22p with these proteins in the spliceosome. 
Analysis of the splicing of two different introns in cells 
that had been metabolically depleted of Prp45p indicated 
that, unlike Prp22p, Prp45p may be required for splicing 
irrespective of the different brarichpoint-3' splice site dis-
tances of the introns. This result argues against a possible 
role for Prp45p in directly modulating Prp22p function in 
3' splice site selection and cleavage, as in that case, one 
would expect to see a similar selective requirement for 
Prp45p only for splicing of introns with short branchpoint-
3' splice site distances. However, recent experiments using 
an intron-specific microarray to obtain an overview of the 
splicing of all pre-mRNAs in S. cerevisiac indicated that 
analyzing the effects of a mutant splicing factor on a few 
selected pre-mRNAs can be misleading (Clark et al. 2002). 
Prpl8p, previously reported to be dispensable for splicing 
introns with branchpoint-3' splice site distances of 17 nt or 
more in vitro, showed no such correlation when the whole 
genorne was analyzed in vivo. It remains a possibility that 
Prp45p could act as a general second-step splicing factor in 
close proximity or even in contact with Prp22p at a stage 
late in the splicing process. Indeed it is conceivable that 
Prp45p might activate Prp22p in its reported function of 
releasing the spliced mRNA from the spliceosome (Com-
pany et al. 1991), leaving Prp45p with the residual intron-
containing postsplicing complex. 
Although the Al category prey (those that are found as 
multiple fusions) in a two-hybrid screen are considered to 
he statistically more significant than others (Fromont-
Racine et al. 1997), prey that occur as single fusions may 
also be functionally significant and may not arise as mul-
tiple fusions if the N terminus of the protein is essential for 
the interaction (A2 category), if most of the open reading 
frame is required (A3 category), or if the interaction only 
works with a specific fragment of the protein, no more and 
no less (A4 category). When multiple two-hybrid screens 
are performed, such single prey fusions become more sta-
tistically significant if they are found in several screens with 
functionally related proteins as bait (but not as nonspecific 
prey with unrelated bait proteins). This is the case with the 
budding yeast protein kinase Pkclp, which was found as an 
interactor with Prp45p (A3) and Prp46p (A3), as well as 
with Ceflp (Al) and Syf2p (A4), as bait proteins (Ben-
Yehuda et al. 2000; Table I). Pkclp has serine/threonine 
protein kinase activity, is required for signal transduction 
function in response to cell stress, and, like several of the 
splicing factors in this interaction network, is required to 
promote progression through the cell cycle from G2 to mi-
tosis (Levin et al. 1992). Interestingly, the A. thaliana ho-
molog of Prp46p, PRLI, acts as a heterologous receptor in  
vitro specifically for the protein kinase C-13  II isoform (Ne-
meth et al. 1998). The yeast Prp46p and Prp45p sequences 
contain 14 or 7 potential Pkc-phosphorylation sites, respec-
tively, as determined in a ScanProsite search, and when 
Neubauer et al. (1998) identified SKIP protein in assembled 
human splicing complexes, the protein separated into three 
distinct spots after two-dimensional gel electrophoresis, 
suggesting that SKIP might be subject to phosphorylation 
or other posttranslational modifications. It will therefore be 
interesting to determine whether the yeast Pkclp interac-
tions with spliceosorne components represents a potential 
mechanism for regulating splicing through protein phos-
phorylation, with Prp46p and Prp45p being potential tar-
gets, or whether Prp46p simply acts as a facilitator for pro-
tein-protein interactions. 
MATERIALS AND METHODS 
Yeast growth media 
Yeast minimal medium (YMM): 0.67 1,N) (wlv) Yeast nitrogen base 
without amino acids, 2% (w/v) glucose was supplemented with all 
amino acids except as indicated for auxotrophic selection. 
YMGRS: 0.67% (w/v) Yeast nitrogen base without amino acids, 
2% (w/v) galactose, 2% (w/v) raffinose, 2%  (w/v) sucrose was used 
for induction of the GAL] promoter. YPDA: 1% (w/v) Yeast ex-
tract, 2% (w/v) Bacto-peptone, 2% (w/v) glucose, 0.003% (wlv) 
adenine sulfate. 
Strains 
Yeast strains used in this work (diploid markers are homozygous 
unless indicated otherwise): BMA38 (MATa/cs, his3200, leu2-
3,112, ura3-1, trplM, ade2-1, can]-100), BMA38a (MATa, 
his3200, leu2-3,112, ura3-1, trp11, ade2-1, canl-100), BMA64(x 
(MATu, his3-11,15, leu2-3,112, ura3-1, trp11, ade2-1) and the 
Clontech strains CG1945, L40, and Y187 for two-hybrid screens. 
Strain YMA45/1 (MATaIcs, his3200, lcu2-3,112, ura3-1, trplzXl, 
adc2- 1, can 1-100, PRP451HIS3-PCA LI  -ProlA:PRP45) was made 
from BMA38 by integration of a linear DNA cassette encoding the 
HIS3 gene, GAL] proniotor, and two lgG binding sites of the 
Staphylococcus aureus protein A directly upstream of the PRP45 
open reading frame. The cassette was generated by PCR from 
plasmid pTL27 (Lafontaine and Tollervey 1996) using oligo-
nucleotides PFUN-1 and PFUN-2. Correct integration of the cas-
sette was checked by PCR and inducible production of protein 
A-tagged Prp45p was monitored by Western blotting. Sporulation 
of YMA45/1 and subsequent selection for histidine prototrophic 
spores produced YMA45/2 (MATa, his3.\200, leu2-3,112, ura3-1, 
trp1 1, ade2- 1, can]-100, HIS3P( ;ALJ  -ProtA:PRP45). BMA38a 
carrying pNOPPATAIL (gift from E. Hurt, Biochemie-Zentrum 
Heidelberg (BZH), Heidelberg, Germany), which encodes the 
double protein A epitope, was used as a control. 
Strain YMAI5IKOI (MA Ta/cs, his3200, leu2-3,112, ura3-1, 
tip I 1, ade2- 1, can 1-100, PRP461prp46::HIS3) was constructed 
from BMA38 by complete replacement of the PRP46 open reading 
frame with a H!S3 cassette generated using oligonucleotides 
PLKO-1 and PLKO-2 as described in Baudin et al. (1993). 
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Strain YMAI5I/2 (MATi, his3-11,15, Ieu2-3,112, ura3-1, 
trplM, ade2-1, TRP1-PM , l .3-HA,PRP46) was generated from 
BMA64a by targeted integration of a linear cassette containing the 
TRPI gene. the MET3-promoter and a double HA-epitope directly 
upstream of the PRP46 coding sequence. The cassette was pro-
duced by PCR from plasmid pUCI9-HA55 (van Nues and Beggs 
2001) with oligonucleotides I5lMetA and 151MetB. 
Oligonucleotides 




Fund: 5' -TATGAATTCATGTTTAGTAACAGAC-3' 





151 MetA: 5' -CCACACAAATCCACGATGACCTAAGAACATTC 
GTTCGCTTAAATCCTTAAATAAATACTACTC-3' 
151 MetB: 5 '-TGTCTACATCTCCTAAAmTCGACTTTGTGAT 
CATTTCCGTCCATACGAGCTCCAGCGTAATCTGGAA-3' 
151 -PR2: 5'-GTATAAAGCCGAAGTCC-3' 
YPLI 51A: 5'-AAGGATCCTAGTGAGAATGGACGG-3' 
YPL15IB: 5'-AAGGATCCTTCCATCTACTCCCAC-3' 
Met3: 3'-TTFAGCTTGTGATCTC-3' 
PGK 5' -ACCGTITGGTCTA(:CCAAGTGAGAAGCCAAGACA-3' 
RP28A: 5' -TCGTACTGATGCTCCATTC-3' 
RP28B: 5'-TGAAACCCTTAGATCTTC-3' 
anti-UI: 5'-CACGCCTTCCGCGCCGT-3' 
anti-U2: 5'-CTACACYTGATCTAAGCCAAAAG- 3 




To make the Gal4:Prp22p two-hybrid bait construct, plasmid 
pBSKS22 (gift from B. Schwer, Cornell University, NY) was di-
gested with Kpnl and blunt-ended by T4 polyrnerase treatment. 
After Ndel cleavage, the PRP22-containing fragment was ligated 
into Ndcl/Smal-digested pAS2 (Frornont-Racine et al. 1997). 
To construct the LexA:Prp45p two-hybrid bait plasmid, the PRP45 
ORE was PCR-ainpliuied from yeast genomic DNA using oligo-
nucleotides Fund I and Func2. The PCR product was cleaved with 
EcoRl, Sail and ligated in frame into EcoRI/SalI-digested 
pBTMI 16 (Vojtek et al. 1993(. 
The LexA:PRP46 two-hybrid bait plasmid was constructed by 
PCR amplification of the YPL151c ORE using oligonuckotides 
YPLI5IA and YPI.151B as primers and cloning into BaniHl-
cleaved pBTMI 16, in frame with the preceding LEXA sequence. 
All constructs were verified by DNA sequencing, and protein 
expression was tested by Western analysis using anti-Ga14-DNA 
binding domain antibodies (Santa Cruz Biotechnology) and/or 
by complementation of a yeast strain bearing a mutation in 
the corresponding genomic sequence. To make pETMA45 (for 
His f,:Prp45p production in E. coli), the PRP45 ORF was isolated 
from pMA45 as an EcoRI-Sall fragment, pET 19h was digested with 
NdeI, and both were treated with Klenow and ligated together. 
Two-hybrid screens 
Two-hybrid screens were performed as described in Fromont-
Racine et al. (1997). In the Prp22p screen, positives were selected 
for growth on YMM-LWH agar and tested for 3-galactosidase 
activity in an X-gal agar overlay assay (Fromont-Racine et al. 
1997). In addition, relative strength of reporter gene activation was 
determined in a 3-galactosidase filterlift assay (Transy and Legrain 
1995). In the Prp45p two-hybrid screen, positives were selected 
first on YMM-LWH agar plates, then suspended in microtiter-
plates and replicated onto YMM-LWH agar containing 20 mM 
3-aminotriazole OAT; which increases the stringency of the His+ 
selection). One hundred fifteen clones that grew on 20 mM 3AT 
were analyzed further. The Prp46p screen was as for Prp45p but 
using 10 mM 3AT, and 34 clones were obtained. 
Monitoring yeast cell growth 
Cultures were grown to mid-log phase under permissive condi-
tions (galactose-based medium or medium lacking methionine), 
then used to inoculate media providing either permissive or re-
pressing (glucose or presence of methionine) conditions to an 
O.D.6( ,() of 0.05-0.1 and grown at 30°C. Maintenance of logarith-
mic growth was ensured by diluting the cultures with prewarmed 
medium to keep the O.D. 60() readings below 0.8. 
Primer extension assay 
Yeast total RNA was prepared using the method of Schmitt et al. 
(1990). Oligonucleotide primers were labeled with T4 polynucleo-
tide kinase, and primer extension was performed and the products 
analyzed on a 6% (w/v) polyacrylamide gel as described (Beltrame 
and Tollervey 1992). 
Splicing extract preparation and 
in vitro splicing reactions 
Preparation of yeast whole-cell extracts and in vitro splicing reac-
tions were performed as described (Lin et a). 1985). Plasmid p283, 
which contains an Aiul fragment of the yeast actin gene, was 
transcribed in vitro with T7 RNA polymerase and la-32PILJTP to 
produce uniformly labeled splicing substrate (O'Keefe et al. 1996). 
Splicing reactions (5 p1 for splicing activity or 50 .iL for immu-
noprecipitation) were incubated at 23°C for 20 mm, and the re-
action products were fractionated on a 6% (w/v) polyacrylamide-8 
M urea gel and visualized by autoradiography. 
Western blot analysis 
Proteins were fractionated by SDS- PAGE and detected using per -
oxidase-anti- peroxidase (PAP; Sigma) and ECL (Amersham) ac-
cording to the manufacturer's instructions. 
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Immunoprecipitations 
Immunoprecipitations of snRNPs and spliceosomes were per-
formed as described (Teigelkamp et al. 1995a), using IgG-agarose 
(Sigma) or anti-Prp8 polyclonal antibodies (anti-8.6), and washes 
containing 150 mM NaCl (or, when indicated, 75 mM NaC1). 
Northern analysis of snRNAs 
Immunoprecipitates obtained using lgG-agarose (Sigma) or anti-
Prp8 polyclonal antibodies (anti-8.6; Teigelkamp et al. 1995a) 
were washed, deproteinized by SDS/proteinase K treatment fol-
lowed by phenol:chloroform:isoamylalcohol extraction, and the 
RNA was fractionated on a 6% polyacrylamide gel. The snRNAs 
were detected by Northern analysis using end-labeled oligonucleo-
tides complementary to the Ui, U2, U4, U5, or U6 snRNAs (Coo-
per et al. 1995). 
Protein production in bacteria 
Proteins were produced in E. coli 131,2 I (DE3 )pLysS cells grown at 
23-30°C to an of 0.3-0.8 (optimal conditions determined 
for each protein). IPTG was added to 0.5-1 mM and cultures were 
incubated for 1-3 h to induce expression. Cell pellets were resus-
pended in chilled lysis buffer A (50 mM Tris-HCI at pH 7.5, 250 
mM NaCl, 10% [w/v] sucrose) containing Sigma P8749 protease 
inhibitor cocktail, lysozyme was added to 0.2 mg/mL, and the 
extract was stirred on ice for 45 mm. After addition of Triton-X-
100 to 0.1% [v/v) and stirring on ice for 5 mm, the lysate was 
centrifuged at 17,000 rpm at 4°C for 45 min and the supernate was 
stored at -70°C until metal affinity purification of the His-tagged 
proteins with Ni-NTA agarose (Qiagen). 
In vitro synthesis of "S-labeled proteins 
PCR-generated templates were used in an in vitro transcription/ 
translation system (Promega TNT T7 Quick for PCR) according to 
the manufacturer's instructions, using 0.37 MBq 5S-methionine 
(Amersham) for labeling. 
Coimmunoprecipitation of proteins 
TNT reaction (6 aL) was mixed with 40 pL His-tagged Prp45 
protein or BCIOO (controls; 20 mM Tris-HCI at pH 7.9, 100 mM 
KCI, 20% [v/v] glycerol) and incubated at room temperature for 
10 min followed by 1 hon ice. Anti pentahistidine antibodies (Qia-
gen) bound to protein A-Sepharose beads were added, or beads 
alone as a control, and samples incubated at 4°C for 2 h with 
mixing. Supernates were removed and beads were washed three 
times with IP 3 (6 mM HEPES, 300 mM NaCI, 2.5 mM MgCl,, 
0.05% [vfvJ Nonidet P40) and suspended in 25 aL 2x SDS buffer 
(125 mM Tris at pH6.8, 4% SDS, 200 mM DTT, 40% glycerol, 
0.02% bromophenol blue). Samples were heated to 70°C and ana-
lyzed by SDS-PAGE (Nu-PAGE 4-12% Bis-Tris in MOPS buffer). 
Gels were dried before autoradiography. 
For immunoprecipitation experiments using yeast extract, 25 1iL 
of HA,-tagged PRP46 splicing extract was depleted of ATP by 
adding 2 mM glucose and incubating at 24°C for 20 mm. 3 S-
labeled PRP45 polypeptides (5 pL TNT reaction) and 4 pL of 
anti-HA antibodies (12CA5, Roche) were added and the NaCl 
adjusted to 150 mM with lP 31 ,. The mixture was incubated on ice 
for 1 h before adding protein A-Sepharose beads. The samples 
were rotated at 4°C for 2 h, then washed three times with ice-cold 
IP 150 (as lP 00 but 150 mM NaCI). The pellets and supernates 
(1.6%) were suspended in lx SDS-loading buffer and analyzed by 
SDS-PAGE as above. 
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